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Summary
A clinician making a diagnosis based on medical images looks for several
different types of indications. These could be changes in the shape of
a particular structure, changes in image intensity within that structure
compared to normal tissue and the appearance of features such as le-
sions which are normally not seen. A full diagnosis may be based upon
information from several different imaging modalities, which can be cor-
relative or additive in terms of their information content. The work
presented in this thesis is situated in the nuclear medicine field. In our
research we mainly focus on Positron Emission Tomography (PET).
PET has proven a very valuable imaging tool to explore a variety of
cellular and molecular processes in-vivo. Because of its high sensitivity,
only very low amounts of a PET tracer (a compound labeled with a
positron-emitting radionuclide) need to be administered and therefore
pharmacological effects and physiological changes are avoided. Once
the tracer is injected in the patient and the radiation is detected by the
PET scanner, an analytical/iterative algorithm is applied to reconstruct
the tracer distribution. This way, PET can provide high contrast and
quantitative functional information about the disease state or therapy re-
sponse, complementary to information provided by anatomical imaging
modalities such as computer tomography (CT) or magnetic resonance
imaging (MRI).
The diagnostic value of a PET image depends crucially on the image
quality, for example, the spatial resolution, signal-to-noise ratio (SNR)
and quantitative accuracy. In oncology, these factors determine whether
xthe physician can detect the tumors (and/or metastases), accurately
identify their locations and distinguish them from ordinary inflamma-
tions. The image quality in turn is largely determined by the PET
system design, PET detector response and is highly impacted by the
reconstruction algorithm.
The state-of-the-art of clinical PET scanners has led to a system res-
olution, that approximates the fundamental limitations of PET imag-
ing. The two main fundamental limitations of resolution in PET are the
positron range and the non-collinearity. A positron travels some dis-
tance in tissue before it captures an electron and subsequently decays
into a pair of 511 keV annihilation photons. Because the position where
the annihilation photons are created is different from the position of the
parent PET isotope, blurring of the PET signal occurs with a magnitude
that is dependent on the energy of the emitted positron and the electron
density of the surrounding tissue. While the positron range is inherent
to PET imaging and can be considered isotropic within homogeneous
tissue, the presence of a strong magnetic field will cause the positron
to travel in a helical path, therefore reducing the positron range in the
plane transverse to the magnetic field but extending it in the direction
along the main magnetic field.
Fully integrated PET/MR systems, combine functional (PET) and
anatomical (MR) imaging techniques. These systems are frequently be-
ing used in clinical research and routine. The acquisitions are generally
done with 18F which is clinically the most relevant PET isotope. How-
ever, other PET isotopes, such as 68Ga and 90Y, are gaining clinical
importance as they are of specific interest for oncological applications
and follow-up of 90Y-based radionuclide therapy. These isotopes have a
complex decay scheme with a variety of prompt gammas in coincidence.
They have a higher positron energy and, because of the larger positron
range, there may be interference with the magnetic field of the MR
compared to 18F. Therefore, it is relevant to determine the performance
of PET/MR for these clinically relevant and commercially available ra-
dioisotopes.
In this PhD dissertation, we propose to derive the impact of using
different PET isotopes for the National Electrical Manufacturers Associ-
ation (NEMA) tests performance evaluation of the GE Signa integrated
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PET/MR. The methods were divided into three closely related cate-
gories: NEMA performance measurements, system modelling and evalu-
ation of the image quality of the state-of-the-art of clinical PET scanners.
NEMA performance measurements for characterizing spatial resolution,
sensitivity, image quality, the accuracy of attenuation and scatter cor-
rections (IQ), and noise equivalent count rate (NECR) were performed
using clinically relevant and commercially available radioisotopes. Then
we modelled the GE Signa integrated PET/MR system using a realistic
GATE Monte Carlo simulation and validated it with the result of the
NEMA measurements (sensitivity and NECR). Monte Carlo simulations
were implemented in GATE and run in the high-performance computer
Vlaams Supercomputer Centrum installed at Ghent University. The sim-
ulated system has an axial and transaxial field-of-view of 25 cm and 60
cm respectively, uses a LYSO scintillator with crystal elements of 25 x
4.0 x 5.3 mm3, an energy window of 425-650 keV and a coincidence win-
dow of 4.57 (±2.29 ns). The geometry was modelled using the cylindrical
PET system in GATE, considering foam, plastic and copper shielding
between the field of view and the detectors. To characterize the effect of
the 3 T MR field on the positron range, we simulated point sources of
positron-emitting radionuclides including 18F, 11C, 15O, 13N, 82Rb and
68Ga positioned in the middle of a homogeneous 20 x 20 x 20 cm3 cube
with different tissue media (soft-tissue, lung-tissue and bone).
For the evaluation of the image quality of the state-of-the-art of
clinical PET scanners, we proposed a noise reduction study using a
Bayesian Penalized-Likelihood reconstruction algorithm on a time-of-
flight PET/CT scanner. The performance and clinical use of a block
sequential regularized expectation maximization (BSREM) penalized-
likelihood reconstruction algorithm were compared to the ordered-subset
expectation maximization (OSEM) with full modelling of PSF and TOF
information for both algorithms. The NEMA IQ phantom and a whole-
body patient study were acquired on a new GE Discovery MI PET/CT
3-rings system (axial FOV of 15 cm) in list mode and different datasets
with varying noise levels were generated. Phantom data were evaluated
using four different contrast ratios (8:1, 6:1, 4:1 and 2:1). These were
reconstructed using BSREM with different β-factors of 300–3000 and
with a clinical setting used for OSEM including point spread function
xii
(PSF) and time-of-flight (TOF) information. Both phantom and patient
data were analyzed with regards to contrast recovery (CR), background
coefficient of variance (COV), contrast-to-noise ratio (CNR), SUV ra-
tio, metabolic active tumour volumes (MATVs) and signal-to-noise ratio
(SNR). This study aimed to evaluate different β-factors compared to a
clinical post-filter kernel for different datasets with varying noise levels
to investigate whether and to what extent noise can be reduced by using
BSREM instead of OSEM.
The outcome of this thesis will allow clinicians to reduce the PET
dose which is especially relevant for young patients. Besides, the Monte
Carlo simulation platform for PET/MR developed for this thesis will al-
low physicists and engineers to better understand and design integrated
PET/MR systems. For some remaining issues, suggestions for future
research will be presented in the final chapter.
Samenvatting
Een arts die op basis van medische beelden een diagnose stelt, zoekt
steeds naar een aantal verschillende soorten indicaties. Dit kunnen ve-
randeringen in de vorm van een bepaalde structuur zijn, veranderingen
in de beeldintensiteit binnen die structuur in vergelijking met normaal
weefsel en het verschijnen van kenmerken zoals laesies die normaal niet
worden gezien. Een volledige diagnose kan gebaseerd zijn op informatie
uit verschillende beeldvormingsmodaliteiten, die correlatief of additief
kunnen zijn in termen van hun informatie-inhoud. Het werk in dit
proefschrift situeert zich op het gebied van nucleaire geneeskunde. In
ons onderzoek richten we ons vooral op Positron Emission Tomography
(PET).
PET heeft zich bewezen als een zeer waardevol beeldvormingsin-
strument voor het verkennen van verschillende cellulaire en moleculaire
processen in vivo. Vanwege de hoge gevoeligheid moeten slechts zeer
kleine hoeveelheden van een PET-tracer (een verbinding gelabeld met
een positron-emitterend radionuclide) worden toegediend waardoor far-
macologische effecten en fysiologische veranderingen vermeden worden.
Nadat de patiënt is geïnjecteerd met de tracer en de straling is gede-
tecteerd door de PET-scanner, wordt een analytisch/iteratief algoritme
toegepast om de tracerverdeling te reconstrueren. Op deze manier kan
PET zowel hoog contrast en kwantitatieve functionele informatie bieden
over de ziektetoestand of therapierespons, aanvullend op informatie die
wordt bekomen via anatomische beeldvormende modaliteiten zoals com-
putertomografie (CT) of magnetische resonantiebeeldvorming (MRI).
xiv
De diagnostische waarde van een PET-beeld hangt cruciaal af van de
beeldkwaliteit, dewelke o.a. bepaald wordt door de ruimtelijke resolutie,
signaal-ruisverhouding (SNR) en kwantitatieve nauwkeurigheid. In de
oncologie bepalen deze factoren of de arts in staat is om de tumoren
(en/of metastase) te detecteren, hun locaties nauwkeurig te identifi-
ceren en ze te onderscheiden van gewone ontstekingen. De beeldkwaliteit
wordt op zijn beurt grotendeels bepaald door het ontwerp van het PET-
systeem, de respons van de PET-detector en wordt sterk beïnvloed door
het reconstructie-algoritme.
De state-of-the-art van klinische PET-scanners heeft geleid tot een
systeemresolutie die de fundamentele beperkingen van PET-beeldvorming
benadert. De twee belangrijkste fundamentele beperkingen van PET
zijn het positronbereik en de acollineariteit. Een positron reist enige
afstand in weefsel voordat het een elektron vangt dewelke vervolgens
annihileren in een paar 511 keV-fotonen. Omdat de positie waar de
annihilatiefotonen worden gecreëerd, verschilt van de positie van de
oorspronkelijke PET-isotoop, treedt vervaging van het PET-signaal op
met een grootte die afhankelijk is van de energie van het uitgezon-
den positron en van de elektronendichtheid van het omliggende weef-
sel. Hoewel het positronbereik inherent is aan PET-beeldvorming en
kan worden beschouwd als isotroop in homogeen weefsel, zal de aan-
wezigheid van een sterk magnetisch veld ervoor zorgen dat het positron
in een spiraalvormige baan reist. Hierdoor wordt het positronbereik in
het vlak dwars op het magnetische veld verkleind, terwijl dit bereik zal
uitbreiden in de richting langs het magnetische hoofdveld.
Volledig geïntegreerde PET/MR-systemen combineren functionele
(PET) en anatomische (MR) beeldvormingstechnieken. Deze systemen
worden vaak gebruikt in onderzoek en klinische routine. De acquisi-
ties worden doorgaans gedaan met 18F, wat klinisch het meest relevante
PET-isotoop is. Andere PET-isotopen, zoals 68Ga en 90Y, worden echter
steeds belangrijker omdat ze van specifiek belang zijn voor oncologische
toepassingen en voor de opvolging van 90Y op radionuclide gebaseerde
therapie. Deze isotopen hebben een complex vervalschema met een groot
aantal prompt gamma’s die gelijktijdig met de annihilatiefotonen wor-
den uitgezonden. Ze hebben een hogere positronenergie en vanwege
het grotere positronbereik kan er interferentie zijn met het magnetis-
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che veld van de MR in vergelijking met 18F. Daarom is het relevant om
de prestaties van PET/MR te bepalen voor deze klinisch relevante en
commercieel beschikbare radio-isotopen.
In dit doctoraatsproefschrift werd de impact afgeleid van het ge-
bruik van verschillende PET-isotopen via de National Electrical Man-
ufacturers Association (NEMA)-testprestatie-evaluatie van de geïnte-
greerde PET/MR van GE Signa. De methoden werden onderverdeeld
in drie nauw verwante categorieën: NEMA-prestatiemetingen, systeem-
modellering en evaluatie van de beeldkwaliteit van de nieuwste klinis-
che PET-scanners. NEMA-prestatiemetingen voor het karakteriseren
van ruimte-lijke resolutie, gevoeligheid, beeldkwaliteit, nauwkeurigheid
van demping en verstrooiingscorrecties (IQ) en ruisequivalente telcadans
(NECR) werden uitgevoerd met behulp van klinisch relevante en in de
handel verkrijgbare radio-isotopen. GATE Monte Carlo-simulatie werd
gebruikt voor het modelleren van een realistisch General Electrics (GE)
Signa geïntegreerd PET/MR-systeem. De simulatie werd gevalideerd
met het resultaat van de NEMA-metingen (gevoeligheid en NECR).
Monte Carlo-simulaties werden geïmplementeerd in GATE en uitgevo-
erd in de supercomputer Vlaams Supercomputer Centrum geïnstalleerd
aan Universiteit Gent. Het systeem heeft een axiaal en transaxiaal
gezichtsveld van respectievelijk 25 cm en 60 cm, LYSO scintillatoren
met kristalelementen van 25 x 4,0 x 5,3 mm3, een energievenster van
425-650 keV en een coïncidentie venster van 4.57 (±2.29 ns). De geome-
trie werd gemodelleerd met behulp van het cilindrische PET-systeem in
GATE, rekening houdend met de afscherming door schuim, kunststof en
koper tussen het gezichtsveld en de detectoren. Om het effect van het
3T MR-veld op het positronbereik te karakteriseren, hebben we punt-
bronnen van positron-emitterende radionucliden gesimuleerd, waaronder
18F, 11C, 15O, 13N, 82Rb en 68Ga gepositioneerd in het midden van een
homogene 20 x 20 x 20 cm3 kubus met verschillende weefselmedia (zacht
weefsel, longweefsel en bot).
Voor de evaluatie van de beeldkwaliteit van de state-of-the-art van
klinische PET-scanners werd een ruisreductiestudie met behulp van een
Bayesian Penalized-Likelihood reconstructie-algoritme op een time-of-
flight PET/CT-scanner uitgevoerd. De prestaties en het klinisch ge-
bruik van een block sequential regularized expectation maximization
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(BSREM) penalized-likelihood reconstructie-algoritme werden vergeleken
met het ordered-subset expectation maximization (OSEM) algoritme
met volledige modellering van PSF- en TOF-informatie voor beide algo-
ritmen. Het NEMA IQ-fantoom en een volledig lichaam patiëntenstudie
werden verkregen op een GE Discovery MI PET/CT 3-ringensysteem
(axiale FOV van 15 cm) in lijstmodus en verschillende datasets met ver-
schillende geluidsniveaus werden gegenereerd. Fantoomgegevens wer-
den geëvalueerd met behulp van vier verschillende contrastverhoudin-
gen (8:1, 6:1, 4:1 en 2:1). Deze werden gereconstrueerd met behulp van
BSREM met verschillende β-factoren van 300–3000 en met een klin-
ische instelling die werd gebruikt voor OSEM inclusief point spread
function (PSF) en time-of-flight (TOF) informatie. Zowel fantoom- als
patiëntgegevens werden geanalyseerd met betrekking tot contrasthers-
tel (CR), afwijkingscoëfficiënt in de achtergrond (COV), contrast-tot-
ruisverhouding (CNR), SUV-verhouding, metabolisch actieve tumorvol-
umes (MATV’s) en signaal-tot-ruis verhouding (SNR). Deze studie had
tot doel verschillende β-factoren te evalueren in vergelijking met een
klinisch post-filter kernel voor verschillende datasets met verschillende
geluidsniveaus om te onderzoeken of en in welke mate ruis kan worden
verminderd door BSREM te gebruiken in plaats van OSEM.
De uitkomst van dit proefschrift stelt clinici in staat om de PET-dosis
te verlagen, hetgeen vooral relevant is voor jonge patiënten. Bovendien
zal het Monte Carlo-simulatieplatform voor PET/MR ontwikkeld voor
dit doctoraatsproefschrift natuurkundigen en ingenieurs in staat stellen
om geïntegreerde PET/MR-systemen beter te begrijpen en te ontwer-
pen. Voor enkele resterende kwesties zullen suggesties voor toekomstig
onderzoek worden gepresenteerd in het laatste hoofdstuk.
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1
Introduction
Several topics that will be covered throughout the course of this the-
sis are introduced. The basic concepts of anatomical-structural and
molecular-functional medical imaging are presented in this chapter.
1.1 Medical imaging
In this section, a short description is given of the two main categories
of imaging modalities available today: structural (or anatomical) and
functional. First, imaging modalities that mainly provide anatomical
and structural information of organs and tissues but are limited in their
ability to provide physiological information, such as X-ray radiography,
Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and
Doppler Ultrasound. The second class of medical imaging modalities
primarily provides functional and molecular information of tissues, e.g.
the density of specific cell types, proteins, etc or the interaction of drugs.
This group includes e.g. functional MRI (fMRI), ultrasound, and the
two main nuclear imaging modalities: Positron Emission Tomography
(PET) and Single Photon Emission Computed Tomography (SPECT).
X-Ray Radiography
An X-ray is a form of high energy (100 eV to 200 keV) electromagnetic
radiation with a short wavelength capable of penetrating solids and ion-
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izing matter. As they are used for clinical purposes, X-ray beams are
emitted from an X-ray source and directed toward a detector (a film
placed behind the patient’s body). When passing through the body,
parts of the beam are absorbed and scattered (due to different densities
of the body) and parts of transmitted X-rays are detected, resulting in
a 2D projected image. This is related to the total absorption through
the path and shows a superposition of bony structures and soft tissue.
An example of a typical X-ray of different parts of the body is shown in
Figure 1.1.
Fig. 1.1: X-ray imaging. The X-rays pass through the body and are attenuated
by high-density internal structures, which is visualised here by white intensities as
a measure of high X-ray attenuation. Image obtained from [1].
There are clinical applications for X-rays, but the most used are
for orthopaedic applications and lung diseases. On the other hand,
mammography uses X-ray radiography to detect breast cancer and there
are several applications in fluoroscopy (interventional radiology). X-ray
imaging can also be used in combination with contrast agents to view
the digestive processes (oral administration) or blood flow (intravenous
administration). A typical example is a cardiac angioplasty. It uses flu-
oroscopy with a contrast agent to guide an internally threaded catheter
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to help open clogged arteries [2].
This technique depicts a 2D image of a body region, and only from
a single angle. This produces a superposition of densities, which repre-
sents major limitations in the analysis of what needs to be investigated.
Recent medical imaging technologies produce data that are integrated
and reconstructed to produce 3D images without superposition. Despite
the recent developments, X-ray radiography is still widely used due to
its low radiation dose.
Computed Tomography
Computed Tomography, most commonly known as CT, is based on the
same principle as X-ray imaging. A narrow X-ray beam is scanning the
patient with a radiation detector on the opposite side of the patient.
This process generates 2D images at different angles that are used to
form a 3D image of the body, using an image reconstruction algorithm
(see Section 2.2).
CT serves a similar purpose as an X-ray, but it provides much more
information, and it has a higher contrast compared to conventional X-
ray imaging (see Figure 1.2). CT is frequently used in diagnosis, mon-
itoring and treatment planning (especially for radiotherapy treatment
planning). Because of its widespread availability and excellent system
performance, CT has become the modality of choice for most institu-
tions for the work-up of different diseases and an easier tool for initial
cancer evaluation [3].
On the other hand, the patient is exposed to radiation. The more of
the patient’s body that is scanned, the more radiation they are exposed
to. Even though CT-scanners are designed to minimize the radiation
dose while generating acceptable image quality, the total radiation ex-
posure is considerably higher than for X-ray radiography. Moreover,
compared to MRI, X-ray based methods offer relatively low soft-tissue
contrast.
Ultrasound
In ultrasound imaging, high-frequency acoustic pulses are sent into the
body reflecting at discontinuities such as the boundary between differ-
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Fig. 1.2: A CT scan of the chest and abdomen. At the bottom, the two images
are a 3D rendering and the aper pictures are cross-sectional slices through the 3D
image. Note that the principle is the same as X-ray imaging, but with more detailed
information.
ent tissues. As the ultrasound waves pass through the tissue and are
reflected back, local images can be created and tissues can be charac-
terized. These local images can be reconstructed (in 2D and 3D) by
measuring the time delay and the intensity of the reflected pulses. Ul-
trasound is also useful for the non-invasive imaging of the abdomen and
pelvis, including imaging the fetus during pregnancy (see Figure 1.3).
Although other techniques give more detail and accuracy, ultrasound
is still very commonly used because the instruments are relatively cost-
effective, quick to perform and it emits no ionizing radiation.
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Fig. 1.3: An example of an image obtained by ultrasound, an "echo" of my lovely
daughter Esther Caribé with 32 weeks of life.
Magnetic resonance imaging
Magnetic resonance imaging is a non-invasive biomedical imaging tech-
nique based on nuclear physics with a high spatial resolution (>0.1 mm)
and different contrast weightings. MR image is based on the measure-
ment of the emitted radio signal by protons exposed to the magnetic field
and excited by radio waves and on the differences in relaxation times
between protons, which are induced by the underlying distribution of
hydrogen atoms and the magnetic susceptibility of surrounding tissues
in the body [2, 4].
An MR image allows us to distinguish different soft tissues much
better than any other modality, including the difference between normal
and pathological soft tissue, with a very high resolution, and without
exposing the patient to ionizing radiation. Some of its most common
applications are in neurological and musculoskeletal imaging. It also al-
lows the integration of many different imaging features such as anatomy,
physiology, metabolism and function. The main drawback of MR imag-
ing nowadays is its high maintenance cost. Part of this thesis will focus
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on the system characteristics and improvement of image quality of an
integrated PET/MR, allowing simultaneous PET and MR imaging mea-
surement, so we will discuss this modality more in detail in the following
chapters.
Nuclear imaging modalities
Nuclear imaging modalities allow the in-vivo measurement of biologi-
cal processes at the cellular and molecular levels [4]. Like X-ray and
CT modalities, it makes use of ionizing radiation. However, instead of
having a radiation beam going through the patient, a small amount of
radioactive isotope is injected into the patient’s bloodstream and the
photon emissions as a result of the radioactive decay are measured and
used for imaging. By combining this radioactive isotope with a molecule
with binding affinity and high selectivity for a specific target, many dif-
ferent cellular function parameters can be assessed. As such tumours
can be detected and located, blood flow can be measured and many
more applications. In Section 2.1.2, an overview is given of the most
common and widely used diagnose and radiotherapeutic tracers.
PET and SPECT
The two main nuclear imaging techniques used for the detection of
gamma radiation are Positron Emission Tomography (PET) and Single-
Photon Emission Computed Tomography (SPECT). In the case of PET
imaging, the radioisotopes decay emitting positrons (β+). The most
widely and clinically used positron emitter is 18F, which almost exclu-
sively decays via β+ (see Tables 2.1 and 2.2). When the positron is
emitted, it travels for a few millimetres through the body until it in-
teracts with a free-electron resulting in an annihilation and producing
two back-to-back gamma photons with energy of 511 keV each (these
photons are emitted in almost opposite direction starting from the in-
teraction point, see section 2.1.4 for more) defining a line through the
patient along which the annihilation event must have occurred. Since
PET is based on the coincident detection of these two opposite gamma
photons along the line-of-response (LOR), a pair of detectors is needed
(clinical PET systems use a full ring of detectors surrounding the pa-
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tient). If the two back-to-back gamma photons are detected within a
certain short time window (depending on the PET system settings) it
is assumed that they originate from the same annihilation event. This
information is saved in sinograms or list-mode that can be used to re-
construct 3D images of the distribution of the PET tracer in the body.
However, a drawback of PET is the positron range and non-collinearity
of the two annihilation photons, which constitute physical limitations
on the image quality of PET (see Chapter 4). Section 2.1 will provide
a full and detailed background of PET systems for the main chapters of
this thesis.
Fig. 1.4: An example of a coronal whole-body SPECT and PET image show-
ing the radiopharmaceutical distribution in the body. Note that SPECT imaging
yields a relativity low image resolution (typically around 10 mm in clinical systems)
compared to PET imaging
Compared to PET systems, SPECT is based on the detection of a
radioisotope that emits gamma photons (γ), which are directly emit-
ted upon a nuclear de-excitation of one of the short-lived excited nuclei.
Because of its physical properties (141 keV and half-life of 6.02 hours),
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99mTc is the most commonly used SPECT radioisotope (predominantly
in bone and brain scans). Both PET and SPECT system detectors use
a scintillator coupled through a light guide to a photodetector. The
general propose of the scintillation is to stop the gamma rays and con-
vert the absorbed energy into visible light (wavelength of light from 380
nm to 780 nm). Subsequently, the absorbed energy is collected by the
photodetector and converted into an electrical pulse. Each modality
uses a dedicated scintillation based on the range of energies of the ra-
dioisotope (see 2.3). PET radioisotopes have a gamma photon energy
of 511 keV, while in SPECT, the energy varies (depending on the ra-
dioisotope) from 110 keV to >350 keV. The energy of the gamma photo
and scintillator material used (in case of SPECT, also the collimator
design), have a significant impact on the spatial resolution. Moreover,
the different radiotracers to which PET and SPECT are sensitive (dual
gamma-emission per nuclear decay for PET and single gamma-emission
per nuclear decay for SPECT) will also determine the type of system
geometries used. Instead of using a full ring of detectors around of the
patient, SPECT systems may consist of one to three rotating detectors,
but normally there are only two detectors fixed at 90◦ or 180◦ on a
rotating gantry (there are several SPECT systems with singular config-
urations specially designed for specific organs). Each rotating detector
has a collimator positioned in front of the scintillation crystal designed
to attenuate all but the near-perpendicularly incident gamma photons,
where are used to record 2D images of the radioactivity (see Figure 1.4).
By rotating the detector heads around the patient, 3D images of the
radiopharmaceutical distribution in the body can be obtained.
The most important advantage of PET imaging over SPECT is that
of exhibiting a much higher sensitivity (approximately 102 to 103 times
higher). This is because the collimator attenuates photons that are not
within a small angular range (see Figure 1.5).
Regarding the image resolution, PET scanners have an almost 4
times higher image resolution (about 2.5 – 4.0 mm in current clinical
systems) than standard SPECT scanners (typically around 10 mm) [4,
5]. In addition to its clinical role, PET and SPECT continue to play a
major role in the biomedical research community. Rapid growth is now
occurring in the number and diversity of PET and SPECT molecular
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imaging tracers targeted to specific proteins and molecular pathways
implicated in disease [5].
Multi-modalities imaging
The combination of multiple imaging modalities can substantially in-
crease the benefit for physician and patient. Nowadays PET scanners,
and a rapidly growing number of SPECT systems, are sold with an
integrated CT scanner in combined PET/CT and SPECT/CT config-
urations. These systems enable the correlation of structure (CT) and
function (PET or SPECT), yielding better diagnostic insight in many
clinical indications. The CT data can furthermore be used to apply a
correction for attenuation and scattering of the photons [5]. In the case
of SPECT/CT, the main advantage is the increased specificity achieved
through a more precise localization and characterization of functional
findings. Another advantage is the shorter overall patient setup, image
time and therefore the patient throughput [4], (Section 2.3 shows an
overview of the currently most used hybrid systems).
On the other hand, the performance of PET/CT systems will always
be limited by the low soft-tissue contrast of the CT and by the organ
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Fig. 1.6: A coronal whole-body PET, MR imaging and PET/MR image comparing
the 18F choline prostate imaging (55 min uptake and 6 bed positions). Note
that the integrated PET/MR provides superior soft tissue contrast for oncological
applications such as prostate cancer (Courtesy University Hospital Zurich).
motion artefacts [2, 4]. Therefore, the combination of PET with MRI
provides several oncological applications (see Figure 1.6), such as brain
tumour evaluation with 11C-acetate and 68Gallium-DOTA-D-Phe1-Tyr-
octreotide (68Ga-DOTATOC) as radiotracers, prostate cancer with 11C-
choline PET and accurate correction of motions artefacts. All of this
can be done without the use of additional radiation dose to the patient.
Chapters 3 and 4 will discuss the technical challenges of PET/MR com-
pared to PET/CT systems because of interferences between the PET
and MR imaging system and its impact on the imaging of different PET
radioisotopes.
1.2 Outline
The essential background for this dissertation is presented in Chapters
1 and 2, We start with a brief history of the medical imaging modali-
ties, followed by a detailed explanation of the differences between these
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modalities. Since this work evaluates image quality and reconstruction
parameters in recent hybrid systems, we go into more details on the PET
system performance parameters and the important characteristics to be
considered, with particular emphasis on NEMA performance measure-
ments for different radioisotopes. Subsequently, a detailed explanation
of the physics of positron emission, the PET scanner and PET image
degrading effects are presented. Next, we explain the basics behind sev-
eral techniques used throughout this thesis: image reconstruction, ac-
ceptance tests for PET and system modelling using GATE Monte Carlo
simulations.
In Chapter 3, we present the important aspects of a fully integrated
PET/MR system performance characteristics and the impact of using
different radioisotopes. NEMA NU 2–2007 performance measurements
are performed for characterizing the spatial resolution, sensitivity, image
quality, and the accuracy of attenuation and scatter corrections for 18F,
68Ga, and 90Y. Scatter fraction and noise equivalent count rate tests are
performed using 18F and 68Ga. Subsequently, we report the effect of the
3T MR field on spatial resolution and sensitivity. Next, the impact of
different reconstruction parameters on image quality and peak NECR
are evaluated and discussed.
In Chapter 4, a realistic Monte Carlo model of the integrated GE
Signa PET/MR is implemented in GATE to simulate NEMA sensitivity
and NECR measurements. We first give a full description of the different
components of the PET/MR geometry, the physics and the radioisotope
sources used in this study. The NEMA sensitivity and NECR results
reported in chapter 3 are used to validated the GATE PET/MR Monte
Carlo model. Further, we use this model to predict the performance
of PET/MR for the radioisotopes 18F, 11C, 15O, 13N, 82Rb and 68Ga
and to evaluate the effect of the 3 T MR field on positron range in
different tissue types such as lung, soft tissue, cortical bone and for
tissue boundaries.
In Chapter 5, the resolution, noise and quantitative accuracy of
the state-of-the-art PET/CT are evaluated using different reconstruc-
tion methods. The NEMA IQ phantom and a whole-body patient study
are acquired in list-mode on a GE Discovery MI PET/CT which have 3
rings of detectors and 15 cm axial FOV PET system. Different datasets
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with varying noise levels are generated. Phantom data are evaluated for
four different contrast ratios (8:1, 6:1, 4:1 and 2:1). These are recon-
structed with a block sequential regularized expectation maximization
(BSREM) algorithm using different β-factors and with a clinically used
ordered-subset expectation maximization (OSEM) algorithm including
point spread function (PSF) modelling and time-of-flight (TOF) infor-
mation. Contrast Recovery (CR), background noise levels and contrast-
to-noise ratio (CNR) are used to determine the system performance
using the phantom data. Findings based on the phantom data are com-
pared with clinical data to confirm whether and to what extent noise
can be reduced by using BSREM instead of OSEM. The results obtained
from this image quality evaluation are presented and discussed at the
end of this chapter.
Finally, in Chapter 6, we give an overview of the most important
results of this dissertation, along with a conclusion and some future
perspectives.
2
Background
A general overview is presented of medical imaging to provide the reader
with enough background knowledge to understand the topics that will
be studied in this thesis. We start with the concept of positron emis-
sion tomography (PET), magnetic resonance imaging (MR), the basics
physics involved, and the various parameters that contribute to the im-
age quality. This is followed by a description of the National Electri-
cal Manufacturers Association (NEMA) performance measurements for
PET scanners. Finally, section 2.5 is dedicated to Monte-Carlo simula-
tions.
2.1 Positron Emission Tomography
PET has proven a very valuable imaging tool to explore a variety of
cellular and molecular processes in-vivo. Because of its high sensitivity,
only very low amounts of a PET tracer (a compound labelled with a
PET isotope) need to be administered and therefore pharmacological
effects and physiological changes are avoided. This way, PET can pro-
vide images with high contrast and quantitative functional information
about the disease state or therapy response, complementary to informa-
tion provided by anatomical imaging modalities such as CT or MRI (see
Figure 1.6).
A typical PET study involves the intravenous injection of a PET
tracer, which is delivered by arterial blood flow to the target tissue.
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Fig. 2.1: The principle and workflow of positron emission tomography: After
producing an appropriate PET tracer and the radiotracer injection, positrons are
emitted within the subject’s body, combine with nearby electrons and annihilate.
The result is a pair of 511 KeV gamma photons released in opposite directions.
PET scanners use pairs of radiation detectors to measure the nearly simultaneous,
coincident interaction of the 511 KeV photons. The data recorded by the scanner is
a collection of coincidence detections. In the reconstruction step, a mathematical
procedure is implemented to convert the acquired data to tomographic images
While the PET tracer binds (ir)reversibly to or is being trapped by its
physiological target, the radioactive label will decay, emitting a positron
which will annihilate with a nearby electron resulting in two simulta-
neous 511 keV photons in opposite direction. These photon pairs are
detected by the PET scanner as a pair of coincident detections within a
predefined timing window (about 4.9 ns for almost all commercial PET
scanners available today) such that the line on which the annihilation
occurred-the so-called line-of-response (LOR), can be determined (see
Figure 2.1). During the acquisition of the scan emission data, physical
effects such as attenuation, scatter, dead time and detector response
can happen. The acquired data are then, (most often) corrected during
the reconstruction process. There are two widely used reconstruction
algorithm methods: analytical or iterative (see Section 2.2).
This way a 3D image of the radiotracer distribution in the body is
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generated at one or various time points after tracer injection. Combined
with the activity level in the arterial blood and percentage of intact
tracer in arterial plasma, this temporal and spatial distribution of ra-
diotracer concentration allows accurate quantification of the underlying
physiological tissue characteristics such as blood flow, metabolism, cell
proliferation, receptor density or enzymatic activity.
More details on the physics, radiopharmaceutical production, instru-
mentation and image reconstruction of PET can be found in the follow-
ing sections.
2.1.1 Physics of nuclear medicine imaging
Nuclear medicine imaging uses ionizing radiation, which is capable of
carrying and depositing energy when interacting. There are different
types of ionizing radiation, which interact differently with matter. The
principal forms and the basics of ionizing radiation found in most imag-
ing modalities available in a modern hospital will be briefly introduced
in the following sections.
Radiation forms in nuclear medicine
Radiation is an energy carrier and when it propagates in a medium, it
can interact with the constituent atoms of that medium. The interac-
tion occurs through a process of energy transfer from radiation to the
medium. This transfer process, in turn, varies greatly and can be af-
fected by many factors, such as the type of radiation, its energy, the
type and density of the environment, among others.
β particle radiation
There are two types of beta particles radiation: β− (beta-minus) and β+
(beta-plus). In this section, we conveniently choose to discuss only the
β+ decay because of the PET imaging formation. The β+ (or positron)
is the antiparticle of the electron, which has the same mass and the
same but positive charge. It originates from a nuclear process in which
a proton (p) of the nucleus becomes a neutron (n). This process can be
expressed by the Eq 2.1:
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1
1β −→10 n+01 β+ + νneutrino (2.1)
A second particle is emitted, which is a neutrino. As the daughter nu-
cleus has an atomic number one less than the parent, one electron is
also ejected through an internal conversion from the daughter nuclei to
balance charge. Positron emitting nuclei may also decay by electron cap-
ture. β+ radiation is mainly used in nuclear medicine for PET imaging.
The most widely used radioisotope for PET imaging is 18F (fluorine-
18). It has a positron emission branching ratio of 96.86 % with a 0.6335
MeV of maximum positron energy. The other 3 % of decays via electron
capture.
Annihilation radiation
Annihilation radiation is the foundation of PET imaging modality. Af-
ter a positron is ejected from the nucleus, it loses its kinetic energy in
collisions with atoms of the surrounding body tissues until it collides
with an electron. The combination of these particles momentarily forms
a metastable "atom" called positronium, which exist for around 10−10
seconds. By an annihilation reaction their mass is converted into energy
(see section 2.1.4, Figure 2.9). In the form of two photons of 511 keV
(rest mass of e− and e+) travelling in opposite directions to allow for
conservation of energy and momentum. Because the rest-mass energy
of an individual particle is 511 keV, the total transition energy of 1.022
MeV is required [4]. At the time of annihilation, the positronium has a
residual momentum, which leads to the non-collinearity of the two an-
nihilated photons (a degradation factor in PET systems performance).
This will be discussed in detail in section 2.1.4.
γ radiation
γ photons are an important form of electromagnetic (EM) radiation.
It consists of photons with wavelength below 3 × 10−11 m and energy
greater than 41.4 keV (which is capable of causing ionization when in-
teracting with the atoms of the environment). Unlike X-rays, γ rays
result from nucleus process such as spontaneous nuclear decay. Despite
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different origins, X-ray and γ ray are essentially high energy photons. γ
rays emission have a characteristic energy determined by the difference
in energy levels between the initial and final state of the nucleus [4, 6].
X-ray radiation
Another type of EM radiation are X-rays. In an X-ray medical device, an
X-ray tube is used to produce X-ray radiation. By applying a strong po-
tential difference (from 20 kV to 100 kV) between a cathode and anode,
electrons are accelerated across at very high speed from the cathode to
the anode. X-rays are produced by colliding electrons with the atoms in
a metallic anode target. There are two particular radiation types coming
from this particular event: Bremsstrahlung (with a continuous energy
spectrum) and characteristic X-rays (present in the spectrum as several
peaks). Bremsstrahlung is caused by the deceleration of the emitted
electron in the electromagnetic field (by electrostatic attraction) of the
nucleus. When a charged particle (e−) is decelerated, X-ray radiation
is emitted. The maximum X-ray energy (which depends only on the
potential difference applied) is defined as Emax = eVTube, where VTube
is the potential difference between the anode and cathode.
Differently of Bremsstrahlung radiation, the characteristic X-rays
are produced when an electron of the outer shell loses energy to fill the
hole when is released by the absorption of an X-ray. The frequency
of a characteristic X-ray is determined by the change in energy level
(quantum state) of the electron according to E = hν. This particular
energy value depends upon the anode material used (usually tungsten
or molybdenum). For X-ray tubes based on a tungsten anode, there
are two particular emissions with energies of 59.3 keV and 67.2 keV. For
the anode based on molybdenum (typically used for mammograms), the
emissions have energies of 17.5 keV and 19.6 keV. As briefly discussed
in 1.1, X-ray radiation has significant importance in the history of the
medical image because the fist radiology images were made using X-rays
[4].
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Interaction of β+ particles and Photons with matter
The β+ particle loses kinetic energy through interactions with the sur-
rounding matter (tissue, in case of the human body). The distance from
the positron-emitting nuclei to the point of annihilation is called the
positron range (see subsection 2.1.4, Figure 2.9) [4, 7]. It also indicates
the location of the radiation origin.
Contrary to β particles, photons can pass through material without
or with only few interactions. As a result, photons are more difficult to
stop than particles. Rayleigh scattering, photoelectric effect, Compton
effect, and pair production are the most common interactions of photons
with matter. Predominating interactions according to the photon energy
and atomic number are shown in Figure 2.2.
Fig. 2.2: Dominance of effects according to photon energy and atomic number
of the material. Rayleigh scattering is not represented as it is not significant in
nuclear medicine imaging. Image obtained from [4].
• The Photoelectric effect corresponds to the interaction of photons
with electrons in the higher energy shells of the atom. The incident
photon transfers all of its energy to the electron, which is released
by the atom. The removal of an inner electron brings the atom
in an excited state. The excited atom returns to the ground state
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by emitting a characteristic X-ray or by releasing another elec-
tron, which is called an Auger electron. The probability of this
process (σPE) decreases with increasing photon energy (Eγ) but
increases with the increasing atomic number (Z ) of the material.
The following approximate relationship holds:
σPE ∝
Z3
E3γ
(2.2)
The photoelectric effect is predominant in human tissues at ener-
gies below approximately 100 keV (see Figure 2.2) and is crucial
for X-ray and CT imaging where attenuation of photons in the
bones (high density tissues) is the source of the image contrast.
• The Compton effect corresponds to the interaction of the photon
with the electron in one of the lowest energy shells. This effect
is predominant in human soft tissues at energies between 100 keV
and 2 MeV. The potential energy of the electron is very low com-
pared to the photon energy and can be considered as negligible.
After the interaction, the photon is scattered and the electron is re-
leased from the atom. The energy lost by the photon comprises the
binding energy of the electron and the kinetic energy it acquires.
The transferred energy does not depend on material properties or
electron density. The scattered photon can interact again with
the matter by either the Compton effect or photoelectric effect, or
simply not interact with the matter again. The scattering angle is
dependent on the energy loss of the photon (E′γ = Eγ−KkineticE),
and can be expressed as:
E
′
γ =
Eγ
1 + Eγ
mec2
(1− cos(θ))
(2.3)
Where mec2 is the total rest mass energy of an electron. Compton
scattering is of prime importance to radiobiology, as it happens
to be the most probable interaction for the gamma rays and high-
energy X-rays used in radiotherapy [6, 7].
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• The Pair production refers to the production of an elementary
particle and its antiparticle. Due to the energy conservation, this
process can only happen when the photon has an energy equal to
the total mass-energy of the two particles (2mec2). This minimum
energy is 1.022 MeV to produce an electron-positron pair. As
shown in Figure 2.2, Pair production becomes especially relevant at
high energies and in the presence of heavy nuclei, as its probability,
or cross-section, is dependent on the energy of the photons and the
atom’s atomic number, according to Equation 2.4:
σpair ∝ Z ln(Eγ) (2.4)
• The Rayleigh scattering consists of the electromagnetic wave pass-
ing near the electron and setting it into oscillation. The oscillating
electron irradiates the energy at the same frequency as the inci-
dent electromagnetic wave. These scattered x-rays have the same
wavelength as the incident beam. This effect predominates at en-
ergies less than 50 keV. This scattering is of interest for low-energy
(or dual-energy) CT imaging. Because Rayleigh scattering is never
the dominant process in interaction of photons with matter, is of
little to no importance in nuclear medicine and, particularly, PET
imaging.
2.1.2 PET radionuclides
In nuclear medicine, radiopharmaceuticals are unique medicinal formu-
lations containing radioisotopes which are used in major clinical areas
for diagnosis and (or) oncology therapy. Knowing the physical charac-
teristics of the commercially available PET radioisotopes is a key to the
radiopharmaceutical preparation.
The choice of radioisotope for a particular application is therefore
dependent on many factors. For diagnostic imaging applications, for
example, the imaging modality (gamma or a positron emitter), the bi-
ological half-life (i.e. the time that it takes for half to be removed by
biological processes) should be in line with the physical half-life of the
radionuclide used. On the other hand, the therapeutic application is
2.1 Positron Emission Tomography 23
Tab. 2.1: Properties of pure positron emission radioisotopes. Data from the
National Institute of Standards and Technology [8], Laboratoire National Henri
Becquerel [9], and Brookhaven National Laboratory [10]. Range of positrons (R)
is in water [11].
Isotope Half-life Branching
β+ (%)
Emax
(MeV)
Emean
(MeV)
Rmax
(mm)
Rmean
(mm)
18F 110 min 96.9 0.634 0.250 2.4 0.6
11C 20.4 min 99.8 0.960 0.386 4.2 1.2
13N 10 min 99.8 1.119 0.492 5.5 1.8
15O 2 min 99.9 1.732 0.735 8.5 3.0
Tab. 2.2: Properties of prompt gamma positron emission radioisotopes. Only the
positrons and prompt gammas with the two highest branching ratios are listed.
Data from the National Institute of Standards and Technology [8], Laboratoire
National Henri Becquerel [9], and Brookhaven National Laboratory [10].
Isotope Half-life Branching
β+ (%)
β+ Emax
(MeV)
Branching
γ (%)
γ E (PG)
(MeV)
68Ga 67.8 min 87.7, 1.2 1.899, 0.821 3.2 1.077
82Rb 1.3 min 81.8, 13.1 3.378, 2.601 15.1 0.777
mainly dependent on the physical properties of the radionuclide, such as
emitted energy radiation, radioactivity half-life and type of decay (by α
or β). As an example, 131Iodine (potassium iodine), 90Y and 177Lu is
used to label antibodies and peptides (a short chain of amino acids).
Most positron emitting radioisotopes are cyclotron-produced. Before
being suitable for the use in medicine, radioisotopes must be attached
to an organic molecule or compound to form a radiopharmaceutical or
radiotracer, so that the radioisotopes can be carried to the target place
of the examination, through the metabolism of the organic molecule.
Some PET isotopes have relevant contribution of prompt gammas, such
as 68Ga, 82Rb, 90Y and have complex decay schemes with a variety of
gammas in coincidences (see Table 2.2 and Chapter 3 to find out how
these high-energy prompt gammas influence the system performance).
Others commonly used PET radioisotopes, such as 18F, 11C, 13N, and
15O have short half-lives and high branching ratios for β+ decay. The
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main properties of these radioisotopes are summarized in Table 2.1.
β−-emitting radionuclides are being used more and more in targeted
radionuclide therapy. 131I therapy is widely used for thyroid, parathy-
roid, and salivary glands. The major advantage of 131I are its low price
and ready availability. 131I has a physical half-life of 8.04 days and
emits by 81% abundance γ photon of 364 keV. The maximum and mean
β energy are 0.61 MeV and 0.192 MeV, respectively [12]. 177Lu is an-
other therapeutic radionuclide frequently used for neuroendocrine and
prostate tumours. With a maximum β energy of 0.5 MeV and half-life
of 2.7 days, 177Lu also emits γ rays at 208 and 113 keV [13].
The administration of 90Y-DOTATOC for treatment of tumours ex-
pressing somatostatin receptors has been widely introduced into routine
clinical practice. 90Y also has been used in radioembolization for primary
and metastatic liver cancer [14]. Radioembolization is a trans-arterial
technique that involves the injection of micron-sized embolic particles
loaded with a radionuclide.
90Y is mainly a β− emitter with a very small branching ratio for
positron production. In 0.003186% of the decays there will be the emis-
sion of an e+/e− pair at 1.76 MeV. As the transition energy is 1.76 MeV,
Here remains 738 keV of kinetic energy to be split between the electron
and the positron in order to conserve the null momentum. With a half-
life of 64.1h, 90Y can produce a weak but usable PET signal [6, 15, 16].
The practices of nuclear medicine and radiopharmacy require the
preparation of radioactive ligands for injection into patients. Figure 2.3
summarizes the currently used diagnostic and radiotherapeutic tracers.
Practices in radiopharmacy for both industries and hospitals are
regulated (in case of the European Union) by the European Medicines
Agency (EMA). In Brazil, the radiopharmaceutical production must be
attested by the National Nuclear Energy Commission [17] and the Na-
tional Health Surveillance Agency [18].
With PET becoming more widely used, the transport logistics have
allowed faster shipments of radioisotopes to small imaging centres. The
majority of PET studies in clinical routine are still being performed
with 18F, because of its physical properties combined with efficient trans-
portation logistics which widely increase its availability. The same holds
for 68Ge (a long-lived radionuclide used to produce via a generator the
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Whole body
Primary tumors and metastases (18F, 11C)
Oncology Therapy (131I, 177Lu, 166Ho, 90Y)
Infectious diseases (99mTc, 67Ga)
Brain Imaging (18F, 99mTc, 123I, 13N, 15O, 11C)
Stroke Imaging (18F, 99mTc, 15O)
Epilepsy (18F, 123I)
Amyloid plaque accumulation 
(Alzheimer’s disease) (18F, 11C)
Parkinson disease (18F, 11C
Leukemia (32P)
Non-Hodgkin Lymphoma (111In) (90Y, 
131I)
Lung ventilation (81mKr, 99mTc, 133Xe )
Lung perfusion imaging (99mTc)
Liver imaging (99mTc, 13N, 18F)
Hepatocarcinoma (131I, 188Re, 90Y)
Gastro-Intestinal absorption (99mTc)
Neuroendocrine (99mTc, 111Ln, 18F, 68Ga) 
(177Lu)
Renal filtration studies 
Kidney diseases (99mTc, 123I, 131I)
Adrenal scintigraphy (99mTc, 18F, 123I, 131I)
Bladder imaging (99mTc)
Prostate cancer (18F, 68Ga, 11C, 111In) (177Lu)
Imaging of the salivary glands 
and the lachrymal tract (99mTc)
Thyroid diseases therapy (131I)
Imaging of the thyroid (123I, 131I, 99mTc, 201TI)
Blood studies (99mTc, 125I, 51Cr, 59Fe, 67Ga)
Cardiac diseases (99mTc, 201TI, 13N, 15O, 18F, 82Rb)
Brest cancer (99mTc, 18F,)
Spleen diseases – Biliary function (99mTc)
Palliative treatment
Bone metastases (32P, 89Sr, 153Sm, 186Re, 223Ra)
Bone scintigraphy (99mTc)
Deep vein thrombosis (99mTc)
Cervix cancer (99mTc)
Polycythaemia and 
thrombocythaemia treatment (32P)
Radiosynovectomy – Polyarthritis 
(knee, hand, shoulder, hip) (169Er, 186Re, 90Y)
DIAGNOSIS & THERAPY
Fig. 2.3: Diagnostic and radiotherapeutic tracers [19].
short-lived radionuclide 68Ga) and 90Y, for which the user is not depen-
dent on the availability of a cyclotron [20].
2.1.3 PET instrumentation
As mentioned before in Section 2.1, PET imaging is based on the detec-
tion of gamma radiation. To visualize a specific function with PET, the
patient must be injected intravenously with a substance (marked with a
positron β+ emitting radionuclide), which distributes in the body such
that it correlates with the function of the organ target. Once the ra-
dioisotope has been distributed in the body, the patient is positioned in
the PET scanner, which essentially consists of a cylindrical configura-
tion of detector blocks (Section 2.3 shows the most recent commercially
available PET systems). The image formation consists of localizing the
positron emitter. After its emission, a positron travels a short distance
(few mm, depending on the energy of the emitted positron) through
surrounding tissue while losing energy. When it has lost sufficient en-
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ergy, the positron annihilates with an electron. After annihilation, two
511 keV photons are emitted in (nearly) opposite directions. When two
interactions are simultaneously detected within a pair of detectors, it is
assumed that an annihilation occurred on the LOR connecting the inter-
actions, as shown in Figure 2.7. By recording many LORs the activity
distribution can be reconstructed (see section 2.2).
PET detector: Photon detection with scintillation detectors
The quality of the PET detector has a large impact on image quality.
Therefore, an optimum detector performance requires the photodetector
to detect scintillation photons as efficiently and accurately as possible.
The photodetection efficiency (PDE) is the probability that an incident
photon is converted to a measurable signal, at the emission wavelengths
of the scintillator.
Scintillators
Scintillation detectors are used in PET scanners as detector elements.
They couple inorganic scintillation crystals that emit visible or near-
ultraviolet light after interaction with an incident 511 keV photon, to
photodetectors that detect and measure the scintillation photons. Then,
this information collected by the photodetector is converted into an elec-
trical signal pulse.
The most commonly used PET scintillators are listed in Table 2.3.
A detector block generally consists of an array of crystals separated by
reflecting material to confine the light in each crystal when an interaction
takes place. The crystal size is directly related to the reconstructed
spatial resolution, but small crystals may require a significant number
of photodetectors to accurately decode the gamma interaction position,
and this increases the total cost of the PET system.
Scintillators have several physical properties that affect the efficiency,
time, and energy resolutions of PET detectors. The density and atomic
number determine the efficiency of the detector, which impacts the de-
tector sensitivity (the fraction of photoelectric and secondary Comp-
ton interactions increase with the atomic number). The light yield de-
termines the number of optical photons generated from each gamma-
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Tab. 2.3: Scintillators used in PET scanners. Note that decay time determines
scanner deadtime and random coincidences rate as well as ability to measure time-
of-flight (TOF) PET imaging (discussed in subsection 2.1.3) [21].
Scintillator Density
(g/cm3)
Light yield
(Ph/MeV)
Emission
wavelength
(nm)
Decay
time (ns)
Cost
LSO(Ce)
(or LYSO)
7.40 27.000 410 40 more
expensive
BGO 7.13 9.000 480 300 expensive
La3Br(Ce) 5.29 61.000 358 35 more
expensive
NaI(TI) 3.57 38.000 415 230 cheap
(relatively)
interaction within some range (9 ph/keV and 26 ph/keV for BGO and
LSO respectively) and determines the time and energy resolution. The
decay time determines how fast the luminescence signal decays after a
detection. Finally, the emission wavelength is the wavelength of the
produced optical photons, which needs to be compatible with the wave-
length of the photodetector [4, 22]. The quantum efficiency of the pho-
todetector (QE), is defined as the probability that a photon absorbed
in the active area of the photodetector gives rise to a signal, determines
the fraction of the produced photons that are converted into electrons
in the photodetector.
There are several types of photodetectors, but the most used in a
PET detector are photomultiplier tubes (PMT) and silicon-photomultipliers
(SiPM) [4, 23]. There is also a new PET detector based on monolithic
scintillator crystal that is currently under investigation by the biomedi-
cal research community, meant to provide the highest scanner sensitiv-
ity possible while still providing a spatial resolution adequate for high-
resolution imaging (see subsection 2.1.3).
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PMTs
A photomultiplier tube consists of a vacuum tube with a photo-cathode
at one end, a series of dynodes at successively higher voltages, and an
anode at the other end of the PMT (see Figure 2.4). When the optical
photons (visible light) are emitted by the scintillator, the photodetec-
tor detects, and by the photoelectric effect, produces electrons that are
emitted in the direction of the dynodes. Then these electrons are accel-
erated by the existing electric field and amplified. The resulting electri-
cal current is proportional to the number of initial scintillation photons
and therefore to the energy deposited in the scintillation crystal by the
incident photon.
Fig. 2.4: Basic principles of PET imaging: a radioactive tracer is injected into
a patient and emits two 511 keV photons after the positron annihilates with an
electron. Using a ring design, photons are detected and measured with crystals
and photomultiplier tubes (PMTs) surrounding the patient (at the top). Image
obtained and edited from [4, 24], under creative commons attribution unported
license.
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As shown in Figure 2.4, a full PET scanner consists of a cylindrical
assembly of block detectors in a ring structure. A block detector con-
sists of small individual scintillation crystals, a few millimetres in size,
oriented towards the patient, and tightly packed into blocks, which are
typically coupled to four or more small photo-multiplier tubes [4, 25].
The advantage of using this block detector is that PMTs have excellent
timing (∼1 ns) and gain properties (∼ 106). However, there are some
limitations which need to be considered. The QE of a PMT is somewhat
poor (from 25% to 43%) [26]. These devices are bulky and operate at
high voltages (typically 200-400 V), and the electron multiplication along
the dynodes does not function in the presence of electromagnetic fields
(this is the main challenge in PET/MR detectors). Several approaches
have been applied to solve this challenge. The Siemens Biograph mMR
uses avalanche photodiodes (APDs) instead of PMTs in PET detector.
Compared to PMTs, APDs has a significantly higher QE (from 55% to
90% at higher wavelengths). However, APDs have a relatively low tim-
ing resolution (∼ 5 ns), low gain (∼ 102 - 103) and require low-noise
electronics for successful operation [26]. Philips Ingenuity TF PET/MR
and GEs integrated Signa PET/MR are based on a silicon-PM detector
technology.
SiPMs
A new generation of digital detectors based-on silicon photomultipliers
(SiPM) has been replacing the analogue PMTs in recent years (see Fig-
ure 2.5). SiPMs are considered the semiconductor analogue of PMTs.
A photon passing through the silicon layer may transfer its energy to a
bound electron. This absorbed energy causes the electron to move from
the valence band into the conduction band, creating an electron-hole
pair. SiPMs are based on a densely packed array of ∼ 103 - 105 indi-
vidual avalanche photodiodes of ∼20 µm - 100 µm operating in Geiger
mode. Each detected photon generates a fast (time ∼ 1 ns), well-defined
single-photoelectron pulse with a high gain (∼ 106). In other words, it
operates in reverse bias to set up an electric field across the depletion
region that will cause these charge carriers to be accelerated towards
the anode (holes) and the cathode (electrons). All photodiodes are con-
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nected through a polysilicon quenching resistor and are read in paral-
lel. When a photon from the scintillator interacts with a photodiode,
it causes a breakdown discharge that results in a pulse of high gain.
Therefore the output of SiPM is the sum of all the pulses from every
photodiode that detected a photon [23, 26, 27].
Fig. 2.5: Right GE signa integrated PET/MR detector with 25 mm deep crystal
lutetium-based scintillator and 25 cm FOV. Left Not that the traditional photo-
multiplier tube is replaced by MR compatible SiPM. Image obtained and edited
from [24, 28], under creative commons attribution unported license.
Compared to the analogue PMTs, SiMPs have comparable gain while
operating in low voltages. Moreover, it combines the advantage of the
compactness, the cost-effective semiconductor technology, the low power
consumption, and the magnetic field insensibility of the APDs. The
drawback is that SiPMs are more sensitive to temperature that PMTs
[29, 30].
Monolithic scintillator detectors
In recent years monolithic scintillator detectors emerged as the next
technology as a promising alternative to the state-of-the-art clinical PET
detector blocks [31]. Detectors based on a monolithic scintillation crys-
tal read out by pixelated photosensors are considered as alternatives
to the clinical PET detectors used today (based on segmented crys-
tals). The advantages are better spatial resolution with intrinsic depth-
of-interaction (DOI) information (the light distribution changes if the
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interaction takes place closer to the surface of the detector), improved
light output and better timing properties [32]. This indicates that in
principle a significantly better image resolution can be obtained (see
Section 2.1.4).
However, in practice, eventual implementation of these monolithic
scintillator detectors would require overcoming a number of technical
challenges [31, 32]. While commercial preclinical systems already make
use of monolithic, the research for clinically applicable monolithic PET
detectors is ongoing [33, 34, 35, 36]. The biggest challenge and limitation
is considered to be the lengthy calibration procedure that is necessary
to obtain high-resolution detectors.
Time-of-flight information
Time-of-flight (TOF) information was early tested in different proto-
types system during the 1980s. These PET systems used Barium fluo-
ride (BaF2) or cesium fluoride (CsF) as a scintillator. However, because
of the limited stopping power of the used scintillators, these systems had
limited spatial resolution and sensitivity [37]. Over the last 10 years,
TOF-PET/CT has vastly improved PET imaging quality and capabili-
ties, with all commercial manufacturers offering a TOF-PET/CT scan-
ner model (see Section 2.3). Current PET systems provide scintillators
with a higher density (see Table 2.3), shorter decay time and modern
electronics (see Figure 2.6).
Faster detectors may calculate the time interval (∆t) between the
arrivals of the two annihilation photons and can more accurately esti-
mate the origin of the annihilation process. The positioning accuracy
∆x depends directly on the detector coincidence resolving time that is
related via the relation: ∆x= (c∆t)/2, where c is the speed of light in
vacuum and (∆t) the timing accuracy. A new generation of TOF-PET
scanners based-on SiPM detectors achieved a coincidence time resolu-
tion of fewer than 400 ps FWHM, making it capable of advanced TOF
performance [23, 30]. Recently, a TOF resolution of 214 ps obtained
with a SiPM-based detector with 3.2 mm LSO crystals was reported by
Siemens Healthineers [38, 39].
As a result, TOF information leads to faster and more uniform con-
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∆𝑡 < 10	𝑛𝑠
Conventional PET
The event occurred 
somewhere along this line
Time-of-flight PET
The event occurred right 
about here
𝑇𝑂𝐹 < 400	𝑝𝑠
TOF Principle
𝑡2 𝑡1∆𝑥 = 𝑐 ∆𝑡2
Fig. 2.6: Conventional PET vs TOF PET. The estimated time-of-flight difference
(∆t) between the arrival times of photons on both detectors in TOF-PET allows
localization (with a certain probability) of the point of annihilation on the line of
response. In TOF-PET, the distance to the origin of scanner (∆x) is proportional
to the TOF difference via the relation; ∆t: ∆x= (c∆t)/2, where c is the speed
of light. t1 is the arrival time on the first detector, and t2 is the arrival time on the
second detector. Image obtained and edited from [24, 37], under creative commons
attribution unported license.
vergence of the reconstruction, improved lesion detectability, more ho-
mogeneous image quality, and more accurate quantification [40, 41, 42].
It has been shown in a number of studies that TOF leads to a significant
improvement of the signal-to-noise ratio (SNR) and contrast recovery in
both phantom, and as well as inpatient studies [21, 15, 43]. Further-
more, if a CT imaging data of the phantom/patient is available, TOF
can be used to discard the possibility of events outside of the patient
reducing the number of randoms [24, 4].
Coincidence Timing Resolution
Since a PET scanner relies on the coincidence detection of a pair of 511
keV photons, the PET system performance is highly influenced by the
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Fig. 2.7: Illustration of coincidence detection. For an annihilation event, the two
annihilation photons are detected. A pulse is formed on each detector channel
and only if two events t are detected within a few nanoseconds, these events are
considered to have originated from the same annihilation event. Otherwise, both
detections are discarded. Image obtained from [24].
scintillation and photodetector used. An important advantage of PET
is the fact that due to the positron annihilation it expects to observe
two photons at roughly the same time (in coincidence) in the detector
ring are expected. In other words, the annihilation event will be located
somewhere on the LOR connecting the interactions. By recording many
LORs the activity distribution of the organ target can be reconstructed
[4, 24]. Due to the fact that the detector cannot determine if the detected
photons are from the same annihilation event, a short-acceptance timing
window of typically a few nanoseconds (4.9 ns for a TOF-PET system)
is predefined for the detection of both events (see Figure 2.7).
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The concept of measuring 2 events from 1 annihilation with in the
coincidence window is called coincidence detection, and a valid detec-
tion is called a coincidence. Fundamentally, three types of events can
occur: true, scattered and randoms, as shown in Figure 2.10 (as will be
discussed in the following sections). Since a PET scanner acquires dif-
ferent coincidence events that contribute to the image formation, there
are also several degradation factors in the image quality correlated to
these coincidences that need to be discussed.
2.1.4 System characteristics
Limitations of PET are due to various physical degradation factors, such
as the positron range, non-collinearity of the annihilation photons, crys-
tal penetration, inter-crystal scattering, photon attenuation, randoms
and scatters [21, 44].
Spatial resolution
Spatial resolution is the ability of the PET scanner to accurately re-
solve spatially separated radioactive sources [45, 46]. In other words, it
represents the minimum distance between two points such that they in
principle can be resolved in a PET image as two separate spatial loca-
tions. It depends on a number of factors such as the physical processes
of the positron decay and annihilation, the design of the scanner, the
detector size and on the image reconstruction algorithms.
Detector spatial resolution: Crystal penetration and inter-
crystal scattering
Currently, the largest degrading factor of the image spatial resolution
in clinical PET systems is the limited accuracy by which the positions,
where each of the annihilation photons interact with the detectors, can
be determined. The positioning error increases for gamma photons that
have a large angle of incidence on the detector and, thus may first pene-
trate one or more adjacent detector elements before being detected. The
error caused by crystal penetration is also called the parallax error (see
Figure 2.8).
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Crystal Penetration
A photon penetrates completely 
through a crystal and is detected by 
its neighboring crystal.
Inter-crystal scattering
The positioning error caused by the 
loss of information in photon 
detection
Flight path of photons
Assigned LOR
Fig. 2.8: Left Crystal penetration causes the parallax error. This effect can be
found in a PET ring scanner of pixelated block detector and most notable for LORs
at the edge of FOV. Right Illustration of the inter-crystal scattering.
In case an event would be assigned to the centre of the firing detec-
tor, the LOR may not pass through the annihilation point [47]. This
effect is geometric and can be modelled analytically. By using depth-of-
interaction (DOI) detector design the parallax error may be reduced.
Another factor that contributes to the image quality degradation
is the inter crystal scattering (see Figure 2.8). The photon scatters
in multiple crystals in a pixelized detector (small scintillation crystals)
block. Thus the crystal that contains the first interaction site, may not
be identified and processed by the system [48, 49].
For all PET detectors based on segmented crystals, the intrinsic
resolution of the scintillation detector RintrinsincR is strongly related to
the crystal size d. RintrinsincR is given by (d/2 ) on the scanner axis
at mid-position between the two detectors and by (d) at the face of
either detectors. Thus, it is the best at the centre of the FOV and
deteriorates at the edges of the FOV. It may contribute to the loss of
spatial resolution due to the errors in the event localization caused by
statistical fluctuation in the photodetector signals, scatter within the
detector and imperfections in the block decoding scheme [50].
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Positron range
A positron travels some distance through the surrounding tissue while
losing kinetic energy. When it has lost sufficient energy, the positron
captures an electron and subsequently decays into a pair of 511 keV an-
nihilation photons (nearly in opposite directions), as is shown in Figure
2.9.
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Fig. 2.9: After annihilation of a positron and an electron, two 511 keV photons
are emitted in (almost) opposite directions. Non-collinearity leads to positioning
errors. Note that the positron range is the distance between the positron emitting
nucleus and the annihilation point event.
The maximum distance between the original emission point and the
position of annihilation depends on the atomic number of the material
and on the initial kinetic energy of the positrons, which in turn depends
on the radioisotope used. Chapter 4 gives an overview of the positron
ranges of different PET radioisotopes used in a clinical setting.
Rpositron is of minor concern for 18F, 11C, and 13N imaging but it
becomes a more prominent issue for high energy isotopes such as 15O
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68Ga, and 82Rb (see Chapter 4, Table 4.4). Since coincidence detection
is related to the location of annihilation (not to the location of β+ emis-
sion), an error occurs in the localization of true position of the positron
emission thus resulting in the degradation of spatial resolution. The con-
tribution of positron range (Rpositron) on the image spatial resolution is
expressed in terms of the full width at half maximum (FWHM).
In case of integrated PET and MRI systems, the presence of a strong
magnetic field (3 Tesla for most of the clinical PET/MR systems) will
cause the positron to travel in a helical path, therefore reducing the
positron range in the plane transverse to the magnetic field but extend-
ing it in the direction along the main magnetic field. Several studies
have already proven a reduced positron range due to the presence of a
magnetic field [11, 51, 52]. This is discussed in more detail in Chapters
3 and 4, where a realistic GATE Monte Carlos model of the PET/MR
is used to evaluate the effect of the MR field on positron range.
Non-collinearity
As the total momentum is preserved in the annihilation process, the 511
keV gamma photons may not be emitted in exactly opposite directions.
The width of the angular distribution of this deviation, referred to as
non-collinearity, is usually assumed to be in the order of ± 0.25◦ [53].
As a consequence, the detected LOR may not intersect the real annihi-
lation point (see Figure 2.9). The effect of non-collinearity on the image
resolution Rnon−collinearity is largest in the centre of the scanner, where
its effect in terms of FWHM can be estimated as:
Rnon−collinearity ≈
(
0.25× pi180◦
)
Dscanner
2 (2.5)
Rnon−collinearity ≈ 0.0022 ·Dscanner (2.6)
where Dscanner is the scanner diameter. The effect of Rnon−collinearity
in the image resolution is directly proportional to the Dscanner [24, 53].
Therefore, the Rnon−collinearity worsens with large diameter. For a clin-
ical scanner with a ring diameter of 70 cm and 90 cm, this effect is in
the order of ∼1.5 mm to ∼2.0 mm, respectively.
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Image spatial resolution
In most cases, multiple factors contribute to spatial resolution and image
blurring. Combining the contributions mentioned, the image spatial
resolution RimageSR of a PET image for events in the centre of the
scanner can be estimated by using Eq 2.7:
RimageSR ≈ krecon ·
√
R2intrinsincR +R2non−collinearity +R2positron (2.7)
Where krecon is an experimental factor that takes into account imperfec-
tions resulting from the reconstruction method (usually a factor of 1.2 to
1.5, depending on the reconstruction settings) [54, 53]. An overview of
the performance characteristics of PET scanners available on the market
is given in Table 2.4.
Sensitivity
PET scanner sensitivity is defined as the fraction of detected positron
annihilation events relative to the activity present in a source (usually
expressed in cps/MBq). To obtain a high scanner sensitivity, a high
gamma photon efficiency of the detectors is essential. Since both anni-
hilation photons have to be detected, the scanner sensitivity is correlated
to the square of the detector’s detection efficiency (i.e what fraction of
the annihilation photons that pass through the detectors are actually
absorbed, converted and detected). It is also important to mention
that detector detection efficiency is highly dependent on the material
and the thickness of the scintillation crystal [27] and the type of used
radioisotope (see Chapter 3). Because the radiation is being emitted
isotropically the solid angle coverage of the scanner is also a limiting
factor (i.e. how much of the solid angle around the patient is being
covered). The sensitivity of a point source at the centre of a single ring
scanner can be expressed by:
Ssensitivity =
A · ε2 · exp−µt
4pir2 (2.8)
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where A is the detector area is seen by each point of the object to be
imaged, ε is the detector efficiency, µ is the linear attenuation, t is the
thickness of the detector and r is the radius of the detector ring [5].
The scanner sensitivity improves with increased geometry efficiency.
This can be done by reducing the scanner diameter and/or by increasing
its axial FOV [23, 30]. As a result, a high sensitivity scanner will reduce
imaging time or permit imaging at lower activity concentration, thereby
decreasing the injected activity. It will also permit dynamic scans with
short-lived isotopes and repeated longitudinal studies without concerns
over administered dose.
Noise sources: randoms, scattering, and photon attenua-
tion
As discussed in 2.1.3, if both 511 keV photons originating from a single
emitted positron are detected in two nearly opposite directions, this is re-
ferred to as a true coincidence (or simply a true) (see Figure 2.10). How-
ever, due to several effects, the determined LOR does not pass through
the voxel in which the annihilation took place and in general corrections
are required in the acquisition and reconstruction.
Fig. 2.10: Three possibilities exist for such a measurement: true, scattered and
random coincidence. In the last two types, the annihilation event (marked with a
red circle) does not lie on the apparent line of response between the two photon
detections. Image obtained from [24].
The first noise source originates from scattered coincidences, when
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one or both photons from a single positron decay undergo single or multi-
ple Compton scattering in the patient’s body. As a result, one (or both)
annihilation photons might be deflected from their initial trajectory and
will either not be detected or they will be detected by a different detector
pair than expected. This wrong spatial association highly contributes
to the deterioration of the image signal-to-noise (SNR) ratio [55]. Since
the annihilation photons lose energy in a Compton event, scattered pho-
tons can be identified and rejected by applying an energy threshold, if
the energy of a detected photon can be determined with a high enough
accuracy [56].
A second type of image SNR deterioration originates from random
coincidences (or simply random). They occur when two unrelated pho-
ton annihilation are registered on a detector pair within the set energy
and timing window. The proportion of randoms increases with increas-
ing energy window, coincidence timing window, and increasing activity
injected (especially for non-pure radioisotopes, see section 2.1.2). These
randoms directly affect image SNR. Random coincidence (R) can be
measured by measuring the single count rate on each detector for a given
time window and then corrections are made by subtracting it from the
prompts between a detector pair [57]. This is given by the Eq 2.9:
R = 2τ · S1 · S2 (2.9)
where τ is the time width of the pulses in nanoseconds for the system
and S1 and S2 are the single count rates in counts/s on each of the two
detectors along the LOR [57]. Another method to measure the randoms
is to employ two coincidence circuits, one with the standard time window
and another with a delayed time window [58].
The third source of error is (somewhat related to the first one),
the photoelectric absorption of one or both annihilation photons in the
patient’s body [59], known as attenuation. As a result, these photons
(from annihilation deep inside the body) have a lower probability to
reach the detector. Without corrections, it will result in a hampering
quantification and a reduction of SNR in the reconstructed image.
One method to correct attenuation and scattering is to calculate
patient-specific attenuation and scattering coefficient maps [59]. In prac-
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tice, this is done by using the measured patient data from CT.
2.1.5 PET data acquisition
In PET data acquisition, the electrical pulse produced by the PET de-
tector undergoes signal conditioning and processing before being han-
dled by the data acquisition system. Thus, the PMT/SiPM outputs
are routed to an amplifier and shaper first, before being digitized by an
analogue to digital converter (ADC) [60]. The position, energy, and the
TOF information (if it is the case) for all valid events will be stored
by the data acquisition module to be used later for performing data
corrections and reconstructions. The digital image is represented by a
matrix of digital values that can be read by a computer and displayed
or modified in order to emphasize the diagnostic information.
Frame vs list-mode
Data are acquired in either frame mode or list mode. In frame-mode,
digitized signals are collected and stored in a matrix of given size and
depth for a specified time or a total number of counts. In other words,
one frame of data represents a set of sinograms during a given acquisi-
tion. In list-mode, digitized signals are coded with time marks as they
are received in sequence and stored as individual events. After the acqui-
sition is completed, data are manipulated to form images. This permits
retrospective framing with frame duration chosen after the data are ac-
quired. This allows more flexibility as additional information such as
photon energy and timing can be included [61]. Furthermore, the list-
mode acquisition provides fast acquisition speeds at the expense of data
volume [62].
Sinograms
In the scanner, coincidence events are observed and identified along their
LORs between pairs of detector elements (see Figure 2.1). To organize
these raw data, the LORs are stored in such a way that all the LORs
passing through a single point form a sinusoid curve in the raw data
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histogram. Each point in image space will, therefore, result in a sinu-
soid on the sinogram containing the data for a single transaxial section
through the patient [4].
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Fig. 2.11: The 2D (also can be acquired in 3D mode) image of the tracer distri-
bution is collected by sorting each event into its appropriate location in sinogram
space where each line of response has a corresponding angle and offset to indicate
its location in the sinogram. Image obtained and edited from [63], under creative
commons attribution unported license.
At this level (see Figure 2.11), the sinogram is normally corrected and
reconstructed by using a reconstruction algorithm. Image reconstruction
is in this sense aiming to resolve the inverse problem of the acquisition,
in which the final product will be a three-dimensional representation of
the tracer distribution, as it is in reality.
2.2 PET reconstruction
After the acquisition of PET data, the next stage in the PET processing
chain is to reconstruct an estimate of the in-vivo tracer distribution.
The image reconstruction process is the most mathematically complex
step and is well described elsewhere. This section will point out the dif-
ferences between the two (analytical and iterative) most common meth-
ods: filtered-backprojection (FBP), which is a well-established method,
2.2 PET reconstruction 43
ordered-subsets expectation maximization (OSEM), which is the widely
used reconstruction algorithm in nuclear medicine and the more recent
iterative approach the Bayesian penalized likelihood reconstruction algo-
rithm, which uses a block sequential regularized expectation maximization
(BSREM) as an optimizer. A full chapter will be dedicated to evalu-
ating the impact on the image quality by using different reconstruction
methods. (see Chapter 5).
2.2.1 FBP
Filtered-back projection is an analytical reconstruction method, which
consists of back-projecting the raw data (rows and columns represent-
ing angular and radial samplings) across the imaging matrix. Once a
sinogram is created, an image of the tracer distribution can be mathe-
matically obtained as shown in Figure 2.12.
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Fig. 2.12: Illustration of the difference between Simple Backprojection and Filtered
Backprojection. Image obtained and edited from [63], under creative commons
attribution unported license.
The simple back-projection has the problem of blurring effect (1
r
)
artefacts caused by “shining through” (as described by [4]) radiations
from adjacent areas of increased radioactivity. It results in an approx-
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imation of the original image (true activity distribution f ′(x,y)). This
result in a blurred version of the original image f(x,y) (see Figure 2.12).
The blurring effect is minimized by applying a ramp filter to the acquisi-
tion data, and filtered projection data are then Backprojected to produce
an image that is more representative of the original image f(x,y). Ap-
plying the ramp filter Hkr in Fourier space produces a modified Fourier
transform for each projection, which is given by P ′(kr,φ)= |kr|P (kr,φ).
P (kr,φ) is the unfiltered Fourier transform. Finally, the inverse Fourier
transform is performed to obtain filtered projection data in the spatial
domain, which are then back-projected in the same way as in the Simple
Backprojection f(x,y).
This reconstruction method requires continuous sampling of the pro-
jection data (both linear and angular projections related to r and φ of
the sinogram) for an accurate back-projection. Additionally, data noise,
positron range, non-collinearity, scattering, and random events are not
taken into consideration in the method [64]. These reasons combined
with the advance of computer processing, make the iterative methods
(see next section) a more attractive reconstruction method. (Note that
FBP still widely used as the optimal reconstruction method for NEMA
spatial resolution test, see Section 2.4).
2.2.2 OSEM
The most common and widely used iterative reconstruction algorithm in
PET clinical imaging is OSEM, an accelerated variant of the maximum
likelihood expectation maximization (MLEM) algorithm. In MLEM,
the maximum likelihood (ML) formulation gives an indication of which
solution fˆ has greatest statistical consistency with the observed data by
maximizing the likelihood fˆ = arg max
f
P{p; f}. P{p; f} is the probability
of detecting pi counts on LOR i, given the tracer distribution f.
OSEM accelerates the convergence of ML by performing updates
based only on a portion of the data, which approximates the MLEM
solution in much less reconstruction time. This technique divides the
data into several subsets following a certain order. Equation 2.10 is
applied to each subset
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fˆ
(k+1)
j =
fˆ
(k)
j∑
m∈S◦
hmj
∑
i∈S◦
hij
pi∑
n
hinfˆ
(k)
n
, (2.10)
where k is the iteration number, i the LOR index and j,m, n the voxel
indices (Figure 2.13 shows a schematic illustration of how iterative recon-
structions estimate the radiopharmaceutical distribution in the patient’s
body).
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Fig. 2.13: Schematic illustration of the steps in iterative reconstruction. An initial
image estimate is made and projections are calculated by forwarding projection.
The calculated forward projection profiles for the estimated image are compared to
the profiles actually recorded from the object and the difference is used to modify
the estimated image to provide a closer match. Image obtained and edited from
[63], under creative commons attribution unported license.
The term ∑
n
hinfˆ
(k)
n is the forward projection that gives an estimate
of the measured data pi. The estimated projections and measured data
are compared by calculating the ratio:
pi∑
n
hinfˆ
(k)
n
(2.11)
The error is backprojected into the image space by Equation 2.12 and
then the backprojected data is normalized, as it is given by Equation
46 2 Background
2.13. ∑
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(2.13)
The back-projection is only performed for the projection data belong-
ing to a subset S◦. At each update, a different subset is selected. This
accelerated convergence through the use of subsets, allows the OSEM
algorithm to generate PET images in clinically feasible times [65]. How-
ever, one drawback to MLEM and OSEM is that it generally cannot be
run to full convergence because the noise in the image grows with each
iteration (see Figure 3.6 in Chapter 3). In order to reduce image noise,
the OSEM algorithm is usually stopped before the convergence occurs,
in order to prevent excessive image noise amplification. In clinical prac-
tice, the algorithm is stopped after 2-4 iterations and 20-30 subsets to
make sure the full image is close to convergence and all high-frequency
components are reconstructed. Additionally, these images are typically
post-smoothed after reconstruction using a low-pass filter to reduce noise
levels [66].
2.2.3 BSREM
As discussed above, one drawback of the maximum likelihood recon-
struction in emission tomography is the excessive noise propagation. An
effective way to suppress this noise propagation is to use the maximum a
posteriori approach [67]. The prior most often used is a Gibbs distribu-
tion which penalizes absolute differences between neighbouring pixels.
The Bayesian Penalized Likelihood (BPL) reconstruction algorithm uses
a Sequential Regularized Expectation-Maximization (BSREM) to im-
prove the image quality by controlling noise amplification during image
reconstruction. It makes use of the Relative Difference Penalty (RDP),
which has the advantage of providing activity-dependent noise control
[2, 68]. BSREM formulation uses the Maximum a Posteriori (MAP)
criterion that can be expressed as:
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fˆ = argmax
f
P{p; f} = argmax
f
P{p; f} · P{f}
P{p} (2.14)
By taking the logarithm and ignoring P{p} (not a function of f) the
MAP criterion is modified:
fˆ = argmax
f
[logP{p; f}+ logP{f} (2.15)
An energy function U (f) = logP{f} can now be utilized to penalize
image solutions that do not possess expected properties (the energy
function U (f) is designed, so that the expected image configurations
are those for which neighbouring pixels have similar intensities). The
solution can be found using the following MAP algorithm:
fˆ
(k+1)
j =
fˆ
(k)
j∑
m
hmj + β
∂U(f)
∂fj
|
fj=fˆ (k)j
∑
i
hij
pi∑
n
hinfˆ
(k)
n
, (2.16)
with β with a positive weighting parameter which controls the influence
of the penalty. As a result, the BSREM only needs to set a penalty
strength instead of the iterations and subsets in conventional OSEM re-
construction. This allows the algorithm to reach full convergence with-
out increasing noise while preserving edges [69]. Therefore, filters for
post-smoothing are not necessary. However, there is a minor risk of us-
ing BSREM when the primary requirement is to detect small lesions.
This will be discussed in Chapter 5.
2.3 Hybrid systems
Hybrid systems have recently become commercially available with the
potential to change medical imaging by providing combined anatomical-
metabolic image information. In this section, I will describe some com-
mercial state-of-art PET/CT and PET/MR hybrid imaging systems.
Tab. 2.4: NEMA data on PET/CT scanners based-on SiPM detectors available
on the market.
GE Siemens Philips
Parameters DMI
3 Rings
DMI
4 Rings
DMI
5 Rings
Biograph
Vision
Vereos
Digital
Axial
FOV (cm)
15 20 25 26.1 16.4
Transverse
FOV (cm)
70 70 70 78 67.6
Crystal T.
(mm)
25 25 25 20 19
Spatial R.
(FWHM)
Rad, 1 cm 4.69 4.1 3.68 3.7 4.11
Tang, 1 cm 4.08 4.19 4.01 3.7 4.11
Axial, 1 cm 4.68 4.48 4.28 3.8 3.96
Rad, 10 cm 5.58 5.47 4.79 4.6 NA
Tang, 10 cm 4.64 4.49 3.83 3.9 NA
Axial, 10 cm 5.08 6.01 4.9 4.3 NA
Rad, 20 cm 7.53 7.53 NA 6.0 5.79
Tang, 20 cm 5.08 4.9 NA 3.6 5.79
Axial, 20 cm 5.47 6.1 NA 4.6 6.2
Sensitivity
(cps/kBq)
7.3 13.7 20.28 16.4 5.7
Counting
rate statistics
Peak NECR
(kcps)
102.3 193.4 268.9 306 171
Peak NEC
Activity
(kBq/ml)
23 21.9 21 32.6 50
Peak NEC
SF (%)
41.2 40.6 41.5 38.7 30
Maximum
Error (%)
3.88 3.14 3.2 1.25 NA
Timing R. (ps) 375.6 375.4 376 NA 316
Energy R. (%) 9.3 9.4 9.6 NA 11.1
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2.3.1 PET and CT
As explained in Section 1.1, the PET modality as a diagnostic tool is
limited by its spatial resolution and the absence of clear anatomical
landmarks. However, integrating PET images with anatomical informa-
tion provided from CT can improve diagnostic accuracy. Several studies
have shown the benefit of PET/CT hybrid imaging. Bar-Sholam et al.
assessed the additional value of hybrid PET/CT over stand-alone PET
and stand-alone CT with a study of 204 cancer patients with 586 sites
suspicious of disease [70]. An improved diagnostic interpretation of 49%
of cancer patients and 30% of sites were reported. The additional value
includes precise lesion characterization, lesion localization and lesion de-
tection. In 14% of cancer patients, combined PET/CT had an impact on
the patient management which included referral and planning of surgery,
chemotherapy, radiotherapy, exclusion of cancer and guidance in inva-
sive diagnostic procedures. Another study with 2847 prostate cancer pa-
tients using 11[C]choline PET/CT has reported a significantly increased
accuracy of prediction of prostate cancer [71].
The ability of hybrid PET/CT systems to accurately identify the
anatomic location of focal lesions and to provide attenuation-corrected
images led to the rapid introduction of commercial systems by the ma-
jor medical imaging companies (all systems nowadays are combined
PET/CT systems). Table 2.4 shows the PET performance and specifica-
tion of the last generation of PET/CT scanners based-on high-resolution
SiPM detectors currently available on the market.
2.3.2 PET and MRI
There are many clinical situations in which MR imaging, rather than
CT, is the anatomic imaging technique of choice (such as the paranasal
sinuses, salivary glands, oral cavity, and brain). Furthermore, the high
resolution as well as high contrast, allows to distinguish different soft tis-
sues much better than any other modality without exposing the patient
to ionizing radiation. As shown in Figure 2.14, over the last decade, the
combination of PET and MRI in one system has proven to be highly
successful in basic preclinical research, as well as in clinical research.
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Fig. 2.14: Number of publications regarding simultaneous PET/MR imaging start-
ing in the year 2000. Image obtained from [72]
Despite the great potential of the fully integrated PET/MR systems,
there were major issues that had to be solved before being used into clin-
ical practice. The first was to make the PET detector MR-compatible.
Secondly, a proper design for the integration of the PET and the MRI
scanner, and finally, the development of MR based attenuation maps for
accurate PET imaging.
MR-compatible PET detector design
Traditional PET detectors are usually made of inorganic scintillation
crystals, lutetium oxyorthosilicate (LSO) or LYSO being the most used,
coupled to PMTs. However, these detectors are sensitive to magnetic
fields. The magnetic field causes the electrons to deviate from their
original path, causing a tremendous loss in gain and rendering PMTs
essentially useless in the magnetic field of several mT [72]. In the early
stages, the focus was mainly on separating the detector crystals from
the PMTs and coupling them via fibre optics, placing all the PMTs in a
magnetic field-free environment. This solution was very impractical and
raised many problems, such as the handling of such a large quantity of
fibre optics, and poor energy and timing resolutions due to light loss [73].
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Tab. 2.5: Comparison of different types of photodetectors used in PET/MR sys-
tems [4].
Gain Bias
Voltage
Size Efficiency Temporal
Resolution
Cost
PMT 106 800V-1kV Larger ∼30% <600 ps High
APD 102 10V-1kV Small ∼80 % ∼1 ns Medium
SiPM 106 30V Small <40% ∼100 ps Low
Avalanche photodiodes (APDs) have been proposed as an alternative to
the standard PMT because these devices are compact and rugged as
well as insensitive to the magnetic field [44]. However, they have a small
gain, large excess noise, and large performance fluctuation according to
bias voltage and temperature (see Table 2.5). The focus shifted to the
development of a new generation of detectors that could replace PMTs
and perform well under magnetic fields. SiPM have been proposed.
It allows the integration of fast PET detectors in an MR environment
and enables TOF information timing resolution (below 400 ps) [74].
Compared to APDs, SiPMs have a much higher gain at much lower
voltages, providing a high SNR [75]. More technical detail on both
types of photodetectors is shown in Table 2.5.
Fully integrated system design
A fully integrated PET/MR system integrates the PET and MRI scan-
ners in a single gantry. The smaller detector bore and long axial extent
(25 cm) of the PET ring (in comparison to state-of-the-art PET/CT)
results in a superior sensitivity of 21 cps/kBq (See Table 2.4), thus al-
lowing a lower PET tracer dosing besides the evident dose reduction
from omitting the CT. However, this configuration has some techni-
cal challenges associated with the mutual interference between the two
imaging modalities including a major redesign of MRI. Most issues with
this design option are related to the limited space available leading to
significant constraints on the PET system. On the other hand, this
system design allows for shorter acquisition time and precise temporal
and spatial registrations, resulting in simultaneous PET and MR image
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acquisition. The reader is referred to Chapter 3 for more details.
Attenuation correction
For quantitative PET imaging, the reconstructed data need to be cor-
rected for attenuation. Contrary to PET/CT, the attenuation map can
not directly be derived from the MRI data acquired by the integrated
PET/MRI. This is due to the fact that MR signals correlate with proton
densities and relaxation properties of tissues. The available methods for
MR-based attenuation correction can be grouped into three categories
including segmentation-based methods, template or atlas registration-
based methods, and joint estimation-based methods [76, 77]. As ex-
plained at the beginning of this chapter, a full description of this topic
is out of the scope of this book.
At this stage, the reader might wonder about the details of the at-
tenuation correction methodology used for phantom studies performed
in this work. NEMA Image Quality measurement (See section 2.4) uses
attenuation correction. The GE PET/MR uses a CT-based template
attenuation correction for the NEMA IQ phantom. Attenuation coef-
ficients for the phantom housing and its fluid fillings are derived from
a predefined µ-map based on CT data. The µ-map is registered to the
non-attenuation corrected reconstructed time-of-flight (TOF)-PET im-
age and subsequently used during PET reconstruction with attenuation
correction [78].
2.4 Acceptance tests for PET systems
In this section, the National Electrical Manufacturers Association (NEMA)
performance measurement tests for PET scanners are described. It cov-
ers the different tests performed in this dissertation, as well as additional
ones commonly performed. See Chapter 3 for more details.
2.4.1 NEMA Performance measurements
In order to reliably compare PET and PET/MR scanner’s performances
amongst different models, it is necessary (or at least recommendable)
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that all manufacturers follow the same set of guidelines for testing of
their scanners. The latest NEMA Standards Publication is NU 2-2018
[46] and provides the procedures to perform the necessary measures to
characterize and classify PET scanners. The publication includes many
different tests, such as spatial resolution, sensitivity, scatter fraction,
count losses, random measurement and image quality, which will be
described below.
2.4.2 Spatial Resolution
Spatial resolution (SR) is defined as the ability to distinguish between
two points in the final, reconstructed image. FBP reconstruction is
commonly used for this test without any post-processing. Resolution
can mean both Full-Width Half Maximum (FWHM) and Full Width
Tenth Maximum (FWTM), so it is important to clarify which one is
being referred to. In both cases, the values are obtained through linear
interpolation of the values of adjacent pixels corresponding to half or
a tenth of the maximum value of the image’s point spread functions.
SR is determined in all directions, through radial, tangential and axial
slices. For this test, glass capillary tubes are used, with sub-millimetric
internal radius and length such that the activity is not spread out for
more than 1 mm.
Fig. 2.15: Left Spatial Resolution phantom with 3 point source locations. Right
Fixture positioning for spatial resolution scan.
A dedicated phantom that holds the capillaries in precise coordinates
is shown in Figure 2.15. The test is performed at the center of the FOV
and repeated at ¼ of the FOV of that distance. Deferentially of the
NEMA NU-2-2007 where the SR measurement is reported at 1 and 10
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cm above the isocenter (See Figure 2.15, left) NEMA NU-2-2012 requires
1, 10 and 20 cm above the isocenter SR measurement.
2.4.3 Sensitivity
Sensitivity is the efficiency of a scanner in obtaining coincidence data
and is usually measured in counts per seconds per kilo becquerel (cp-
s/kBq). It depends greatly on the geometry of the scanner (geometric
efficiency) and also on the detection efficiency intrinsic to the detectors
(intrinsic efficiency). The geometric efficiency is dependent on the width
and length of the scanner, more specifically on the detectable solid an-
gle, inside which coincidences can be detected. The sensitivity test for
PET scanners is performed with very low levels of activity spread out
throughout a 70 cm plastic tube, to minimise the effect of dead time.
This low injected activity, allows the count losses and random events rate
to be at less than 1% and 5%, respectively. For 18F, NEMA recommends
an activity between 5 to 10 MBq at scan start time.
Successive measurements are taken, adding a layer of attenuating
material (aluminum) between each scan (Figure 2.16, A). The tubes
are positioned parallel to the axial direction and are held in place by a
phantom holder (Figure 2.16, B), to minimize movement of the source
between each scan. The procedure is repeated two times, at different
radial positions: at the centre of the FOV and with a 10 cm offset from
the centre. The attenuation-free sensitivity is obtained by extrapolat-
ing the value from the multiple attenuated measurements. The NEMA
sensitivity data are then collected for a period of time to ensure that at
least 10.000 trues per slice are collected. To obtain the system sensitiv-
ity, the data for each of the 5 layers should be made to fit the following
equation 2.17:
Si = S0 × exp−2µAlXi (2.17)
where µAl is the attenuation coefficient of the material, Xi is the accu-
mulated layer thickness and S0 is the attenuation-free sensitivity. This
procedure is done for measurements at the centre of the FOV and with a
10 cm radial offset from the centre. The final reported sensitivity value
is the average of both values.
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Fig. 2.16: (A) Five layers of attenuating material (aluminium) of 2.5 mm thickness
each,(B) shows X and Y adjustment knobs (one full turn approximately 1 mm of
adjustment),(C) Support one side with White knob and in (D) Support other side
with the smallest tube.
2.4.4 Scatter fraction, Count losses and Random
The scatter fraction, count losses and random measurements also re-
ferred to as count rate statistics test, are obtained from a single test that
aims to calculate a system’s ability to measure high activity sources and
to recognize scattered radiation, as opposed to radiation coming directly
from the positron annihilations. Peak NECR and the activity at which
it occurs is the output of this test.
This test is performed overnight with a scatter phantom, a long, 70
cm polyethylene cylinder through which a 70 cm line source runs all
through its height, 4 cm below the center (Figure 2.17). The scatter
phantom is positioned parallel to the axial direction of the scanner and
the line source is filled with very high levels of activity (between 850
- 900 MBq). Successive measurements are obtained to measure each
rate (total prompts and true, random and scattered coincidence rates)
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Fig. 2.17: In (A, B, and C) shows the steps on how to add activity to the red
mark in the line source. (D) shows the PET scatter phantom positioned on the
cradle, and in (E) shows the rotated scatter phantom (drilled hole for line source
directly below central axis of cylinder).
for multiple levels of activity. The rates are plotted against the activity
concentration. For each activity concentration A, the total, RTotal,A true
RTrue,A, random RRandom,A, and scattered RScatter,A events count rates
are calculated, respectively by:
RTotal,A =
CTotal,A
Totalacquisition,A
(2.18)
RTrue,A =
CTotal,A − Cr+s,A
Totalacquisition,A
(2.19)
where Cr+s,A is the number of random plus scatter counts.
RRandom,A = RTotal,A − TTrue,A(1− ScatterFraction) (2.20)
RScatter,A =
TTrue,A
(1− ScatterFraction) ×RTrue,A (2.21)
The scatter fraction (SF) is obtained only for the lowest activity acqui-
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sitions, where the count losses and randoms rate are expected to be less
than 1% of the trues rate.
SF =
∑
A
Cr+s,A
CTotal,A
(2.22)
2.4.5 Image Quality
Image quality is determined from a test that aims to simulate the whole
body. It used two phantoms: a body phantom that simulated soft tis-
sue, hot and cold lesions and lung tissue and the scatter phantom used
previously (Figure 2.17). The background volume of the phantom is
usually filled with an activity concentration of 5.3 kBq/ml (52 MBq of
18F for 9800 ml as the NEMA recommendations). For the six spheres
(10 mm, 13 mm, 17 mm, 22 mm, 28 mm, and 37 mm) in diameter the
sphere to background ratio is recommended to be 4:1 or 8:1 (depending
on the context of the measurement). A central cylinder is filled with
foam beads to simulate lung tissue (Figure 2.18, A). A dedicated im-
age quality study using four different contrast ratios (8:1, 6:1, 4:1, and
2:1) is reported in Chapter 5. By coupling the scatter phantom to the
body phantom the test becomes more realistic, as the scatter phantom
simulates the scattered radiation that comes from body parts that stay
out of the scanner. The phantom data experiments are obtained during
a single bed position scan (usually 5.0 to 10 min) in the full FOV of
the TOF PET/CT. The central slice contained the six spheres and the
adjacent slices are also used for the background ROIs. 60 background
ROIs of each slice of the reconstructed image (12 ROIs on each of five
slices) are drawn on the slices as close as possible to ± 1 cm and ± 2
cm on either side of the central slice. The contrast recovery (CR) is
determined for each hot sphere j by:
CRH,j = 100×
(
CH,j
CB,j
− 1
)
(
aH
aB
− 1
) (2.23)
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Fig. 2.18: Preparing NEMA IQ Phantom. After filling lung region with foam beads
(A), the remaining spaces are filled with water to simulate lung attenuation.(B)
the "cold" (non-radioactive) spheres (28 and 37 mm) are filled with water and blue
food coloring. In (C) after stirring well the activity injected in the background
(according to respective contrast ratio), part of the activity is removed and (D)
then inserted into four hot spheres (usually 10 mm, 13 mm, 17 mm, and 22 mm).
where CH,j is the average number of counts in the ROI in the transverse
image slice that contains the centre of the sphere j. CB,j represents the
average number of counts in the background ROI for sphere j. The terms
aH and aB are the actual activity concentrations in the hot spheres and
background respectively. The phantom has also 2 large spheres which
are not usually filled with isotope. For each non-radioactive sphere j the
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percentage contrast recovery CRC,j was calculated by:
CRC,j = 100×
(
1− CC,j
CB,j
)
, (2.24)
where CC,j and CB,j are average counts in the ROI for sphere j and
average of all background ROI counts for sphere j. The background
coefficient of variance (COV) is calculated as:
BackgroundCOV,j =
SDj
CB,j
(2.25)
where SDj is the standard deviation and CB,j is the average of all counts
for of the 60 background ROI counts for sphere j. The residual lung error
(LE) calculation is defined by NEMA as:
LE,j =
Clung,i
CB,i
× 100% (2.26)
where Clung,i is the average counts for an ROI drawn in the lung insert
on slice i, and CB,i the average background counts for slice i.
2.5 Monte Carlo methods
A Monte Carlo (MC) method can be described as a statistical method
that uses random numbers as a base to perform a simulation of a speci-
fied situation. They are usually applied to simulate complex, nondeter-
ministic processes which are difficult or impractical to reproduce with
real experiments. The applications of the Monte Carlo method in medi-
cal physics cover almost all topics, including radiation protection, diag-
nostic radiology, radiotherapy and nuclear medicine [79, 80].
2.5.1 Relevance of MC to nuclear medicine
In nuclear medicine [80], The Monte Carlo method is a widely used re-
search tool for different areas of diagnostic nuclear imaging, such as
detector modelling and systems design, image correction and recon-
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struction techniques, internal dosimetry and pharmacokinetic modelling.
With the advent of high-speed supercomputers, the Monte Carlo method
has received considerable attention, particularly in nuclear medicine,
and a large number of applications were the result of such investigations
[81, 82, 83]. Several researchers have also used Monte Carlo simulation
methods to study potential designs of dedicated small animal positron
tomographs [84, 85, 86]. Another promising application is the devel-
opment and evaluation of image reconstruction algorithms and correc-
tion methods for photon attenuation and scattering in nuclear medicine
imaging [87]. It allows a detailed investigation of the spatial and energy
distribution of Compton scatter, which would be difficult to perform
using present experimental techniques.
2.5.2 GATE Monte Carlo simulations
In this dissertation and a large portion of the current literature on PET,
Monte Carlo simulations of the imaging process are performed using the
simulation software GATE, the Geant4 Application for Tomographic
Emission [83]. Figures 2.19 and 2.20 show an example of a PET/MR
system configuration and NEMA IQ phantom obtained using GATE.
This is open-source software and continues to be developed by mul-
tiple internationally recognized research groups, together forming the
OpenGATE collaboration. It builds upon Geant4 [88], a simulation
toolkit collaboratively developed in C++ for comprehensive modelling
of the physics of particle interactions. It is specifically developed to
facilitate the use of certain Geant4 libraries for nuclear medicine appli-
cations, and it allows the design of standard geometries but also a sig-
nificant amount of freedom in the system design. It also allows for the
source and scanner components to move, and models the source decay
evolution in time. It tracks the trajectory of the photons and simulates
effects that occur as it goes through the phantom and detector materi-
als, such as photoabsorption, Compton scatter and Rayleigh scattering.
From running a program in GATE, the time and position of all photon
detections are recorded, and with this information, we can produce the
system performance that a real scanner would obtain. GATE simulation
also gives more information about the processes occurring than a real
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Fig. 2.19: Modelled GE Signa PET/MR geometry. CylindricalPET outline in
white; rsector outlined in green; detector block and crystal represented in red; 12
attenuation layers represented in gray. For scale, the axis length is 10 cm is all
directions.
experiment.
In this dissertation, GATE is used in Chapter 4 to predict the GE
Signa PET/MR NEMA performance for different radioisotopes and to
evaluate the effect of the MR field on positron range. The simulated
data is validated using the measured data obtained in Chapter 3.
Fig. 2.20: Modelling of the GE Signa PET/MR system and NEMA IQ Phantom
in GATE (axial slice at the center of the spheres). The detector material is shown
in red, the attenuation media between scanner bore and crystal front face in green,
and the NEMA IQ phantom placed in the center of the scanner.
3
Performance characteristics
of PET/MR for different
radioisotopes
In this chapter, we will discuss the important aspects of the fully inte-
grated PET/MR system performance and the impact of using different
radioisotopes.
3.1 Introduction
The Signa PET/MR has MR-compatible silicon photomultiplier (SiPMs)
detector technology characterized by a superior light detection as com-
pared to conventional PET technology [23, 28, 89]. The advantage of
SiPMs versus avalanche photodiodes (APDs) is a faster response, en-
abling the combination of excellent Time-of-Flight (TOF) PET (close to
400 ps) imaging with MR scanning. The smaller detector bore and long
axial extent (25 cm) of the PET ring (in comparison to state-of-the-art
PET/CT) results in a superior sensitivity of 21 cps/kBq, thus allowing a
lower PET tracer dosing besides the evident dose reduction by omitting
the CT [90]. Hybrid PET/MR is a relatively new multimodality imaging
technique, and offers the potential for combined structural, functional,
and molecular imaging assessment of a wide variety of oncologic, neuro-
logic, cardiovascular, and musculoskeletal conditions [50, 91]. However,
the challenges beyond those of a technical nature remain for PET/MR
imaging, including the standardization of appropriateness criteria, image
acquisition parameters and clinically relevant and commercially available
isotopes.
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With PET becoming more widely used, the transport logistics have
allowed faster shipments of radioisotopes to smalls imaging centers. The
majority of PET studies in clinical routine are still being performed with
18F, because of its physical properties combined with efficient trans-
portation logistics which widely increase its availability. The same holds
for 68Ga and 90Y, of which the use is not dependent on the availability
of a cyclotron. However, the physical properties of the PET radioiso-
topes are quite different from 18F. 18F almost exclusively decays via
positron emission (96.8%) and with a relatively low maximum energy of
the positron of 0.6335 MeV. The maximum and mean range of 18F are
equal to 2.4 and 0.6 mm. The other 3% of decays is via electron capture
[92].
The use of the generator-based isotope 68Ga has seen a steady in-
crease in the last years. It is obtained from a 68Ge/68Ga generator ob-
viating the need for a cyclotron on site. One generator will typically be
used for about 1 year [93] and the equilibrium between 68Ga and 68Ge is
re-attained rapidly enough to allow multiple radiotracers preparations a
day. 68Ga is used for labeling both small compound and macromolecules,
such as 68Ga-PSMA targeting the prostate-specific membrane antigen
or 68Ga-labeled tracers targeting the somatostatin receptor expressed
by neuro endocrine tumors, which are considered as key applications for
combined PET/MR [94, 95, 96]. 68Ga is not a pure positron emitter
and has a more complex decay scheme than 18F. Non-pure isotopes emit
additional gammas that may even directly fall into the energy window
accepted by the PET scanner. These high energy gammas have some
probability of generating spurious coincidences after scattering in the pa-
tient or via e+/e− pair production in the detector or the patient [97, 98].
In 87.8% of the decays 68Ga will emit a positron with a maximum en-
ergy of 1.899 MeV and a mean energy of 0.89 MeV with a halflife t1/2 =
67.6 min. The much higher energy of the positron emission (compared
to 18F) leads to an increased maximum and mean range of 8.9 and 2.9
mm. It also emits additional gammas of 578.52 keV (0.034), 805.83 keV
(0.094), 1077.35 keV (3.22), 1261.08 keV (0.094) and 1883.16 keV (0.137)
(Note: number in parenthesis represents the mean energy, see A).
In the same way, 90Y has gained attention in nuclear medicine for
therapeutic and diagnostic applications. 90Y is used in radioemboliza-
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tion of liver tumors. Tiny glass or resin beads called microspheres are
administered in the hepatic artery and are transported into the blood
vessels at the tumor site. The spheres get physically trapped and the
radioactive isotope 90Y delivers a high dose (via electrons) of radia-
tion to the tumor. Several centers also use their PET system to image
the therapeutic isotope 90Y. Studies have shown that 90Y-DOTA and
90Y-DTPA have a potential in intra-vascular radionuclide therapy and
90Y can simultaneously work as an imaging agent and a therapeutic
[16, 99, 100]. 90Y is mainly a β − emitter with a very small branching
ratio for positron production. In 0.003186% of the decays there will be
the emission of an e+/e− pair at 1.76 MeV. As the transition energy is
1.76 MeV, there remains 738 keV of kinetic energy to be split between
the electron and the positron in order to conserve the null momentum.
With a halflife of 64.1h, 90Y produces a weak but useable PET signal
[6, 15], as illustrated by several clinical and phantom studies.
Furthermore, these isotopes may be of particular interest for PET/MR
in prostate cancer, liver studies and follow up of radionuclide therapy.
Therefore, it is relevant to determine the performance of PET/MR for
these clinically relevant and commercially available isotopes in order
to ensure correct functionality and optimal image quality. For PET
scanners in particular, the National Electrical Manufacturers Associa-
tion (NEMA) has defined a standard to assess the performance of the
tomographic system, which is widely accepted by manufacturers [101].
The NEMA NU 2-2007 standard identifies 18F as the radionuclide to be
used for all tests. Due to factors such as positron range, interference
with magnetic field and non-pure emissions with additional gammas the
results may be different when non-conventional radioisotopes, such as
68Ga and 90Y [102, 103] would be used.
The aim of this study is to assess the impact of using different PET
isotopes for the NEMA Tests performance evaluation of the GE Signa
integrated PET/MR. NEMA NU 2–2007 performance measurements for
characterizing spatial resolution, sensitivity, image quality, accuracy of
attenuation and scatter corrections (IQ), noise equivalent count rate
(NECR) were performed using 18F and 68Ga. For 90Y all tests except
NECR tests were also performed.
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3.2 Materials and Methods
All phantom experiments were performed on the MP24 version of the
GE Signa integrated PET/MR whole-body hybrid system, installed in
UZ Leuven, Belgium. The MR component of the hybrid system consists
of a 3.0 Tesla static magnetic field, a radiofrequency (RF) transmit body
coil and a gradient coil system which provides a maximum amplitude of
44 mT/m and a maximum slew rate of 200 T/m/s. The PET component
is comprised of 5 detector rings, each consisting of 28 detector blocks.
Total axial FOV is equal to 25 cm. Table 3.1 contains a summary of
important design and performance parameters.
Tab. 3.1: Design and PET performance specifications.
PET
Axial PET 25 cm
Transaxial FOV 60 cm
Photodetector SiPM
Scintillator LYSO
Crystal element size 25x4.0x5.3 mm3
Electronics Integrated in-bore
Time resolution <400 ps
Energy window 425-650 keV
Coincidence timing window 4.57 ns (± 2.29 ns)
NEMA NU 2-2007 PET test*
Sensitivity 22.5 cps/kBq
Peak NECR 212.2 kcps
Activity at Peak NECR 18.1 kBq/ml
Scatter Fraction at Peak NECR 44.1 %
Spatial Resolution (Axial) (5.53 – 6.95) mm @ 1 and 10 cm
* GE healthcare acceptance tests [101]
The PET detectors are based on a Lutetium-based scintillator (LYSO)
readout with MR-compatible Silicon Photomultiplier technology [23].
Before NEMA testing, a well counter calibration scan was performed
with 18F in a uniform cylindric phantom. As recommended calibration,
the activity injected was measured using two dose calibrators (Capitec
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- CRC-55tR) with settings for different isotopes. The following mea-
surements were performed according to the NEMA NU 2-2007 protocol.
In this study, we conveniently choose to evaluate the PET/MR using
NEMA NU-2 2007 because GE Healthcare have reported their accep-
tance testing on this version [101].
3.2.1 Spatial Resolution
A high activity concentration of approximately 200 MBq/ml was used to
generate point sources (drop of activity raised in a capillary). In total,
more than 500,000 counts were acquired. Both axial and transaxial res-
olution were measured at two different positions in the axial z-direction:
in the central position of the FOV and at a position a quarter of the total
axial FOV away from the center. The source point position was adjusted
until all x-y-z values fall between ± 2 mm from the required position. At
each of these axial positions, the resolution was measured centrally in
the FOV (1 cm horizontal offset relative to the center) as well as 10 cm
horizontal offset and 10 cm vertical offset relative to the center. Data
was reconstructed with filtered back-projection. The Full Width at Half
maximum (FWHM) and Full Width at Tenth of Maximum (FWTM) of
the point source response function in all three directions were determined
by one-dimensional response functions along profiles through the image
volume in three orthogonal directions. In order to report the limitation
of the NEMA SR test, a new alternative approach using molecular sieve
(with 2.5 mm of diameter), placed at the top of the capillary glass will
be tested for 68Ga.
3.2.2 Sensitivity
Sensitivity was tested with the NEMA sensitivity phantom, composed
of a line source with 5 different thicknesses of aluminium. The 70-cm-
long line source was filled with a volume of approximately 2.3 ml. The
activity level was equal to 10.7 MBq and 8.7 MBq at scan start for 18F
and 68Ga (ensuring that the scan acquired at least 2,000,000 counts).
For 90Y, the activity level was adjusted to 444.9 MBq, to compensate
for the low positron abundance and to keep the scan time acceptable.
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Using this activity, the total number of counts collected was above 2
million counts. This measurement was done in the center of the FOV
and at 10 cm away from the center of the FOV. Data was collected
for a period of time to ensure that at least 10.000 trues per slice were
collected. The system sensitivity was calculated by fitting the decay
corrected count rate of each acquisition to an exponential function of
the aluminium thickness and extrapolating the value for a hypothetical
acquisition with no aluminium tubes over the source (no attenuation).
Axial sensitivity profiles were generated by calculating the sensitivity of
each slice for the transaxially centered data acquisitions that used only
the smallest aluminium tube.
3.2.3 Scatter fraction, Noise Equivalent Count Rate
A 70 cm long plastic tube line source (3.2 mm in inner diameter) was
filled with a calibrated activity of 905 MBq and 871 MBq in a 5.0 ml
of solution for 18F and 68Ga respectively. The line source was inserted
4.5 cm below the central axis of a 70-cm-long cylindrical polyethylene
test phantom. The center of the NEMA scatter phantom was posi-
tioned at the FOV center and the data were acquired overnight. Af-
ter wards twenty-nine frames of data were extracted from the list mode
data, NEMA specifications were used to derive the trues, randoms, scat-
ter, and NECR from the prompts dataset in each frame after a long
overnight scan acquisition. The results were plotted as a function of ef-
fective activity concentration. In addition, the accuracy of count losses
and randoms corrections was determined by extrapolating image results
from low count rates (Note: the overnight NECR scan requires between
850 and 900 MBq of activity at the beginning of scanning).
3.2.4 Image Quality, Accuracy of Attenuation and
Scatter Corrections
Image quality was measured by acquiring the NEMA image quality
phantom. A 5 cm diameter cylindrical insert filled with styrofoam pel-
lets was positioned in the center of the phantom to simulate lung tissue.
The warm background volume of the phantom was filled with an activ-
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ity concentration of 5.3 kBq/ml. Four hot spheres with diameters of 10,
13, 17, and 22 mm were filled with an activity concentration 4 x the
background for 18F and 68Ga. For 90Y a higher 8:1 ratio was used since
typical contrasts in liver therapies are normally higher than 4:1. The
two cold spheres with diameters of 28 and 37 mm were filled with water
(except for the 90Y image quality test, in which all of the spheres were
filled with an 8:1 ratio of activity). Background activity from outside
the scanner FOV was generated by a line source inserted into the same
cylindrical phantom as used in the scatter fraction, count losses, and
randoms measurement. It contains a 116 MBq solution of the isotope
used in the measurement and was placed on the bed axially adjacent to
the body phantom. The percent contrast recovery for the hot and cold
spheres and the background variability were calculated, as defined in the
NEMA standard. The percentage contrast recovery (in an ideal case =
100 %) is determined for each hot sphere j by Eq. 2.23. CS,j is the
average counts of regions of interest (ROIs) on the spheres (a circular
ROI with a diameter equal to the inner diameter of the sphere). These
are positioned in the transverse image slice that contains the centers of
the spheres. CB,j represents the average counts in the background ROI.
The terms aH and aB are activity concentration in the hot spheres and
background respectively. The phantom has also 2 large spheres which
are not filled with isotope. For each non-radioactive sphere j the per-
centage contrast recovery CRC,j was calculated by Eq. 2.24. In order
to determine the percentage background variability Nj as a measure for
the image noise for sphere j (in an ideal case = 0 %), the following Eq.
2.25 was used. SDj is the standard deviation of the background ROI
counts for sphere j. In addition, the central cylinder of the phantom
did not contain any activity, and the relative error was calculated to de-
termine the accuracy of scatter and attenuation correction as described
by Eq. 2.26. Clung,i is the relative error per percentage units for each
slice i, Clung,i is the average counts in the lung insert ROI and CB,i is
the average of the 60 (37 mm) background ROIs drawn for the image
quality analysis [19].
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Image-quality phantom images
The phantom data were obtained with a 10 min scan for 18F and 68Ga
acquisitions. For 90Y, a long 15h scan time and a shorter 30 min repre-
senting a clinical acquisition were obtained using list mode data selec-
tion. The image quality phantom was reconstructed in a volume of 89
images using Ordered Subset Expectation Maximization reconstruction
algorithm (OSEM) including Time-Of-Flight (TOF) and scatter correc-
tions with 2, 3, and 4 iterations of 28 subsets. The scatter correction for
68Ga and 90Y were defined as "dirty" emitters to account for the gamma
photons. These isotopes allow an additional fitting parameter in the
scatter tail scaling process [104]. All reconstruction schemes have a ma-
trix size of 256 x 256 with 2.08 × 2.08 × 2.78 mm3 voxel size including
TOF information. In order to evaluate different reconstruction settings,
the images were reconstructed using 2 mm and no post-smoothing filter
with and without Point Spread Function (PSF). The GE PET/MR uses
a system-generated approach that include a CT-based template attenu-
ation correction for the NEMA IQ phantom.
3.3 Results
3.3.1 Effect of the 3T MR field on Spatial Resolu-
tion
The spatial resolution (FBP reconstruction) results for each isotope are
presented in Table 3.2. As a double check, the 18F-measured values (at
the same equipment across all isotopes) was used as a reference for all
measurements performed on the GE Signa PET/MR. The FWHM radial
and tangential resolution is slightly degraded for 68Ga and 90Y.
In comparison with the 18F measured values, the relative differences
were 17.8% and -1.3% at 1 cm and 27.9% and 3.5% at 10 cm in the axial
direction for 68Ga and 90Y respectively. With regards to the FWTM in
the axial resolution at 1 and 10 cm off center, the percentage difference
relative to 18F values were 70%, and 3.3% at 1 cm and 57.3%, and 12.3%
at 10 cm off center for 68Ga and 90Y respectively. Figure 3.1, shows the
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Tab. 3.2: Spatial resolution tests: FHWHM and FWTM for 1 cm and 10 cm off
center of FOV
FWHM (mm) 18F 68Ga 90Y
At 1 cm
Transverse* 4.05 4.18 4.42
Axial 6.08 7.16 6.00
At 10 cm
Radial 5.75 5.80 5.79
Tangential 4.38 4.46 4.44
Axial 6.85 8.76 7.09
FWTM (mm)
At 1 cm
Transverse* 8.62 8.68 9.02
Axial 11.97 20.35 12.36
At 10 cm
Radial 10.68 10.70 10.78
Tangential 8.61 8.78 8.84
Axial 14.01 22.04 15.73
* Transverse (radial and tangential values are
averaged together).
limitation of the NEMA SR test. The spatial resolution has increased
for 68Ga using the molecular approach by 9.1% and 19.2% at 1 cm and
10 cm off centre.
3.3.2 The primary factor for the Sensitivity
Sensitivity test results for 18F, 68Ga and 90Y, are 21.8, 20.1, and 0.653
×10−3 cps/kBq at the center position and 21.2, 19.7, and 0.667×10−3
cps/kBq at 10 cm off-center. Table 3.3 gives the measured average
sensitivity values at the transaxial center and 10 cm off-center. Also,
data are compared to the average 18F measured and theoretical values.
These estimated values were calculated based on the difference in
branching ratio relative to the 18F. The sensitivity values are in line
with the lower positron fraction of the isotopes.
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Fig. 3.1: Alternative approach to measure the SR using molecular sieve instead of
capillary glasses for higher positron energy emitters, such as 68Ga. (A) molecular
sieve was placed in the SR phantom at the top of the capillary tube. Comparison
of the SR results with and without using molecular sieve at 1 cm (B) and at 10
cm (C).
Tab. 3.3: Sensitivity test results: comparision between the average sensitivity
measured and theoretical values relative to 18F.
Isotope Branching ratio Average Sensitivity Theoretical
measured values (cps/kBq)*
18F 0.968 21.5 -
68Ga 0.879 19.9 19.5
90Y 31.86×10−6 0.66×10−3 0.71×10−3
* Values relative to 18F measured value
3.3.3 Count rate performance and accuracy mea-
surements
The peak NECR, the corresponding activity concentration and scatter
fraction at peak NECR are presented in Table 3.4 and Figures 3.2 and
3.3 for 18F and 68Ga. Table 3.4 summarizes the comparison between
18F and 68Ga in terms of scatter fraction at peak NECR, peak NECR,
activity concentration at peak NECR, and maximum absolute error.
For 18F the NECR has a maximum of 216.8 kcps at an activity
concentration of 18.6 kBq/ml. At the peak, the scatter fraction was
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Tab. 3.4: Scatter Fraction, peak NECR, and soucer activity test results for 18F
and 68Ga.
Scan Type Unit Measured Values
Isotopes 18F 68Ga
Scatter Fraction at Peak NECR % 43.3 42.9
Peak NECR kcps 216.8 205.6
Activity at Peak NECR kBq/ml 18.60 20.40
Maximum Absolute Error % 3.0 6.0
43.3 %, comparable to the results obtained on three separate scanners
installed in three institutions [24].
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Fig. 3.2: NEMA counting rate measurements: count rates vs activity concentra-
tion for both radioisotopes 18F and 68Ga. Notice than peak of the NECR curve of
68Ga is lower (at clinical NECR) and appears at higher activity concentrations.
For 68Ga the trues, random and scatter count rates at the same
activity concentration are lower in comparison to 18F. The measured
NECR peak for 68Ga was also clearly lower and peaks at 205.6 kcps.
This peak is obtained at a higher activity concentration of 20.4 kBq/ml.
The scatter fraction at peak NECR was below 1% lower compared to
value measured for 18F (Figure 3.3 and Table 3.4). After the full 15h
acquisitions (for both isotopes) the maximum absolute value of the slice
error was 3.0% and 6.0% for 18F and 68Ga.
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Fig. 3.3: NEMA counting rate measurements: scatter fraction vs activity concen-
tration for both radioisotopes 18F and 68Ga
3.3.4 Image Quality: Positron range effect
The results for contrast recovery versus sphere diameter of the image
quality phantom are shown in Figures 3.4 and 3.5. In the Figure 3.4A,
the contrast recovery of the reconstructed image of the phantom without
PSF and post-smooth filter was lower for 68Ga and 90Y as shown in
Figure 3.5A the relative difference to 18F measured values.
30
40
50
60
70
80
90
100
5 10 15 20 25 30 35 40
C
on
tra
st
 R
ec
ov
er
y 
[%
]
Sphere diameter [mm]
F-18
Ga-68
Y-90
30
40
50
60
70
80
90
100
5 10 15 20 25 30 35 40
C
on
tra
st
 R
ec
ov
er
y 
[%
]
Sphere diameter [mm]
F-18 TOF-PSF-OSEM 2mm
Ga-68 TOF-PSF-OSEM 2mm
Y-90 TOF-PSF-OSEM 2mm
A B
Fig. 3.4: Contrast recovery of TOF-OSEM 4 iteration and 28 subsets as a function
of sphere size for 10 min (18F and 68Ga) and 15 h (90Y) acquisition times and
different isotopes. The cold and radioactive spheres are indicate using open (18F
and 68Ga) and filled circles (90Y), respectively. A without PSF and post-smoothing
filter and B with PSF and 2 mm post-smoothing filter
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Fig. 3.5: Percentage difference relative to 18F for each sphere size: A without
PSF and post-smoothing filter and B with PSF and 2 mm post-smoothing filter.
(Note: (A) The contrast recovery is affected by the mean magnetic field, the
CR difference relative to 18F is higher for the CR of the small spheres. (B) The
resolution modelling improves CR.)
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Fig. 3.6: Axial slices of the phantom reconstructed using TOF-OSEM for 2, 3, and
4 iterations and 28 subsets for different acquisition times and different isotopes: A
without PSF and post-smoothing filter and B with PSF and 2 mm Gaussian filter.
The contrast recovery increased when compared using TOF, PSF and
post-smooth filter, as showed in Figures 3.4B and 3.5B. The background
variability, and the lung region relative error for 18F, 68Ga and 90Y are
shown in Table 3.5 for different sphere sizes. 90Y has a much lower image
quality and suffers from low counts. The residual lung error is clearly
higher than for 18F and 68Ga. This is also visually confirmed by the
clinical reconstructions (30 min acquisition) in Figure 3.6.
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When compared in terms of number of iterations (Figure 3.6), the
noise level increased with increasing the number of iterations for all
isotopes.
Tab. 3.5: Background variability and residual lung error of TOF-OSEM 4 iteration
and 28 subsets image reconstructed, with and without PSF and 2mm post-smooth
filter for 18F, 68Ga, and 90Y respectively.
*TOF-OSEM TOF-PSF-OSEM 2mm
18F 68Ga 90Y 18F 68Ga 90Y
Background Variability [%]
10 mm 6.1 7.5 9.0 7.4 7.2 8.6
13 mm 5.0 5.8 7.9 6.2 6.0 7.7
17 mm 4.2 4.4 7.0 5.0 4.7 6.9
22 mm 3.3 3.3 6.3 4.0 3.5 6.2
28 mm 3.1 2.7 5.9 3.6 2.6 5.7
37 mm 2.7 2.1 4.9 3.0 2.0 4.7
Lung Error [%] 1.6 1.1 6.4 1.4 1.0 4.3
*4 iterations and 28 subsets
3.4 Discussion and future work
The aim of this study was to assess the impact of using different PET
isotopes for the NEMA Tests performance evaluation of the GE Signa
integrated PET/MR. The performance and characteristics of PET/MR
have been investigated based on NEMA NU-2 2012 with regard to 18F
[102, 103, 105], but not for different PET isotopes. Furthermore, the
NEMA NU-2 2012 version is only slightly different from the 2007 version.
The most substantial changes are relatively minor, mostly designed to
make the test easier to conduct, more reproducible, or more clearly
defined [101]. In this study, we conveniently choose to evaluate the
PET/MR using NEMANU-2 2007 because GE Healthcare have reported
their acceptance testing on this version [105].
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The system performance of the GE Signa integrated PET/MR was
substantially different, in terms of NEMA spatial resolution and image
quality for 68Ga and 90Y PET imaging test as compared to 18F. In the
transverse plane the magnetic field reduces the effective positron range,
the dominant factor on spatial resolution seems to be the detector pixel
size and the transverse resolution is therefore comparable with the result
of 18F. This effect was confirmed by other studies with simulations for
different isotopes and field strengths [52, 106]. The main magnetic field
along the axial direction leads to an increased positron range in this di-
rection and a pronounced reduction of the range in the transversal plane
for high-energy positrons. On the other hand, the positron range effect
of the magnetic field is not significant for 18F [107] and no significative
effect was found for 90Y. In agreement with these studies, the FWHM
difference relative to 18F measured values were 17.8% and -1.3% at 1 cm
and 27.9% and 3.5% at 10 cm off center in the axial direction for 68Ga
and 90Y respectively, as shown in Table 3.2. However, the NEMA spatial
resolution test is designed to characterize the detector, rather than the
isotope, which leads to limitations to account for the effect of magnetic
field on positron range on the transaxial resolution measurements. The
capillary is very small, and any positron that escapes the capillary is not
accounted for in the measurements. In addition, axially the annihilation
could occur in the tube sealing compound and beyond that, the axial
test is slightly poor due the rebinning process and larger pixel size in
the z-axis. On the other hand, the spatial resolution has increased for
68Ga using the molecular approach by 9.1% and 19.2% at 1 cm and 10
cm off centre. In the last version of the NEMA NU 2-2018 protocol, the
spatial resolution test point source is specified in terms of point source
dimensions as opposed to capillary tube dimensions. The capillary tube
now is specified as an option [46]. The NEMA image quality test was
also substantially different in the measured contrast recovery, as shown
in Figures 3.4 and 3.5. It seems that the inferior resolution also affects
the contrast recovery of the radioactive spheres in the NEMA quality
phantom for 68Ga and 90Y. While the results look visually (Figure 3.6)
similar between 18F and 68Ga for TOF-OSEM without resolution mod-
elling and post-smooth filter, there is (Figures 3.4A and 3.5A) a clearly
lower contrast recovery for the smaller spheres in 68Ga and also lower
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contrast recovery in 90Y, which is probably caused by the increased
positron range and loss in resolution. A similar approach using different
PET isotopes in a brain phantom measured at different field strengths
was conducted by Shah et al. [107]. The contrast of the reconstructed
image of the brain phantom filled with 68Ga was significantly affected
by the magnetic field in the axial direction more than 18F (low-energy
positron emitter). At the current time, GE PET/MR system allows a
extra fitting parameter for radionuclides labelled “dirty” in the recon-
struction settings. However, errors in scatter correction and the use of
different sphere to background ratios might have influenced these re-
sults [23, 108, 109, 110]. A low-frequency offset of the data makes the
images appear to have more or less contrast recovery. And different ra-
tios lead to different contrast recovery. This can explain the crossing of
the 90Y curve (ratio 8:1) in Figure 3.4. Regarding the noise level and
the average lung residual error (Table 3.5), the results were comparable
between 18F and 68Ga, but for 90Y the background variability and the
lung error are clearly higher than for 18F and 68Ga, which is also visu-
ally seen (15h and 30 min acquisition) in Figure 3.6. However, when
comparing the reconstructed images using resolution modelling and 2
mm post-smooth gaussian filter to reduce the noise, the contrast recov-
ery increased with acceptable noise level, as shown in Figure 3.4B and
3.6B. Although high-energy positron emitters are affected by the field
strengths, recent developments in reconstruction methods including ded-
icated positron range correction have successfully corrected this effect
[111]. A new Bayesian penalized likelihood reconstruction algorithm
which uses a block sequential regularized expectation maximization as
an optimizer (including TOF and PSF), was introduced in the last few
years by GE Healthcare (Q.Clear) on their PET scanners in order to im-
prove clinical image quality. Unlike traditional OSEM reconstruction,
which increases the noise with the number of iterations (Figure 3.6),
this algorithm improves image quality by controlling noise amplification
during image reconstruction [30]. The performance characteristics of
Q.Clear will be tested in Chapter 5. The mean sensitivity results shown
in Table 3.3 are in line with theoretical values as expected for 68Ga and
90Y test. The primary factor for the sensitivity change is the scale fac-
tor related to the positron emission fraction (96.7%, 87.9%, 0.003186%
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for 18F, 68Ga, and 90Y respectively). The low branching ratio of 90Y
explains the substantial quality difference of the reconstructed trans-
verse image quality phantom as compared with 18F and 68Ga images, as
shown in Figure 3.6. Several design factors (Table 2) including Compton
scatter recovery [30, 21], the longer axial FOV and reduced detector ring
diameter lead to higher count rates and an increased sensitivity, both
in stand-alone operation and with simultaneous MR image acquisition
[112]. NEMA count rate performance and accuracy measurements sum-
marized in Table 3.4 and Figure 3.2, suggest that the scanner provides
excellent accurate quantitative measurements and utilizes effective ran-
doms and dead time correction methods for 18F [108]. For 68Ga, the
scatter fraction at NECR peak (Table 3.4 and Figure 3.3) was slightly
lower compared to values measured for 18F. This is primarily due to the
fact that 1.2% (1.883 MeV) fraction of 68Ga that decays by β+ results
in a prompt gamma (1.077 MeV) [97, 98] contamination into the PET
data. The prompt gammas of 68Ga can directly fall into the energy
window and be accepted by the PET scanner. This happens when the
1.077 MeV scatters in the phantom and generates an energy falling in
the main energy window. In this case there will be a coincidence with
a true 511 keV resulting from the same decay [15]. Contributions in
which only the gamma is detected would add to randoms which does
not affect the calculation for scatter fraction. The 68Ga NECR test was
clearly lower than measured for 18F and appears at a slightly higher
activity concentration (Figure 3.2). The lower peak NECR can be ex-
plained by the additional 1.077 MeV gamma which leads to additional
detections increasing the deadtime of the detector blocks. These can
also lead to additional randoms or scatter when they lose enough en-
ergy for falling into the energy window. However, the effect from these
prompt-gammas is clearly very small from a scatter fraction perspective
and for all activity concentration values below NECR (Table 3.4), the
maximum absolute value of the slice error is 2.9% and 6.0% for 18F and
68Ga, respectively. There is also no appreciable impact in the measured
residual activity of the lung insert in the IQ phantom (Table 3.5).
In summary, the overall GE Signa PET/MR system performance
with TOF capability based on SiPM detectors, shows substantially dif-
ferent system characteristics for each of these commercially available
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isotopes. However, the NEMA spatial resolution test is designed to char-
acterize the detector, rather than the isotope, which needs to be adapted
in order to well account for the effect of magnetic field on positron range
on the transaxial resolution measurements. The variety of prompt gam-
mas in coincidence of these isotopes and the interference of the MR field
on positron range however, seems to have been compensated by the PET
scanner technologies, which, in combination with recently developments
in reconstruction methods (regularized TOF OSEM and PSF), lead to
a comparable noise-equivalent count rate and a good scatter fraction.
3.5 Conclusion and original contribution
NEMA NU 2–2007 performance measurements using 18F, 68Ga, and 90Y
resulted in substantially different system characteristics, specifically in
terms of spatial resolution and recovery coefficients of the image qual-
ity measurements. NEMA spatial resolution test needs to be adapted
in order to correctly account for the difference in positron range in the
transaxial resolution measurements. And when NEMA image quality
test is compared using TOF-OSEM-PSF and post-smooth gaussian fil-
ter, the contrast recovery increased with acceptable noise level. The
primary factor for the sensitivity change can be explained by the scale
factor related to the positron emission fraction of the isotopes. Scat-
ter fraction and NECR differences between the 18F, 68Ga are relatively
small: for 68Ga the peak NECR is lower and appears at higher ac-
tivity concentrations. The maximum absolute value of the slice error is
2.9% and 6.0% for 18F and 68Ga respectively. These performance results
are compensated by the PET scanner technologies and reconstructions
methods.
The work described in this chapter resulted in several conference
[113, 114, 115, 116, 117] publications and a Springer Nature - EJNMMI
Physics publication [118].
4
GATE Monte Carlo model of
the PET/MR: Modelling and
Validation
In the previous chapter, the NEMA tests were performed on the GE
Signa PET/MR system using different radioisotopes and those results
will be used to validate our GATE Monte Carlo model. In this chapter,
a realistic GATE Monte Carlo model of the PET/MR and the NEMA
test are modelled and validated. This model is use to predict the NEMA
performance of the GE Signa PET/MR for other radioisotopes and to
evaluate the effect of the MR field on positron range.
4.1 Introduction
The simultaneous image acquisition of combined PET and MRI was first
developed for small animal imaging in the late 90s [119] whereas the
application in humans dates from a decade ago [120]. The development
of compact PET detectors based on silicon photomultipliers (SiPMs)
made it possible to integrate PET detector rings into the bore of an MR
scanner and to develop fully integrated PET/MR systems, such as the
GE Signa PET/MR [23, 37, 121].
Other than the advantage of simultaneous imaging in comparison
to the PET/CT systems, the magnetic field could affect the positron
range influencing the spatial resolution of the PET. The positron range
stands for the distance from the emitting nucleus to the annihilation
point with an electron and its value is proportional to the energy of the
positron. A charged particle in a magnetic field with a strength, in the
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order of some Tesla, will describe a helical path around the magnetic
field lines, therefore reducing the positron range in the plane transverse
to the magnetic field [106, 122].
Most of the studies done in PET are based on 18F because it is the
most relevant isotope in the clinic [92]. However, with the increasing
clinical relevance of other radioisotopes, such as 15O, 13N, 11C, 82Rb
and especially 68Ga, the need arises to assess the scanners’ performance
with these radioisotopes due to their different decay scheme and physi-
cal properties. 18F almost exclusively decays via positron emission with
a branching ratio of 96.8% and has a relatively low maximum positron
energy (0.6335 MeV). Properties of 15O, 13N, 11C, are in line with 18F
properties and are considered pure β+ emitters, with the probability of
positron emission being close to 100% and with a maximum energy of
1.735 MeV, 1.198 MeV and 0.960 MeV respectively. On the other hand,
82Rb and 68Ga have more complex decay schemes with multiple positron
emission branches with different energies and with a significant contri-
bution of prompt gamma emissions [6, 93, 94]. In addition, these PET
radioisotopes also have higher positron energies of 3.381 MeV and 1.8991
MeV respectively (energy of the most abundant positron). The impact
of a high magnetic field during PET scanning needs to be evaluated,
especially for high energy positron emitters.
Among the test most widely used, and accepted by the manufac-
tures to evaluate a PET scanner capability, are the sensitivity and Noise
Equivalent Count Ratio (NECR) tests. Sensitivity expresses the fraction
of coincidences due to β+ decay that is registered by the PET system for
low activity concentration. NECR is an estimation related to signal-to-
noise ratio and evaluates the impact of increasing the radiotracer dose
on the PET signal. The aim of this study is to assess the impact of
using different PET isotopes for the sensitivity and NECR performance
evaluation of the GE Signa PET/MR and to investigate the effect of
the magnetic field on the positron range of different PET radioisotopes.
These figures of merit have been evaluated under the NEMA NU 2–2012
protocol [101].
This work has three blocks: (A) Develop a realistic GATE Monte
Carlo model of the GE Signa integrated PET/MR (B) Validation of the
model with the measured sensitivity and Noise Equivalent Count Rate
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(NECR) under the NEMA NU 2–2012 on a 3T GE Signa PET/MR using
18F and 68Ga taken from [118]. (C ) Use the GATE-model to predict the
performance of the system for the isotopes 18F, 11C, 15O, 13N, 82Rb, 68Ga
and to evaluate the effect of the 3T-MR field on positron range.
4.2 Material and Methods
The MR component of the GE Signa PET/MR system has a static mag-
netic field of 3.0 tesla with a maximum radiofrequency amplitude of 44
mT/m and a maximum slew rate of 200 T/m/s. The PET consists
of 5 rings of 28 detectors (25 × 4.0 × 5.3 mm3) based on lutetium-
yttrium-oxyorthosilicate crystals with MR-compatible SiPM technology
[27]. The composition results in a FOV of 25 and 60 cm in the axial
and transaxial direction respectively. NEMA NU 2–2012 performance
measurements using 18F resulted in slightly different system character-
istics compared to the other isotopes due to their physical properties.
All results were compared to the acceptance testing results from litera-
ture data on a similar GE Discovery MI PET/CT system with 5-rings
and on GE Signa PET/MR system for 18F as shown in Table 2.4. The
absolute sensitivity and NECR for 18F, 11C, 15O, 13N, 82Rb and 68Ga
radioisotopes were estimated according to the NEMA test phantoms.
The results were validated with published and measured values.
4.2.1 GATE simulations
Monte Carlo simulations were implemented in GATE and run on the
high-performance computer Vlaams Supercomputer Centrum installed
at Ghent University. GATE is a toolbox based on Monte Carlo simula-
tions adapted for nuclear medicine applications [83].
4.2.2 GE Signa PET/MR Model
A model of the GE Signa Integrated PET/MR was implemented in
GATE. The system has an axial and transaxial field-of-view of 25 cm
and 60 cm respectively, an LYSO scintillator with crystal elements of
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25 x 4.0 x 5.3 mm3, uses an energy window of 425-650 keV and a co-
incidence window of 4.57 ns (±2.29 ns). The geometry was modelled
using the cylindrical PET system in GATE, considering foam, plastic
and copper shielding between the field of view and the detectors. The
simulated system was used to calculate the annihilation distribution of
the positrons in different tissues and includes the following physical pro-
cesses: positron decay, multiple scattering, ionization, bremsstrahlung
and electron annihilation. To characterize the effect of the 3 T MR field
on the positron range, we simulated point sources of positron-emitting
radionuclides including 18F, 11C, 15O, 13N, 82Rb and 68Ga positioned in
the middle of a homogeneous 20 x 20 x 20 cm3 cube with different tissue
media (soft-tissue, lung-tissue and bone). For each isotope, 5 million
events were simulated with and without a 3T-MR field applied in the
z-direction (axial). The positron energy and the decay schemes of each
radioisotope are shown in appendix A.
4.2.3 Sensitivity test
Sensitivity measurements were performed according to the NEMA NU
2–2012 protocol [101]. The sensitivity test is performed at two different
locations in the FOV by multiple measurements of a 700 mm long source
filled with low levels of activity while successively adding aluminum lay-
ers. The line source is placed inside the NEMA sensitivity phantom
that consists of an aluminum cylinder of 2.5 mm thickness with accu-
mulated 2.5 mm aluminum sleeves surrounding the line source. The
low activity level minimizes random counts and effects of system dead
time while the dense aluminum shielding of the source assures sufficient
annihilation events to measure the PET signal.
Sensitivity is calculated by extrapolating to the attenuation-free count
rate via exponential regression of the five measurements using the Eq.
2.17, discussed in Chapter 2. The simulations consisted of a low ac-
tivity (5 MBq) line source, firstly positioned in the center of the FOV
and secondly at a radial distance of 10 cm from the center. To measure
the sensitivity, five different simulations with successive combined sleeve
thickness (1, 2, 3, 4 and 5 sleeves) around the line source were acquired
and the trues only count rate was obtained for each simulation. This
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procedure is done for simulations at the center of the FOV and with a
10 cm radial offset from the center. The final reported sensitivity value
is the average of both values. The sensitivity values at different readout
levels were compared to the sensitivity profile measured on the scanner.
Post-processing sensitivity data
ROOT’s “Coincidences” tree stores pairs of Singles that meet the condi-
tions specified in the digitizer. Each pair is identified by an eventID for
each particle (eventID1 and eventID2 ), which identifies the radioactive
decay the Singles comes from. Furthermore, the entire history for each
particle of the pair is recorded, from their original position’s coordinates
to the interactions (Compton or Rayleigh scattering effect) they suffer
before reaching the detector. A coincidence is considered to be ran-
dom when the eventID for particle 1 differs from particle 2. When they
are equal, a coincidence can still be considered scattered or true. True
coincidences are obtained after checking for any Compton or Rayleigh
scattering. When a true coincidence is found, its position along the
z-direction (the position of where the radioactive decay took place) is
stored into a 1D histogram, which can be used later to obtain an axial
sensitivity distribution, or profile, for the scanner.
4.2.4 Noise equivalent count rate test
NECR is measured with a 700 mm long and 203 mm wide polyethylene
cylinder over several levels of activity and thus considers the random
counts and scanner dead time. Through a sinogram-based analysis, the
peak NECR, corresponding activity and scatter fraction can be extracted
from these measurements [101]. The scatter fraction was assessed by
simulating a polyethylene cylinder containing a 70 cm long plastic tube
line source (3.2 mm inner diameter) with high activity. To simulate the
NECR in GATE, the activity in the line source was acquired using a
total of 11 different activity levels (varying from 1 to 800 MBq) in order
to reduce the computational time. The number of scattered and total
coincidences was estimated for each slice as the integral of the summed
radial profiles, as prescribed by the NEMA protocol.
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Post-processing NECR data
The analysis is based on sinograms and is aimed at estimating the rate
at which the scanner acquires coincidence data, be it true, random, or
scattered coincidences. The sinogram data consists of the angle and the
displacement of the LOR. The GATE output file (‘.dat’) file containing
the columns of data are then read into MATLAB as a 2D matrix and
transformed into a 2D histogram with 320 bins for the angle information
in the vertical axis, which varies from 0 to pi, and 640 bins for the
displacement data in the horizontal axis, varying from -300 to 300 for
the GE Signa. All the steps of the post-processing data are shown in
Figure 4.1.
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Fig. 4.1: Post-processing NECR data: A - Extract in ROOT the sinogram data
for each coincidence, B - Set to 0 all pixels located further than 12 cm away from
the center of the FOV, C - Sinogram after alignment according to the maximum
values for each projection angle, D - Sum each projection of the sinogram, E -
Select a 40 mm wide strip to Estimate random + scatter counts, F - Compute
Scatter Fraction, Count Rates and NECR.
NEMA prescribes an alignment of the sinogram by finding the max-
imum value of the pixel for each projection, and shifting each angle so
that the maximum value is at the center of the sinogram, with S = 0
mm, as shown in Figure 4.1C. After alignment, pixels in every projection
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angle that have the same displacement are summed in order to obtain a
sum projection, according 4.1.
C(r)i,j =
∑
θ(r − Smax(θ),θ)i,j (4.1)
where r is the pixel, θ is the projection, and Smax represents the location
of the pixel with the maximum value in each projection, as shown in
Figure 4.1D. In order to estimate the background counts, the NEMA
procedure filters the sum projection of the total coincidences into a 40
mm wide strip (Figure 4.1E). The value of the left and right bins at the
edge of the curve are then averaged and multiplied by the number of
pixels in the strip. By adding this value to the number of coincidences
outside the strip, the number of random plus scatter counts, Cr+s (see
Chapter 2, section 2.4.4), is obtained.
4.2.5 Positron range evaluation
The GATE-model was also used to simulate the influence of the magnetic
field on the positron range for lung tissue (0.26 g/cm33), soft tissue (1.00
g/cm33), bone (1.42 g/cm33) and for commercially available isotopes.
To characterize the effect of the 3T-MR field on the positron range, we
simulated point sources of positron-emitting radioisotopes including 18F,
11C, 15O, 13N, 68Ga, and 82Rb positioned in the middle of a homogeneous
20 x 20 x 20 cm3 cube with different tissue media (soft-tissue, lung-tissue
and bone). The point source was also positioned at the boundary of
the lung and soft tissue. For each radioisotope, 5 million events were
simulated with and without the 3T-MR field applied in the z-direction
(axial).
The three-dimensional (3D) range of each recorded positron is calcu-
lated according to Eq 4.2, looping over the individual coordinate (x,y,z)
variables.
R =
√
x2 + y2 + z2 (4.2)
The mean 3D positron range is obtained using numpy function.
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4.3 Results
The simulated results were compared to the NEMA measured values on
the PET/MR published in Chapter 3.
4.3.1 GATE-model of the GE Signa PET/MR
The GATE-model of the GE Signa PET/MR including the MR-body
(grey) and NEMA phantoms with the activity isotopically distributed
on a 70-cm-line source (red) are presented in Figure 4.2 according to
NEMA NU 2-2012 protocols.
Fig. 4.2: Visualization of the GATE-model of the GE Signa PET/MR system
including the NEMA sensitivity and NECR phantoms (upper) with a 70-cm-line
activity source (red).
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We have modelled the GE Signa PET/MR using GATE for Monte
Carlo simulations. The simulated results were compared with published
and measured NEMA sensitivity and NECR results for 18F and for 68Ga
taken from Chapter 3.
4.3.2 Sensitivity
The results obtained for the simulated sensitivity measurement per-
formed on GE Signa PET/MR with a 3T MR field using a 18F and
68Ga sources, (21.2 cps/kBq and 19.2 cps/kBq, respectively) are com-
parable to values measured following the NEMA protocols, 21.5 cps/kBq
and 19.9 cps/kBq respectively as shown in Table 4.1.
Tab. 4.1: Sensitivity test results for 18F and 68Ga at 0 cm and 10 cm off center.
These results are compared to the 18F and 68Ga-measeured values [118]
Measured (cps/kBq) Simulated (cps/kBq)
0 cm 10 cm 0 cm 10 cm
18F 21.831 20.063 21.205 21.112
68Ga 21.173 19.689 19.098 19.017
Tab. 4.2: Averaged (1 cm and 10 cm off center) sensitivity test results for different
isotopes [118]
Branching
Ratio (%)
Measured
(cps/kBq)
Simulated
(cps/kBq)
Theoretical values
(cps/kBq)
18F 96.76 21.5 21.2
15O 99.89 - 20.9 22.20
13N 99.82 - 21.5 22.18
11C 99.75 - 21.1 22.16
82Rb 95.45 - 20.3 21.21
68Ga 87.90 19.9 19.2 19.53
Table 4.2 shows the average of the simulated NEMA sensitivity test
for 18F, 15O, 13N, 82Rb, 68Ga at the transaxial center and 10 cm off-
center. The theoretical values were calculated based on the 21.5 cps/kBq
sensitivity measured value for 18F taken from Chapter 3 and taking
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into account each radioisotopes’ total positron branching ratio. The
simulated sensitivity values are in line with the measured and theoretical
values for 18F and 68Ga. Thus validates the simulation model.
There is a limitation regarding the annihilation in the sensitivity
phantom’s attenuation layers, which significantly affects the regression
method used to estimate the attenuation-sensitivity for 82Rb. Figure
4.3A shows the limitation regarding the measurement with the first at-
tenuation layer, that falls outside the trend of the rest of the measure-
ments.
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Fig. 4.3: Sensitivity data plotted against the accumulated attenuation layer thick-
ness and exponential regression for 82Rb. In A and B - Show the fitted equation
and coefficient of determination for simulations at the center of the FOV (0 cm,
blue) and for 10 cm radially off center (10 cm, orange) with 5 attenuation layers
and with 4 attenuation layer, respectively.
Figure 4.3B, shows the attenuation-sensitivity profile without the
first attenuation layer measurement and extrapolated the sensitivity
based on the other measurements. The average sensitivity value (0 and
10 cm values) increased in Figure 4.3B to 21.4 cps/kBq, compared to
19.8 cps/kBq when measured with 5 layers (Figure 4.3A). NEMA sen-
sitivity test needs to be adapted for 82Rb.
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4.3.3 Noise equivalent count rate
The results for the measurements of peak NECR, the corresponding
activity concentration and the scatter fraction at peak NECR for 18F,
11C, 15O, 13N, 82Rb, 68Ga are presented in Table 4.3.
Tab. 4.3: Measured and simulated scatter fraction, peak NECR and source activity
for different isotopes.
Scatter Fraction
at Peak (%)
Peak NECR
(kcps)
Activity at Peak
NECR (kBq/ml)
18F [118] 43.3 216.8 18.60
18Ga [118] 42.9 205.6 20.40
18F 38.8 216.8 17.4
15O 38.8 216.4 18.2
13N 38.2 212.0 16.5
11C 38.5 217.6 16.7
82Rb 39.1 173.5 19.6
68Ga 38.7 207.1 20.1
This table summarizes the comparison between simulated and mea-
sured values taken from PET/MR data in Chapter 3. Figure 4.4 shows
the true, random and scattered coincidence rates as a function of the
activity concentration. The curves and the acceptability of the test are
presented for 18F, 15O, 13N, 82Rb, 68Ga.
NEMA count rate statistics simulation results for 18F and 68Ga are in
agreement with published, measured values in Chapter 3, thus validating
the built GATE model, as well as the analysis method. 11C, 13N and 15O
offer similar results to 18F in terms of peak NECR and scatter fraction.
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Fig. 4.4: Simulated NEMA count rates test for 18F, 15O, 11C, 13N, 82Rb and
68Ga, as a function of the activity concentration.
4.3.4 Positron range evaluation
The positron range of the high energetic radioisotopes was substantially
affected by the 3T magnetic field. The variation of mean range be-
tween different tissues is enormous, especially in the case of lung-tissue,
compared to soft-tissue and bone. The effect is more noticeable for high
positron energy emitters, such as 15O, 68Ga and 82Rb, reducing the range
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in the transverse plane (x/y-direction) by a factor 3-4 when compared to
the range in z-direction in lung-tissue. The transversal (x/y-directions)
and axial (z-direction) positron range values are presented on Figures
4.5, 4.6, 4.7 and Tables 4.4, 4.5 and 4.6.
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Fig. 4.5: Simulated 3D mean positron range for lung-tissue in a 3T static magnetic
field.
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Fig. 4.6: Simulated 3D mean positron range for Soft-tissue in a 3T static magnetic
field.
While significant changes are seen in the transversal plane, the mag-
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Fig. 4.7: Simulated 3D mean positron range for Bone in a 3T static magnetic
field.
netic field does not show any impact of the magnetic field on the ab-
solute values of the positron range in the axial direction. Annihilation
point density distribution profiles are presented in Figure 4.8, showing a
spread-out density distribution in the z-direction. Figure 4.9 confirms a
strong dependency on the density of the tissue surrounding the source.
The effect of the magnetic field is also clearly seen all throughout the
different radioisotopes and different tissues, although it is much more
prominent for high energy emitters in less dense tissues.
Tab. 4.4: Mean 3D positron range for different tissues and radioisotopes in a
3T-MR field.
Max Energy (keV) Branching Ratio (%)
Mean 3D Range
(mm)
Soft Lung Bone
18F 633.5 96.86 0.52 1.70 0.34
15O 1732.0 99.89 1.66 4.28 1.17
13N 1198.5 99.82 1.01 2.63 0.69
11C 960.2 99.75 0.96 1.97 0.51
82Rb 3378.0 95.45 3.82 10.12 2.74
68Ga 1899.0 87.90 2.04 4.59 1.26
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Tab. 4.5: Mean positron range of the transversal direction (x or y -direction) for
different tissues and radioisotopes with and without 3T-MR field.
Mean x or y Range (mm)
Radioisotope Max Energy
(keV)
Soft Lung Bone
0 T 3 T 0 T 3 T 0 T 3 T
18F 633.5 0.27 0.26 0.95 0.73 0.17 0.17
15O 1732.0 0.93 0.77 3.74 0.97 0.61 0.57
13N 1198.5 0.54 0.49 2.15 0.74 0.35 0.34
11C 960.2 0.48 0.39 1.52 0.63 0.26 0.25
82Rb 3378.0 2.42 1.62 9.10 2.25 1.54 1.28
68Ga 1899.0 1.01 0.95 4.04 1.00 0.66 0.61
Tab. 4.6: Mean positron range of the axial (z-direction) for different tissues and
radioisotopes with and without 3T-MR field.
Mean z Range (mm)
Radioisotope Max Energy
(keV)
Soft Lung Bone
0 T 3 T 0 T 3 T 0 T 3 T
18F 633.5 0.27 0.27 0.95 1.08 0.17 0.17
15O 1732.0 0.93 0.93 3.75 0.374 0.61 0.61
13N 1198.5 0.54 0.54 2.15 2.15 0.35 0.35
11C 960.2 0.48 0.51 1.52 1.52 0.26 0.26
82Rb 3378.0 2.42 2.42 8.95 8.96 1.54 1.55
68Ga 1899.0 1.01 1.16 4.05 4.04 0.66 0.66
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Fig. 4.8: Simulated annihilation endpoint coordinates (y/x and y/z) for an 82Rb
point source positioned in the middle of a homogeneous lung tissue at 0T (left)
and 3T (right) static magnetic field in z-direction.
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Fig. 4.9: Simulated annihilation endpoint coordinates (y/z) for an 68Ga point
source positioned between lung tissue and soft tissue (dashed black line) at 0T
(left) and 3T (right) static magnetic field in z-direction.
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4.4 Discussion and future work
In this work we have modelled and validated the GE Signa PET/MR to
evaluate the performance and characteristics of the system for using dif-
ferent PET isotopes. The GE Signa PET/MR and the NEMA sensitivity
and NECR measurements were modeled using GATE for Monte Carlo
simulations. GATE-model was validated with published and performed
measurements on the same scanner [118]. The effect of the 3T-MR field
on positron range was also investigated in different tissue types (lung
tissue, soft tissue and bone) for clinically relevant and commercially
available isotopes such as 18F, 11C 15O, 13N, 82Rb, 68Ga.
Regarding the GATE Monte Carlo simulations, the NEMA sensitiv-
ity tests shown in Table 4.1 and Table 4.2 are in line with the theoret-
ical values expected for all measured and simulated PET radioisotopes
(compared to the 21.5 cps/kBq GE Signa PET/MR sensitivity measured
value). Sensitivity changes correspond to the scale factor related to the
branching ratios of the isotopes. Several design factors including Comp-
ton scatter recovery [21, 30, 118], longer axial FOV and reduced ring
diameter lead to a higher count rate and an increased sensitivity [43].
For the pure β+ emitters 11C 15O and 13N the sensitivity was com-
parable to that of 18F. However, 68Ga and 82Rb show considerable dif-
ferences. For 68Ga, this was to be expected as the literature values show
lower sensitivity of about 2 cps/kBq less than 18F [118], which is also
seen in the simulations. The case of 82Rb is quite particular. With a
positron branching ratio similar to 18F (<2% difference), the sensitiv-
ity is much lower than what was expected. Taking a closer look at the
data reveals a difference in the behavior of the radioisotope regarding
the annihilation in the sensitivity phantom’s attenuation layers. The
phantom design needs to be adapted (Figure 4.3). Due to the extremely
high energy of 3.381 MeV of the emitted positrons, the measurement
with only one attenuation layer might falls outside the trend of the rest
of the measurements for this radioisotope, and the other radioisotopes.
In addition (for 82Rb in particular), a significant portion of the coinci-
dences being detected outside the scanner bore, which, in theory, should
not be possible as no LOR can be placed outside the scanner when two
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photons are registered in the detectors. However, due to the additional
777 keV prompt-gamma emission, two gamma photons coming from the
same particle can be registered inside the scanner, even when the source
is outside of the scanner.
NEMA count rate simulated test summarized Figure 4.4 and Table
4.3, shows agreement with the measured values reported in chapter 3
and previous work using 18F [27]. These results suggest that the GATE-
model can be used to study the system performance of the GE Signa
PET/MR. For 11C, 13N and 15O (pure positron emitters), the results
confirm a peak NECR similar to 18F with the effective activity concen-
tration scaled by the inverse of the positron fraction. These isotopes
have short half-lives and high branching ratios for β+ decay.
For the higher positron energy emitters (68Ga and 82Rb), the simu-
lated count rates test was slightly lower compared to the 18F measured
and simulated values, as shown in Chapter 3 and Table 4.3. These is the
primarily due to a 1.2% (1.883 MeV) and 13.1% (2.604 MeV) fraction of
68Ga and 82Rb that decays by β+ and results in prompt gamma contam-
ination into the PET data. These additional prompts lead to additional
randoms, scatters and additional detections increasing the deadtime of
the detector blocks. However, the recent developments in reconstruction
methods (regularized TOF OSEM and PSF), have led to a comparable
noise equivalent count rate and a good scatter fraction [118].
In concordance with other positron range studies [52, 106, 107, 118,
123, 124], we confirmed a strong tissue dependency of positron range. In
addition, we found borders between different tissue densities to have a
noticeable impact on its distribution, with positrons annihilating along
the border in the denser tissue, as shown in Figure 4.9 (a point source
placed between lung and soft-tissue with and without 3T-MR field in the
z-direction). As expected, there is a preeminent 3T magnetic field effect
on higher positron energy isotopes. This strongly reduces the positron
range by a factor of 3-4 in the transverse plane (x/y) perpendicular to the
magnetic field resulting in a significantly increased density distribution
in z-direction, as shown in Figure 4.8 and Table 4.4, 4.5 and 4.6. This
finding suggests, there may be some effect from the presence of mag-
netic field. However, this transverse positron range reduction effect will
be only partially observed in the resolution properties of the PET/MR
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system due to the limiting factor of the 4 mm spatial resolution of the
PET detector.
There are limitations to consider in the simulations. The dead time
digitizer settings have a certain degree of uncertainty as these values
are not published by the manufacturer. The NEMA methods for data
analysis of sensitivity via exponential regression can affect the sensitivity
when applied to simulated data [125]. This might explain the slightly
lower simulated sensitivity values compared to theoretical values. The
scatter fraction determined directly from the event counts in the ROOT
file slightly underestimates the one estimated using the NEMA method.
For all of isotopes simulated the SF were around 38% to 40%, which
is slightly lower compared to 43.3% measured for 18F. The 75 second
half-life of 82Rb would make NECR experiments with real data difficult.
This study has been limited to a 3T magnetic field, reflecting the mean
MR field of the GE Signa PET/MR. Additional tests such as image
quality may be necessary when to study the PET signal in air tissue
boundaries such as lung nodules with high-energy positron emitters.
In summary, the results obtained for the simulated sensitivity and
NECR measurement performed on GE Signa PET/MR with a 3T-MR
field for different radioisotopes, are comparable to literature values mea-
sured following the NEMA protocols, thus validating the simulation
model. With this validated GATE-model of the GE Signal Integrated
PET/MR it is possible to evaluate different reconstruction algorithms
settings using time-of-flight, attenuation or motion correction to esti-
mate their attenuation maps.
4.5 Conclusion and original contribution
GATE Monte-Carlo simulations were used to predict sensitivity and
NECR performance of the GE Signa PET/MR according to the NEMA
test for 18F, 15O, 13N, 11C, 82Rb and 68Ga radioisotopes. Additionally,
we have investigated the positron range effects for different tissue types.
Sensitivity and NECR results obtained with the simulated GATE-model
matched with published values. The system performance was substan-
tially different for different isotopes. Differences in sensitivity are due
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to the scale factor from the positron emission fraction of the radioiso-
topes. The 68Ga and 82Rb NECR test is affected by larger deadtime
and more randoms due to more prompt gammas. The positron range is
tissue-dependent and a magnetic field reduces the positron range by a
factor of 3-4 in the plane perpendicular to the magnetic field and was
found to lead to a measurable increase in the density distribution in z-
direction for higher positron energy emitters. Implementing correction
using radionuclide specific PSF models in the PET iterative reconstruc-
tion algorithms may be useful.
The work described in this chapter gave rise to several conference
publications [126, 127, 128, 129] and a manuscript has been submitted
for publication in the Frontiers in Physiology - Medical Physics and
Imaging journal (currently under review).
5
Noise reduction using a BPL
reconstruction algorithm on
a TOF-PET/CT
In chapter 4 we discussed the performance characteristics of a fully inte-
grated PET/MR system and the impact of using some clinically relevant
and commercially available radioisotopes. However the resolution, noise
and quantitative accuracy of PET are not only affected by the hardware
but also highly influenced by the reconstruction method as discussed
in chapter 3. In this chapter, we will discuss the accurate quantitation
(SUV - Standardized Uptake Value) in PET imaging and the significant
challenge with delivering consistently accurate SUV measurements in
PET imaging.
5.1 Introduction
Fluorodeoxyglucose (FDG) PET/CT scans provide 3D images of metabolic
activity combined with the anatomic structure. This functional imaging
modality is widely used for cancer diagnosis in the initial stage and to de-
termine the severity or to assess treatment response [37, 130]. PET/CT
technology is constantly being improved and new systems are also com-
bined with emerging improvements in image reconstruction. This leads
to changes in the resulting images which need to be tested and clini-
cally validated. The resolution, noise and quantitative accuracy of PET
are not only affected by the hardware but also highly influenced by the
reconstruction method.
Nowadays the most commonly used PET image reconstruction al-
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gorithm in clinical practice is a statistical iterative method known as
the Maximum Likelihood Expectation Maximization (MLEM) [131, 132,
133]. This is a slowly converging method, but images are obtained in
clinically acceptable times with acceleration through the use of subsets
in Ordered Subsets Expectation Maximization (OSEM). However, this
accelerated convergence can be problematic since the best result tends
to oscillate between different subsets. One of the advantages of statisti-
cal reconstruction techniques is the ability to better model the emission
and detection process [134]. The effects of attenuation, detector nor-
malization and contamination by scattering and randoms are nowadays
corrected in the reconstruction algorithm. These improved models of
the interaction in patient and system lead to a more quantitative final
image. In the latest systems the modelling of point spread functions
(PSF) and Time-of-Flight (TOF) information have also been included
and this has shown to lead to a major improvement in image quality
[134, 135]. However, OSEM is also suffering from noise increase with in-
creasing number of iterations. In order to reduce image noise, the OSEM
algorithm is usually stopped before contrast convergence occurs, in or-
der to prevent excessive image noise amplification. In clinical practice,
the algorithm is stopped after 2-4 iterations and 20-30 subsets. Addi-
tionally, these images are typically post-smoothed after reconstruction
using a low-pass filter to remove noise levels and Gibbs artefacts can
occur due to resolution modeling [136, 137, 138].
A new Bayesian Penalized Likelihood Reconstruction algorithm which
uses a block sequential regularized expectation maximization as an op-
timizer, was introduced in the last few years by GE Healthcare. The
algorithm, named Q.Clear on their PET scanners, is introduced to im-
prove clinical image quality. The algorithm is expected to reach con-
vergence without increasing noise while preserving edges [139]. Thus,
instead of the kernel filter, image characteristics are determined by a
regularization β-parameter which penalizes relative differences between
neighboring pixels avoiding excessive smoothing over large edges. Also,
Gibbs artefacts from resolution modeling are avoided [140]. Several re-
search groups have investigated the improvements of the OSEM and
BSREM reconstruction algorithms [30, 141, 142, 143, 144, 145] but not
with regards to image quality acquired on the new Discovery MI with 3-
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rings (GE Healthcare) silicon photomultiplier based TOF-PET/CT with
sensitivity of 7.3 cps/kBq and an axial FOV of 15 cm. The lower sensitiv-
ity can be compensated for by using more activity or longer acquisition
times, however, this is not always possible due to practical, financial or
dosimetric constraints.
In this Chapter, the performance and clinical use of BSREM were
compared to OSEM with full modelling of PSF and TOF information for
both algorithms, acquired on the new Discovery MI with 3-rings (axial
FOV of 15 cm). Both phantom and patient data were analyzed with
regards to Contrast Recovery (CR), background COV, CNR, SUV ratio,
total lesion glycolysis (TLG) and SNR. This study aimed to evaluate
different β-factors compared to a clinical post-filter kernel for different
data-sets with varying noise levels to investigate whether and to what
extent noise can be reduced by using BSREM instead of OSEM.
5.2 Material and Methods
5.2.1 PET/CT System
All data were acquired on a digital GE Discovery MI PET/CT (DMI)
system, installed at the Ghent University Hospital, Belgium. The in-
vestigated system consists of three detector rings; each PET ring uses
136 detector blocks containing a 4 x 9 array of lutetium-based scintilla-
tor (LBS) crystals coupled to a 3 x 6 array of silicon photomultipliers
(SiPMs) with Anger multiplexing for crystal identification. Table 5.1
contains a summary of important design and performance parameters
[46].
A well counter cross-calibration scan was performed with 18F in a
uniform cylindrical phantom before starting the tests as a regular quality
control and assurance procedure.
5.2.2 Image reconstruction
The phantom and patient data were reconstructed using a matrix size
of 256 x 256 with 2.08 × 2.08 x 2.78 mm3 voxels size. Data sets with
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Tab. 5.1: Design and performance specifications of the GE Discovery MI com-
mercial system.
GE Discovery MI 3 detector rings
Axial FOV 15 cm
Patient Bore Size 70 cm
Photodetector SiPM
Scintillator LBS* (LYSO)
Crystal element size 3.95 x 5.3 x 25 mm3
Coincidence timing window 4.9 ns
Sensitivity 7.5 cps/kBq
Scatter fraction 41.7%
Peak NECR 102.3 kcps @ 24.7 kBq/ml
Clinical NECR 29.6 kcps @ 2.4 kBq/ml
*Lutetium based scintillator
multiple acquisition times were generated to evaluate the effect of count
statistics on the reconstructed images. BSREM (Q.Clear) reconstruc-
tion was done for different penalization β-factors 300, 400, 500, 600,
750, 1000, 1500, and 3000. These reconstructions were compared to the
OSEM reconstruction with 3 iterations, 16 subsets and a Gaussian post-
filter with a FWHM of 5.0 mm, as recommended by the manufacturer
to be used in a clinical setting. All reconstructions included attenuation
and scatter correction based on CT as well as PSF modelling and TOF
information.
5.2.3 Phantom data
The NEMA (National Electricals Manufacturers Associations) IEC im-
age quality phantom was used for these experiments. To simulate lesions
of different sizes, the phantom has 6 fillable spheres of different diam-
eters (10 mm, 13 mm, 17 mm, 22 mm, 28 mm, and 37 mm). The
phantom contains a lung insert, which consist of a cylinder positioned
in the center of the phantom with an inner diameter of 44.5 mm and a
volume of 194 ml. The lung insert was filled with low-density styrofoam
pellets and pure water to simulate human lung tissue. The phantom
5.2 Material and Methods 105
was prepared according to the NEMA NU 2-2012 protocol (all spheres
were filled with 18F) [46]. The background volume of the phantom was
filled with an activity concentration of 5.3 kBq/ml (52 MBq of 18F for
9800 ml). The sphere to background ratios were chosen to be 8:1, 6:1,
4:1 and 2:1 for the six spheres.
The phantom data experiments were obtained during a single bed
position scan of 20 min. The central slice contained the six spheres
and the adjacent slices were also used for the background ROIs. 60
background ROIs of each slice of the reconstructed image of the phantom
(12 ROIs on each of five slices) were drawn on the slices as close as
possible to ±1 cm and ±2 cm on either side of the central slice. The
CRs were determined for each hot sphere by Eq. 2.23 described in
Chapter 2 Section 2.4. The background Coefficient of Variation (COV)
was calculated using Eq. 2.25. Contrast-to-noise ratio was defined as
CR divided by the background COV. The SUV values were obtained
using a VOI drawn on the OSEM reconstruction of 20 min acquisition
and then propagated to the BSREM reconstructions.
The CR data, CNR and background COV of the phantom data were
obtained in a single bed-position with full 20 min acquisition. Datasets
of 10, 5.0, 2.5, and 1.0 min, representing shorter scans with lower count
statistics, were obtained using list-mode selections. Reconstructions of
the phantom data were analysed using the NEMA NU 2–2012 protocol
and compared based on different reconstruction parameters.
5.2.4 Clinical data
In our institution, an informed patient consent and a positive advice by
the ethics committee are necessary for retrospective patient studies. The
Belgian registration number (Belgisch Registratienummer) for this study
is B670201939137. Images were analyzed according to FDG PET-CT
European Association of Nuclear Medicine (EANM) procedure guide-
lines for tumor imaging [146]. The images were analyzed using OsiriX
MD 10.0 tools fully optimized for a macOSMojave 10.14 system installed
in the Ghent University Hospital, Belgium. A 71-year-old patient with
multiple B-cell lymphoma lesions of different sizes was selected for this
study. The patient fasted at least 6 h before receiving an intravenous in-
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jection of 340 MBq of 18F-FDG. Before the injection of the radioactivity
tracer, a blood sample was taken to ensure the blood glucose levels (97
mg/dl). FDG-PET/CT imaging started 60 min after the intravenous
injection of FDG. The total acquisition time (9 time lengths per bed-
position), was 10 min (1.07 min/bp). From this dataset, scans of 5.0 min
(0.34 min/bp) and 2.5 min (0.17 min/bp) were generated in list-mode.
The TOF-PSF-OSEM image with post-smoothing with a 5.0 mm Gaus-
sian filter was chosen to delineate the reference lesion volumes (VOIs).
The VOIs were delineated using the a 41% threshold of the maximum
voxel value and then propagated to the BSREM reconstructions.
The same reconstruction parameter settings were used as for the
phantom data. The noise level was calculated as standard deviation (SD)
divided by the SUVmean of a large spherical reference volume (	: 3.0 cm)
placed in the liver (normal uptake). The lesion SNR was computed as the
difference between the SUVmean of the lesion VOI and the background
SUV of the reference VOI placed in the liver, divided by the SD of the
value in the reference VOI. Contrast was calculated as lesion SUVmean
divided by SUVmean of the liver reference VOI. The signal to noise was
evaluated for the different lesions by comparing lesion signal to the noise
level in the liver (see Table 5.3). The TLG was evaluated as the lesion
SUVmean multiplied by the volume of the lesion.
5.3 Results
5.3.1 Phantom data
Contrast Recovery. The results for CR versus background COV of the
image quality phantom for each sphere size and for a contrast ratio
of 8:1 are shown in Figure 5.1. All plots show a similar trend: the
contrast increases when reducing the β-factor and the COV decreases
as β increases in value.
Overall, the CR of BSREM reconstructions reach a plateau with
only a small gain when changing β from 500 to 300. This is especially
the case for the phantom data with low count statistics. There is also
a decrease in CR coefficients. Comparing CR of BSREM for different
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levels of regularization to the CR of OSEM, reveals higher (or at least
similar) contrast recovery for β parameters down to 300, except for the
smallest sphere.
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Fig. 5.1: Contrast recovery of BSREM (β =300-3000, including TOF and PSF)
and TOF-OSEM (3 iterations, 16 subsets, post-filter 5.0 mm and PSF) as a func-
tion of the background coefficient of variation for different acquisition times (20,
10, 5.0, 2.5 and 1.0 min) and a contrast ratio of 8:1. Different plots are shown
with decreasing sphere diameter.
For the largest spheres (37, 28, 22 and 17 mm), the CR seems to reach
a steady value, where its dependence on the β-parameter decreases. As
the sphere size decreases, the convergence of the BSREM reconstructions
appears to be dependent of the sphere size. The difference relative to
OSEM for each sphere sizes as a function of the β-parameter is shown in
Figure 5.2. The CR of OSEM reconstruction under clinical settings at
high count statistics (20 min) and contrast ratio of 8:1 match to the CR
of BSREM with β =750. Figure 5.3 shows a similar trend (as a function
of the acquisition time) for the ratios 6:1 and 4:1.
There is no difference at high count statistics on the CR behavior be-
tween the ratios 8:1, 6:1 and 4:1, although the CR of BSREM decreases
as the acquisition time reduces. This dependence on the count statistics
seems to be more prominent at low count levels (1.0 min) and in the
smallest sphere of the 2:1 ratio. The dependence on sphere size, count-
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Fig. 5.2: Left: Difference relative to the contrast recovery of TOF-OSEM (3
iterations, 16 subsets, post-filter 5.0 mm and PSF) at high count statistics (20
min) for each sphere size as a function of the regularization parameters. Right:
Comparison of the contrast recovery as a function of the sphere size of BSREM
with β =750 (including TOF and PSF) and OSEM for 20 min acquisition. All
plots correspond to a contrast ratio of 8:1.
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Fig. 5.3: Comparison in terms of contrast recovery as a function of sphere size
between (Top) TOF-OSEM (3 iterations, 16 subsets, post-filter 5.0 mm and PSF)
and (Bottom) BSREM with β =750(including TOF and PSF) for different counting
statistics and contrast ratios.
ing statistics and contrast ratio, is also confirmed by the CNR analysis.
Figure 5.4 presents the CNR of BSREM with β =750 and OSEM recon-
struction as a function of the sphere sizes for different counting statistics
and contrast ratios.
For the ratios 8:1, 6:1 and 4:1, the CNR of β =750 increased by
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Fig. 5.4: Comparison in terms of CNR as a function of sphere size between (Top)
TOF-OSEM (3 iterations, 16 subsets, post-filter 5.0 mm and PSF) and (Bottom)
BSREM with β =750 (including TOF and PSF) for different counting statistics
and contrast ratios. Note that the maximum scale value showed in the graphs are
different between both reconstructions.
a factor of 2 (for same count level) compared to OSEM reconstruction,
although CNR decreases with reduction of counting statistics and sphere
size. The same trend was observed for the contrast ratio of 2:1, although
there is a clear reduction in the CNR compared to the other ratios.
Tab. 5.2: Comparison in terms of background COV between TOF-OSEM (3 it-
erations, 16 subsets, post-filter 5.0 mm and PSF) and BSREM with β =750 for
a volume of 26.52 ml at different counting statistics. All values correspond to a
contrast ratio of 8:1.
Time (min) Background COV (26.52 ml)
OSEM β750
1.0 0.186 0.095
2.5 0.119 0.059
5.0 0.084 0.041
10 0.059 0.028
20 0.043 0.021
Noise properties. For reduced count statistics of the contrast 8:1
(reducing the acquisition time from 20 to 10, 5.0, 2.5 and 1.0 min),
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BSREM has in general a lower COV than OSEM. Moreover, OSEM was
more sensitive to noise compared to BSREM with large differences in
COV between the different noise levels for OSEM setting. When reduc-
ing the number of counts by a factor of 2, the COV can be controlled
by increasing the β parameter in the lower count dataset (losing con-
trast recovery). Similarly, the post-filter can be increased in OSEM.
By comparing the reconstruction algorithms for different count levels,
the following observations are made: The curves of BSREM at 50 % of
counts are always outperforming the curves of OSEM at the full 100 %
of counts.
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Fig. 5.5: Qualitative evaluation of the transaxial images of the NEMA phantom
of TOF-OSEM (3 iterations, 16 subsets, post-filter 5.0 mm and PSF) and BSREM
with β =750 (including TOF and PSF). Contrast ratios of 8:1, 6:1, 4:1 and 2:1 are
shown in rows and acquisition times (1.0, 2.5 and 20 min) in column. Background
level is 5.3 kBq/ml in all cases.
For the 4 largest spheres, the BSREM curves for 25 % of the counts
are also outperforming OSEM at 100 % of counts. For any length of the
study the highest contrast recovery is observed for the smallest regular-
ization parameter (300). The contrast recovery decreases with increasing
β parameter. In comparison with OSEM the contrast is higher for a β
between 300 to 600 and comparable for β =750 at 20, 10 and 5.0 min
but slightly lower for 2.5 and 1.0 min acquisitions. Furthermore, tak-
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ing as a reference the full dataset (20 min) reconstructed with OSEM
(post-filter 5.0 mm), it is clear from Figure 5.1 that the contrast (for
all sphere sizes) with β =300 to 600 is still higher for 20,10, 5.0 and 2.5
min. For the smallest sphere, the optimal beta is around β =300 and
400. The background COV comparison to OSEM is shown in Table 5.2.
The COV of OSEM (20 min) is worse than the COV of BSREM with β
=750 for 20, 10 min and 5 min. The COV of OSEM (10 min) is worse
than the COV of BSREM with β =750 for 10, 5.0 and 2.5 min. This
represents a background COV reduction by a factor of 4. The quantita-
tive noise reduction found in Table 5.2 is also visually confirmed by the
reconstructions in Figure 5.5.
For all contrast ratios at 1.0, 2.5 and 20 min, BSREM (with β =750)
reconstructions appears to have better background COV compared to
OSEM reconstructions. However, β =750 has excessively smoothed the
smallest sphere in the 2:1 ratio. This is also confirmed in the Figure 5.1,
which suggests using a β value around 300 and 400 for small lesion at
high count level. Increasing the β-factor leads to extra contrast loss and
should only be done when the count level is low, and contrast can be
traded in for reduced background COV.
5.3.2 Clinical data
For the patient data the contrast of the data sets with three different
count levels (10, 5.0 and 2.5 total acquisition time) was evaluated for
6 different lesions volume (3.92 ml, 2.46 ml, 1.81 ml, 0.84 ml, 0.54 ml
and 0.35 ml) as a function of noise level on the liver. The representa-
Tab. 5.3: Reference values measured in a healthy liver for OSEM and BSREM.
BSREM
Measure OSEM β300 β500 β750 β1000 β1500 β3000
Volume (cm3) 14.137
SUVmean 2.221 2.187 2.192 2.197 2.193 2.204 2.212
SUVSD 0.480 0.441 0.301 0.241 0.206 0.152 0.092
TOF PSF OSEM (3 iterations and 16 subsets and 5mm Gaussian filter).
Measured in a sphere placed in liver for 10 min (total) acquisition time.
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tive example of this patient data is presented in Figure 5.6. The curves
follow a similar trend as in the phantom reconstructions (Figure 5.1).
BSREM outperformed OSEM reconstructions in terms of noise levels
with a lower noise level. Also, the largest difference is seen for big-
ger lesions where reduced noise is combined with higher contrast. The
quantitatively measured values of the reference VOIs are shown in Table
5.3.
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Fig. 5.6: Contrast (SUV ratios) of BSREM (β =300-3000, including TOF and
PSF) and TOF-OSEM (3 iterations, 16 subsets, post-filter 5.0 mm and PSF) as
a function of noise level of a large VOI (	: 3.0 cm) placed in normal liver for
different acquisition times (10, 5.0 and 2.5 min). Different plots are shown with
decreasing lesion volume.
As shown in Table 5.4, the noise level measured in the liver with
BSREM is clearly lower than for OSEM with post-filter. As excepted
from the phantom data analysis, the noise in the liver of OSEM recon-
struction (10 min) is worse than the noise of BSREM with β =750 for
10 min, 5.0 min and is comparable to 2.5 min. Lower noise can be ob-
served for BSREM in all other cases (also when lowering the counts with
a factor 4). This leads to a noise reduction in the liver by a factor of 4.
The SNR of BSREM with β =750 and OSEM reconstruction are also
shown in Table 5.4 for different count levels.
Similar trend to phantom data presented in the Figure 5.4 is observed
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Tab. 5.4: Noise level of a large VOI (	: 3.0 cm) placed in the liver and the
SNR with all lesion sizes averaged are presenting for TOF-OSEM (3 iterations, 16
subsets, post-filter 5.0 mm and PSF) and BSREM with β =750 (including TOF
and PSF). Reference values measured in a healthy liver.
Time (min)* Noise (14.137 ml) SNR (Lesion VOI Averaged)
OSEM β750 OSEM β750
2.5 0.443 0.228 20.256 41.710
5.0 0.318 0.156 15.088 29.092
10 0.217 0.109 10.243 19.448
* Total of 9 range of times per bed-position
SNR for BSREM with β =750 (averaged for all lesion size) increased
by a factor of 2 times for the same counting level. The SNR of both
reconstructions decreases with reduction of counting statistics.
Figure 5.7 shows quantitatively the SUV values of the evaluated
whole-body 18F-FDG PET images of a patient with multiple lymphoma.
In terms of SUVmean and TLG values for all lesion sizes, BSREM (with β
=750) reconstructions of 5.0 and 2.5 min are quantitatively similar to the
OSEM reconstruction (10 min). Also, a qualitative visual evaluation has
the same trends as the phantom reconstructions in Figure 5.5. Based
on visual and quantitative differences we found similar trends to the
phantom data analysis (Figures 5.1, 5.3 and 5.4). It is possible to reduce
the count level of a clinical whole-body 18F-FDG PET/CT imaging with
at least a factor of 2.
Another similarity to consider, especially in terms of noise reduc-
tion without loss in contrast analyses, is that BSREM reconstruction
increased the CNR and SNR by a factor of 2 (for both, phantom and
the cinical data) compared to OSEM at same count level.
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Fig. 5.7: Coronal whole-body 18F-FDG PET images of patient with multiple lesions
of different sizes of B-cell lymphoma. The arrows indicate the SUVmean (red), and
TLG (black) of the lesions. Images were reconstructed using BSREM with β =750
(including PSF and TOF) and OSEM PSF TOF (3 iterations and 16 subsets and
5 mm gaussian filter) for 2.5, 5.0 and 10 min.
5.4 Discussion and future work
This study addressed the noise reduction performance of BSREM (Q.clear)
compared to OSEM for both phantom and patient data acquired on the
new Discovery MI 3-rings silicon photomultiplier based TOF-PET/CT
with sensitivity of 7.5 cps/kBq and axial FOV of 15 cm. Differences of
the performance between OSEM and BSREM are expected due to the
nature of the selective filtering of both algorithms, which can lead to a
direct result on different anatomical information [145]. The aim was to
investigate if the extent of noise can be reduced without a loss in image
quality by using BSREM instead of OSEM.
The latest developments in detector technology and timing resolu-
tion of the digital PET/CT result in an increased sensitivity and count
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rate statistic compared with conventional PET/CT [147, 148]. These
improvements combined with emerging developments in reconstruction
methods, lead to changes in the clinical routine which need to be consid-
ered and harmonized in order to obtain the most optimal image quality.
This should be done in the shortest possible acquisition time, which is
preferable in terms of patient care [109, 149]. BSREM reconstructions
were compared to OSEM with PSF and TOF information using 3 itera-
tions and 16 subsets and a Gaussian filter with a FWHM of 5 mm, which
were the settings recommended by the manufacturer and are expected
to be used in a general clinical setting. However, in most of the clinical
centers, the reconstruction settings are chosen by the physicians based
on the visual assessment of several PET scans. Furthermore, the op-
timization of BSREM reconstructions has been previously investigated,
such as Reynés-Llompart G, et al. [145] using a range of β: 50-500
parameters on a BGO PET/CT. Other previous studies [30, 109, 141]
have used a range of β: 200-800 to examine the BSREM algorithm. In
this work we extended the range to β: 300-3000 to assess, from a clinical
point of view which β-parameter has comparable contrast recovery to
OSEM on the new GE Discovery MI PET/CT. Afterward, we evaluated
qualitatively and quantitatively what is the impact on the noise is under
the condition of different contrast ratios and count statistics.
Regarding the contrast recovery and background COV for equal count
levels, the phantom data analysis showed (Figures 5.1 and 5.2) that for
the four largest spheres (17, 22, 28, and 37 mm diameters), BSREM
results in increased contrast recovery compared to OSEM. β =750 (Fig-
ure 5.2) has comparable resolution to OSEM reconstruction, but with
a reduction of 4 times the background COV (Table 5.2). Although β
=750 has a comparable CR to OSEM, these results pointed out that the
optimal penalization factor depends on the contrast ratio, acquisition
time and sphere size. This suggest that a high value of β can lead to a
negative impact on the detectability of the small lesions. As presented in
Figure 5.1, the phantom results suggest an optimum β-value between 300
and 400, which maximizes the CR and the CNR of the smallest sphere.
This is also in agreement with the previous studies [30, 109, 141, 145].
BSREM outperforms OSEM with regards to the COV for all sphere
sizes. The investigated clinical data showed a trend similar to the phan-
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tom study. For any acquisition time of the phantom data, the highest
contrast recovery was found for a β =300 (Figures 5.1 and 5.6), but
this value also has the highest background COV of any other BSREM
reconstruction. These trends were also confirmed by the clinical data
analysis (Figure 5.6 and Table 5.4), where the noise level and contrast
are higher for β =300. The use of a lower FWHM value (FWHM <
5 mm) of the smoothing post filter would have maximized the CR and
the CNR of OSEM reconstruction, however this would had increased
the COV. In comparison with OSEM on the clinical data, BSREM re-
construction (especially for tumor lesions with VOI =3.92 cm3 and VOI
=2.46 cm3) resulted in an increased tumor SUVmean, SUVmax and an
improved contrast at a matched level of noise. The SNR of the av-
erage of all lesion sizes increased by a factor of 2 at the same count
level (Figure 5.4). However, for lesions smaller than 1.0 cm3 (Figures
5.6 and 5.7) both reconstructions were equivalent in terms of SUV val-
ues. The same behavior was also found in the phantom data analyses
(Figures 5.1 and 5.2). A previous study [150] has reported that while
PSF modelling commonly leads to visually enhanced images with higher
contrast, it can simultaneously lead to notable edge artifacts affecting
the quantification of small lesions. Thus, it is important to assess in
which conditions is beneficial and warranted to use PSF modeling. For
reduced count levels based on phantom data, BSREM has in general
a lower COV than OSEM. When reducing the number of counts by a
factor of 2, the COV can be controlled by increasing the β-parameter in
the lower count dataset (losing contrast recovery). A similar factor of 2
was observed in the clinical data. BSREM with a β =750 increased SUV
values and TLG when compared to OSEM for the same acquisition time
(Figure 5.7). However, there was no difference in SUV values between
OSEM (10 min) and BSREM (2.5 min), confirming that it is possible to
have noise reduction with BSREM while preserving contrast.
Previous studies [109, 149, 150] have suggested β =400 and β =550
as an optimum factor. Another recent study with 45 patients in initial
stage of lung cancer has reported a β-values between 450-600 to be
ideal for lung cancer [150]. Michael Messerli et. al. [151] highlights
the importance for careful standardisation of β-value when following-
up non-small cell lung cancer. The optimum factor changes towards
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higher β-values in patients who received dose lower than 2 MBq/kg
comparing to patients who received doses higher than 2 MBq/kg. The
higher β-values appears to be more appropriate for patients with lower
18F-FDG activity. In our study, the most favorable β-factor for both
phantom and clinical data was in the same range with β =750 at higher
count levels. However, the choice of β might depend on several primary
aspects, such as contrast, SNR, counting statistics, radiation dose or
lesion detectability. Thus, the β-parameter should be chosen dependent
on the requirements and context of the examination. Other aspects to
consider are the acquisition duration and the axial FOV size of the TOF
PET/CT used. According to EANM’s procedure, good clinical whole-
body 18F-FDG images are usually obtained with an acquisition time of
3.0 min/bp [146]. The acquisition time reported evaluating the BSREM
algorithm used 3 different count statistics varying from 3.0 to 1.0 min/bp
reconstruction [109] which has somewhat a discrepancy compared to
the range used 1.07, 0.34 and 0.17 min/bp in our study. This peculiar
time ranges per bed-position was chosen to evaluate the BSREM under
condition of reduced count statistics and, consequently, this decreased
range would probably lead to an increase of the β-factor. An axial
FOV of 20 cm of the PET/CT scanner, would lead to improvements in
sensitivity and count rate statistics compared to an axial FOV of 15 cm
used in our study.
There are other limitations that should be considered in this study.
All results from the clinical data analysis were taken based on one lym-
phoma patient with multiple lesions of different sizes. It is possible
that an analysis of a larger and diversified group of patients would im-
prove the results concerning the SUV lesion volume dependence. Conse-
quently, it was not possible to evaluate the influence of body mass index
of the overweight patients on β-factor [150]. Additionally, there is a re-
striction concerning the 18F-FDG PET imaging tracer. The use of any
other higher positron energy radioisotope would have led to a statisti-
cal uncertainty due to the random nature of radioactive emissions [118].
There is a minor risk of using BSREM when the primary requirement
is to detect small lesions. Under the condition of higher count statis-
tics, the combination of TOF-PSF-OSEM would lead to a comparable
lesion detectability to BSREM, but if OSEM reconstruction is adopted,
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caution should also be taken regarding the increase of noise with the
increase of the number of iterations. Lowering the counts by a factor
of 2-4 (e.g. from 10 min to 2.5 min), BSREM would therefore lead
to a comparable contrast recovery, CNR, background COV and SUV
values than TOF-PSF-OSEM reconstructions at higher count statistics.
On the other hand, this reduction, allows clinicians to reduce the PET
activity needed for many exams, benefiting especially young patients.
In general, BSREM outperforms OSEM reconstructions allowing noise
reduction without losing data information.
5.5 Conclusion and original contribution
Penalized-Likelihood BSREM reconstruction improves image quality and
allows noise reduction by a factor 2-4 while preserving contrast compared
to OSEM reconstructions. Lowering of the injected dose or shortening
the acquisition time is therefore possible by introducing regularization
in the image reconstruction without a loss in image quality.
This work described in this chapter yields to several conference [117,
152, 153, 154, 155] publications and a Springer Nature - EJNMMI Physics
publication [156].
5.6 Ethics approval and consent to par-
ticipate
An informed patient consent and a positive advice by the ethics com-
mittee are necessary for retrospective studies in our institution. The
Belgian registration number for this study is B670201939137.
5.7 Consent for Publication
The patient gave their written consent to our Healthcare Institute for
use data including anonymized pictures.
6
Conclusion and future
perspectives
In this chapter, we give a general overview of all chapters and the most
important results obtained during this work. For some remaining issues,
suggestions for future research will be presented. We will conclude this
chapter with a conclusion.
6.1 Summary
This thesis covers the evaluation of image quality and reconstruction
parameters in state-of-the-art PET/CT and PET/MR systems. In the
first stage, we evaluated the NEMA performance and characteristics
of the TOF-PET/MR for 18F, 68Ga and 90Y radioisotopes. Secondly,
we used the measured data to develop and validate a realistic GATE
Monte Carlo model of the integrated GE Signa PET/MR. This model
was used to predict the NEMA performance for PET radioisotopes (18F,
11C, 15O, 13N, 82Rb and 68Ga) and to evaluate the effect of a 3T MR
field on positron range. Thirdly, we evaluated the image quality of the
new generation of SiPM based TOF-PET/CT system. A noise reduction
study was performed to evaluate the impact of varying noise levels on
the image quality and to investigate whether and to what extent the
impact of noise can be reduced by using BSREM instead of OSEM.
For that purpose, we compared the image quality measurements for 18F
using different contrast ratios.
In Chapter 2, we gave an overview of different imaging techniques
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that were relevant for this work. In the first part, we described the con-
cept of anatomical and molecular-functional imaging to help the reader
understand the context of this thesis. Before describing positron emis-
sion tomography, an overview of radionuclide and radiopharmaceutical
application was presented. This was followed by an introduction to
PET. Next, we presented the basics of the PET detector technology
covering coincidence detection and TOF-PET. Subsequently, effects that
degrade the PET image quality and quantitative accuracies, such as the
effects related to positron emission physics, limitations of the detector
technology and subject dependent effects were discussed. Finally, we
summarized the image representation of the patient’s body containing
the tracer distribution on the PET imaging (discussed in the subsection
2.1.5).
In the second part, the state-of-the-art PET image reconstruction
algorithms were introduced. Because of noise propagation in iterative
reconstruction algorithm such as OSEM, we discussed an efficient and al-
ternative way for noise suppression by introducing a regularization term
with a regularization parameter which controls the relative strength of
the regularizing term and therefore the noise behaviour. This section was
followed by an overview of how PET imaging evolved into hybrid imag-
ing in combination with CT (PET/CT) and MRI (PET/MRI). To ob-
jectively compare PET/CT and PET/MR system performance, NEMA
performance measurement (spatial resolution, sensitivity, NECR, image
quality and accuracy) for PET scanners were described. Finally, be-
cause this thesis uses extensively GATE Monte Carlo simulations, we
discussed in the last part of this chapter Monte Carlo simulation meth-
ods in nuclear medicine.
In Chapter 3, we discussed the important aspects of the performance
of a fully integrated PET/MR system and the impact of using different
radioisotopes. PET/MR imaging is frequently used in clinical research
and routine. NEMA characterization of these systems is generally done
with 18F which is clinically the most relevant PET isotope. However,
other PET isotopes, such as 68Ga and 90Y, are gaining clinical impor-
tance as they are of specific interest for oncological applications. These
isotopes have a complex decay scheme with a variety of prompt gammas
in coincidence. 68Ga and 90Y have higher positron energy and, because
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of the larger positron range, there is significant interference with the
magnetic field of the MR compared to 18F. Therefore, it was relevant to
determine the performance of PET/MR for these clinically relevant and
commercially available isotopes.
The results of the system performance tests were presented and dis-
cussed in the final part of chapter 3. The system performance of the
integrated GE Signa PET/MR was substantially different, in terms of
NEMA spatial resolution for 68Ga PET imaging test as compared to
18F and 90Y. We reported that in the transverse plane the magnetic
field reduces the effective positron range, the dominant factor on spa-
tial resolution seems to be the detector pixel size and the transverse
resolution is therefore comparable with the result of 18F. The FWHM
difference relative to 18F measured values were 17.8% and -1.3% at 1 cm
and 27.9% and 3.5% at 10 cm off-centre in the axial direction for 68Ga
and 90Y respectively. Subsequently, we found the NEMA spatial reso-
lution test is not well designed to account the effect of magnetic field
on positron range on the transaxial resolution measurements. To ac-
count the positron range effects, NEMA spatial resolution test needs to
be adapted. For that, we also measured a new approach measuring the
point source distribution with a molecular sieve instead of using capil-
lary glasses. Figure 3.1, shows the limitation of the NEMA SR test. The
spatial resolution has increased for 68Ga using the molecular approach.
The biggest change for image quality with 68Ga are the increased
positron range as compared to 18F. We showed that the inferior res-
olution also affects the contrast recovery of the radioactive spheres in
the NEMA quality phantom for 68Ga. However, the contrast recovery
increased when compared using TOF, PSF and post-smooth filter, as
showed in Figures 3.4B and 3.5B. Subsequent we evaluated the lung
residual error (Table 3.5). The results were comparable between 18F
and 68Ga, but for 90Y the background variability and the lung, error is
higher than for 18F and 68Ga, which is also visually seen (15h and 30
min acquisition) in Figure 3.6.
Regarding the Sensitivity test, the primary factor for the sensitiv-
ity change is the scale factor related to the positron emission fraction
(96.7%, 87.9%, 0.003186% for 18F, 68Ga, and 90Y respectively). The low
branching ratio of 90Y explains the substantial quality difference of the
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reconstructed transverse image quality phantom as compared with 18F
and 68Ga images (Figure 3.6).
In the last part of Chapter 3, we gave a general discussion of the re-
sults obtained from NEMA count rate performance measurements. Two
major conclusions were drawn. First, the scatter fraction at NECR peak
(Table 3.4 and Figure 3.3) for 68Ga was slightly lower compared to 18F.
This is primarily due to 1.2% (1.883 MeV) fraction of 68Ga that decays
by β+ can result in a small prompt gamma (1.077 MeV) [97, 98] contam-
ination into the PET data. The prompt gammas of 68Ga can directly fall
into the energy window and accepted by the PET scanner. This happens
when the 1.077 MeV photon scatters in the phantom and generates en-
ergy in the energy window. Second, the 68Ga NECR test was lower than
for 18F and the peak appears at a slightly higher activity concentration
(Figure 3.2). The lower peak for the NECR can be explained by the
additional 1.077 MeV gamma-ray which leads to additional detections
and increases the deadtime of the detector blocks. These can also lead
to additional randoms or scatter when they lose enough energy and fall
into the energy window. However, the effect of these prompt-gammas is
very small compared to the scatter fraction (Table 3.4). The maximum
absolute value of the slice error is 2.9% and 6.0% for 18F and 68Ga,
respectively.
Further validation of a realistic GATE Monte Carlo model of the
PET/MR using the NEMA measurements was presented in Chapter 4.
Three major findings were presented and discussed. In the first part of
the chapter, we gave an overview of the physical properties of the 18F,
11C, 15O, 13N, 82Rb, 68Ga radioisotopes and the GATE Monte Carlo
simulation setup. Monte Carlo simulations were implemented in GATE
using the high-performance computer Vlaams Supercomputer Centrum
installed at Ghent University. Subsequently, we implemented a realistic
GATE model of the GE Signa integrated PET/MR. The geometry was
modelled using a cylindrical PET system in GATE, considering foam,
plastic and copper shielding between the field of view and the detectors.
In the subsection 4.3.1, we presented the GATE-model of the GE Signa
PET/MR NEMA scatter and sensitivity phantoms with the uniform
activity distribution in a 70-cm-line source (Figure 4.2) as described by
the corresponding NEMA protocol.
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In the second part of this chapter, we gave a general discussion of
the results obtained from the simulated phantom data. The GATE-
model was validated with NEMA measurement of the sensitivity and
noise equivalent count rate for 18F and 68Ga as described in Chapter
3 [118]. NEMA sensitivity tests shown in the Tables 4.1 and 4.2 were
in line with the theoretical values for all measured and simulated PET
radioisotopes (compared to 21.5 cps/kBq sensitivity measured value).
For 11C 15O and 13N the sensitivity result was comparable to that of
18F. For 68Ga, a lower measured and simulated sensitivity of about 2
cps/kBq less than 18F [118] was observed as expected and described
in literature values show. With a positron branching ratio similar to
18F (<2% difference), the sensitivity obtained for 82Rb was much lower
than what was expected. The NEMA sensitivity phantom design needs
to be adapted to accurately measure the sensitivity for 82Rb. Due to
the extremely high energy of 3.381 MeV of the emitted positrons, the
measurement with only one attenuation layer shows that it falls outside
the trend of the rest of the measurements for this radioisotope com-
pared to the other radioisotopes. Equally important, because of the
additional 776.5 keV prompt-gamma emission, a significant portion of
the coincidences coming from the same particle can be registered inside
the scanner, even when the source is outside of the scanner. In terms of
NEMA count rate statistics, simulation results for 18F and 68Ga showed
good agreement with published and measured values of Chapter 3. The
comparison between simulated and measured values for PET/MR are
summarized in Table 4.3. Figure 4.4 shows the true, random and scat-
tered coincidence rates as a function of the activity concentration. The
curves of the test are presented for 18F, 15O, 13N, 82Rb, 68Ga. Compar-
ing the NECR of 68Ga and 82Rb emitting higher energy positrons with
18F measurements and simulations, the simulated count rate curves were
slightly lower. Because of the simultaneous emission of prompt gammas
(3.2% with 1.077 MeV and 15.1% with 0.777 MeV for 68Ga and 82Rb,
respectively) additional random and scatter events are detected which
increase the dead time of the detector blocks.
Finally, we used the GATE-model to predict the performance of the
system for 18F, 11C, 15O, 13N, 82Rb, 68Ga and to evaluate the effect
of the 3T-MR field on positron range in different tissue types (lung
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tissue, soft tissue and bone). We confirmed a strong tissue dependency
of positron range as shown in Figure 4.9. The effect of the magnetic field
is also clearly seen throughout the different radioisotopes and different
tissues, although it is much more prominent for high energy emitters
is less dense tissues. As expected, there is also an effect of the 3T
magnetic field on isotopes with a higher positron energy isotopes range.
This effect strongly reduces the positron range by a factor of 3-4 in
the transverse plane (x/y) perpendicular to the magnetic field resulting
in a significantly increased density distribution in z-direction. While
significant changes are seen in the transversal plane, the magnetic field
does not have an impact on the positron range in the axial direction,
which is the same direction as the MR field. Because of the limited
spatial resolution of 4 mm of the PET detector, this transverse positron
range reduction effect will be only partially observed in the resolution
properties of the PET/MR system.
In Chapter 5, we discussed the accurate quantitation (SUV - Stan-
dardized Uptake Value) in PET imaging and the significant challenge
with delivering consistently accurate SUV measurements in PET imag-
ing. Q.Clear is a block sequential regularized expectation maximiza-
tion (BSREM) penalized-likelihood reconstruction algorithm for PET.
It tries to improve image quality by controlling noise amplification dur-
ing image reconstruction. In this chapter, the noise properties of this
BSREM were compared to the ordered-subset expectation maximiza-
tion (OSEM) algorithm for both phantom and patient data acquired
on a state-of-the-art PET/CT. All data were acquired on a digital GE
Discovery MI PET/CT (DMI) system, installed in Ghent University
Hospital, Belgium. To access this issue, the performance and clinical
use of BSREM was compared to OSEM with full modelling of PSF and
TOF information for both algorithms acquired on the Discovery MI with
3-rings (axial FOV of 15 cm). Both phantom and patient data were ana-
lyzed with regards to CR, background COV, CNR, SUV ratio, metabolic
active tumour volumes (MATVs) and SNR. This study aimed to evaluate
different β-factors compared to a clinical post-filter kernel for different
datasets with varying noise levels to investigate whether and to what
extent noise can be reduced by using BSREM instead of OSEM.
In the first part, the method is described in detail. The NEMA IQ
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phantom and a whole-body patient study were acquired on a GE DMI
3-rings system in list mode and different datasets with varying noise
levels were generated. Phantom data was evaluated using four different
contrast ratios (8:1, 6:1, 4:1 and 2:1). These were reconstructed using
BSREM with different β-factors of 300, 400, 500, 600, 750, 1000, 1500
and 3000 and with a clinical setting (3 iterations, 16 subsets with 5.0
mm FWHM) used for OSEM including point spread function (PSF) and
time-of-flight (TOF) information. Contrast recovery (CR), background
noise levels (coefficient of variation, COV), and contrast-to-noise ratio
(CNR) were used to determine the performance in the phantom data.
Findings based on the phantom data were compared with clinical data.
For the patient study, the SUV ratio, metabolic active tumour volumes
(MATVs), and the signal-to-noise ratio (SNR) were evaluated using the
liver as the background region.
The results of the phantom data were presented in subsection 5.3.1
and discussed in the final part of this chapter. Two major parts were
discussed. The first part is regarding the Contrast Recovery. Based
on the phantom data for the same count statistics, BSREM resulted
in higher CR and CNR and lower COV than OSEM. In all plots, we
observed a similar trend: the contrast increases when reducing the β-
factor and the COV decreases as β increases in value. We found the
CR of BSREM with β = 750 that matches to the CR of OSEM at high
count statistics for 8:1. A similar trend was observed for the ratios 6:1
and 4:1.
A dependence on sphere size, counting statistics, and contrast ratio
were confirmed by the CNR of the ratio 2:1. For the largest spheres (37,
28, 22 and 17 mm), the CR seems to reach a steady value, where its
dependence on the β-parameter decreases. As the sphere size decreases,
the convergence of the BSREM reconstructions appears to be dependent
on the sphere size. The difference relative to OSEM for each sphere sizes
as a function of the β-parameter is shown in Figure 5.2. Additionally,
for the phantom data with low count statistics, we also observed that
the CR of BSREM reconstructions reaches a plateau with only a small
gain when changing β from 500 to 300. Comparing CR of BSREM for
different levels of regularization to the CR of OSEM, reveals higher (or
at least similar) contrast recovery for β parameters down to 300, except
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for the smallest sphere.
The second part is regarding the Noise properties. For reduced count
statistics of the contrast 8:1 (reducing the acquisition time from 20 to 10,
5.0, 2.5 and 1.0 min), BSREM has in general lower COV than OSEM.
Moreover, OSEM was more sensitive to noise compared to BSREM with
large differences in COV between the different noise levels for OSEM
setting. BSREM with β = 750 for 2.5 and 1.0 min acquisition has
comparable COV to the 10 and 5.0 min acquisitions using OSEM. The
background COV comparison to OSEM is shown in Table 5.2. The COV
of OSEM (20 min) is worse than the COV of BSREM with β =750 for
20, 10 min and 5 min. The COV of OSEM (10 min) is worse than the
COV of BSREM with β =750 for 10, 5.0 and 2.5 min. This resulted
in a noise reduction by a factor of 2–4 when using BSREM instead of
OSEM.
For the patient data, a 71-year-old patient with multiple B-cell lym-
phoma lesions of different sizes was selected for this study. The patient
fasted at least 6 h before receiving an intravenous application of 340
MBq of 18F-FDG. The total acquisition time (9-time lengths per bed-
position) was 10 min (1.07 min/bp). From this dataset, scans of 5.0 min
(0.34 min/bp) and 2.5 min (0.17 min/bp) were generated in list-mode.
The TOF-PSF-OSEM image with post-smoothing with a 5.0 mm filter
was chosen as reference lesion volumes (VOIs). Finally, the VOIs were
delineated using the 41% threshold of the maximum voxel value and
then propagated to the BSREM reconstructions.
The results were presented in the last part of this chapter. We ob-
served a similar trend to the phantom data. SNR was reduced by at least
a factor of 2 while preserving contrast. In agreement with phantom data
analysis, BSREM outperformed OSEM reconstructions in terms of noise
levels with a lower noise level. Also, the largest difference is seen for big-
ger lesions where reduced noise is combined with higher contrast. The
quantitatively measured values of the reference VOIs are shown in Ta-
ble 5.3. Regarding the noise properties, the noise in the liver of OSEM
reconstruction (10 min) is worse than the noise of BSREM with β =750
for 10 min, 5.0 min and is comparable to 2.5 min. Lower noise can be
observed for BSREM in all other cases (also when lowering the counts
with a factor 4). This leads to a noise reduction in the liver by a fac-
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tor of 4. The SNR of BSREM with β =750 and OSEM reconstruction
are also shown in Table 5.4 for different count levels. However, under
the condition of higher count statistics, the combination of TOF-PSF-
OSEM would lead to a comparable lesion detectability to BSREM, but if
OSEM reconstruction is adopted, caution should also be taken regarding
the increase of noise with the increase of the number of iterations.
In general, BSREM outperforms OSEM reconstructions allowing
noise reduction by a factor of 2-4 without losing data information. This
would allow clinicians to reduce the PET activity/acquisition time needed
for many exams, benefiting especially young patients.
6.2 Future perspectives
This is the first published NEMA PET performance measurement and
characteristic for different clinically relevant and commercially available
isotopes. NEMA procedures are intended for characterizing a PET imag-
ing system. However, NEMA test has some major limitations. The spa-
tial resolution results presented in Chapter3 were affected by the mean
MR field. An alternative approach to measuring the SR using molecular
sieve instead of capillary glasses was proposed for 68Ga SR measure-
ments (see Figure 3.1). This approach has shown an improvement of
9.1% and 19.2% at 1 cm and 10 cm off centre for 68Ga measurements.
It confirms that the NEMA SR test needs to be adapted. As we pointed
out, the branching ratio can be used to predict theoretical sensitivities
for the different isotopes. But the NECR predictions are more difficult
than the sensitivity test. NECR is highly dependent on block deadtime
with prompt gammas affecting the deadtime, even if their energy does
not fall within the energy window. Therefore, the high-energy gamma
from 82Rb and 68Ga will affect the NECR. A way to quantify the qual-
ity of the system timing resolution is to perform the TOF test method,
first introduced by Wang et al. [157] and later on included in the latest
version of the NEMA NU 2-2018 protocol [46]. This method uses the
list-mode data acquired during the standard NEMA NECR measure-
ments for timing resolution characterization. Although NEMA NU 2-
2018 protocol only recommend to use 18F for this measurement, it would
128 6 Conclusion and future perspectives
be of great scientific interest to measure the TOF resolution for 82Rb,
68Ga and 90Y and plotting timing resolution (in ps) versus the activity
concentration (in kBq/ml). Since there are no count rate performance
data reported in this book for 90Y, it would be interesting to perform the
NECR test for 90Y. The line source could remain in the scatter phantom
for several weeks, and every day, be repositioned for a frame of acqui-
sition. However, it is recommended to use specific activities and acqui-
sition times similar to that of clinical whole-body 18F-FDG, instead to
counterbalance by increasing acquisition times [158]. Additional NEMA
tests such as image quality may be necessary when resolving PET signal
in air tissue boundary such as lung nodules with high-energy positron
emitters. Certainly, we do not recommend that all sites measure all ra-
dionuclides they use with the NEMA NU 2 approach. If sites want some
intuition how that would extend to other radionuclides, then they would
reference publications in this book. Furthermore, a secondary conclu-
sion of this thesis is drawn regarding the effect of the magnetic field on
the measurements/simulations and this study has been limited to a 3T
magnetic field of the GE Signa PET/MR. In terms of literature data,
a direct comparison of resolution measurements between PET/CT and
PET/MR is available but only for 18F. Although it is not a straight-
forward comparison because PET/CT systems have larger PET ring
diameters, it would be interesting to compare both systems in terms of
RC and contrast rations for the different radioisotope. That is why the
results presented in this book are useful. With the GATE-model of the
GE Signal Integrated PET/MR, it is possible to simulate the NEMA
performance without 3T and with different magnetic field strengths and
to evaluate the performance of different reconstruction algorithms using
time-of-flight.
The noise reduction results presented in Chapter 5, should be ex-
plored for other applications. In PET centres with different PET sys-
tems or a multicenter setting, the resolution of different PET systems
is generally harmonized for clinical use and optimal exchange of patient
data. We found a beta value that matches the resolution of an OSEM
reconstruction using 3 iterations, 16 subsets, and a 5 mm FWHM Gaus-
sian postfilter. As such, we could compare in detail the noise character-
istics of OSEM and BSREM reconstructions while both reconstruction
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approaches were matched in terms of resolution. Findings showed that
BSREM reconstruction algorithm allowed a noise reduction without a
loss of contrast by a factor of 2-4 compared to OSEM reconstructions
for all data evaluated. This reduction can be used to lower the injected
dose or shorten the acquisition time. However, the patient data used
for this study is very limited. Even though we choose for this study a
patient with multiple B-cell lymphoma lesions of different sizes (in line
with the sphere sizes of the image quality phantom) the analysis of a
larger and diverse group of number patients, would be interesting to
reconfirm findings. Conducting observational research in different clini-
cal centres using patient with small lesions (< 0.5 ml) for a diagnostic
test is another way to reconfirm (the dependence on sphere size) with
our phantom study. Besides the noise reduction using a more advanced
reconstruction approach, it would be very interesting to study the use
of deep learning network training to improve noise characteristics. This
would be especially valuable for the development and validation of new
image reconstruction methods based on deep learning.
6.3 Conclusion
In this thesis, we have evaluated the system performance and image qual-
ity of state-of-the-art PET/CT and PET/MR systems for different PET
isotopes. The system performance of GE Signa integrated PET/MR
was substantially different, in terms of NEMA spatial resolution, image
quality, and NECR for 68Ga and 90Y compared to 18F. On the other
hand, the larger positron range of PET radioisotopes emitting higher
energy positrons was affected by the presence of a 3T MR field in case
of PET/MR. Subsequently, we used GATE Monte-Carlo simulations to
predict sensitivity and NECR performance of GE Signa PET/MR for
18F, 11C, 15O, 13N, 82Rb and 68Ga radioisotopes. Differences in sensitiv-
ity are in line with the different branching ratios for positron emissions
of the different PET isotopes. 82Rb and 68Ga NECR values are affected
by deadtime effects because of more random and scatter events due to
prompt gamma emissions. Finally, the Penalized-Likelihood BSREM
reconstruction improves image quality compared to standard OSEM re-
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constructions and allows noise reduction by a factor 2-4 while preserving
contrast. Therefore, lowering of the injected dose or shortening the ac-
quisition time is possible without a loss in image quality by introducing
regularization in the image reconstruction. Therefore, the results of
this thesis will allow clinicians to reduce the PET dose which is espe-
cially relevant for young patients. Besides, MC simulation platform for
PET/MR developed for this thesis will allow physicists and engineers to
better understand and design integrated PET/MR systems.
A
Decay schemes of
radioisotopes for PET
In this appendix, we provide formal decay schemes of different radioiso-
topes.
18F (T1/2 = 109.7 min)
18O (stable)
𝛽!
0.634 MeV
96.86%
𝜀 (EC)
3.14%
Fig. A.1: Fluorine-18( 18F)
11C (T1/2 = 20.4 min)
11B (stable)
𝛽!
0.960 MeV
99.75%
𝜀 (EC)
0.25%
Fig. A.2: Carbon-11 (11C)
15O (T1/2 = 2.04 min)
15N (stable)
𝛽!
1.732 MeV
99.89%
𝜀 (EC)
0.11%
Fig. A.3: Oxygen-15 (15O)
13N (T1/2 = 9.9 min)
13C (stable)
𝛽!
1.199 MeV
99.82%
𝜀 (EC)
0.18%
Fig. A.4: Nitrogen-13 (13N)
82Rb (T1/2 = 1.3 min)
82Kr (stable)
𝛽!
3.381 MeV
81.81%
𝜀	and 𝛽!	
3.01%
𝜀	and 𝛽!	
1.06% 𝛽!
2.605 MeV
13.10%
𝛾
0.777 MeV
15.1%
Fig. A.5: Rubidium-82 (82Rb)
Fig. A.6: Yttrium-90 (90Y)
68Ga (T1/2 = 67.7 min)
68Zn (stable)
𝛽!
1.899 MeV
87.68%
𝜀 (EC)
8.94%
𝜀 (EC)
1.80% 𝛽!
821.7 MeV
1.20%
𝛾
1.077 MeV
3.2%
Fig. A.7: Gallium-68 (68Ga)
B
Clinical evaluation
Complete evaluation of reconstruction algorithm performance requires
task-based assessment of image quality under broad imaging conditions.
Quantitative figures of merit for lesion SNR, contrast, and noise were
used as described here.
Lesion SNR
For each lesion, the SNR was computed as the difference between the
mean lesion and liver SUVmean, compared to the liver noise.
SNR = SUVLesion,mean − SUVLiver,mean
SUVLiver,σ
(B.1)
where SUVliver,mean and SUVLiver,σ are the mean and standard devia-
tion, respectively, of a 5 cm3 VOI placed in a healthy liver zone. The
VOIs were delineated using the a 41% threshold of the maximum voxel
value.
Contrast
The contrast was defined as:
Contrast = SUVLesion,mean
SUVLiver,mean
(B.2)
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TLG
The total lesion glycolysis was defined as:
TLG = SUVLesion,mean × V OILesion (B.3)
Noise
The noise was defined as:
Noise = SUVLiver,σ
SUVLiver,mean
(B.4)
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